CONSOLIDATED SCHEDULE OF INVESTMENTS £ in Thousands, $ in Thousands |
6 Months Ended |
12 Months Ended |
|
|
Jun. 30, 2024
USD ($)
shares
|
Dec. 31, 2023
USD ($)
shares
|
Jun. 30, 2024
GBP (£)
shares
|
Dec. 31, 2023
GBP (£)
shares
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment, basis spread, variable rate |
|
8.50%
|
|
8.50%
|
|
8.50%
|
|
8.50%
|
|
Investment cost |
|
$ 3,609,118
|
|
$ 3,247,033
|
|
|
|
|
|
Investments, at fair value: |
|
3,568,539
|
|
$ 3,248,046
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Series Class A Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
238
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 156
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Dec. 27, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
69,239
|
|
|
|
69,239
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Electronics & Computer Hardware (1.05%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.05%
|
|
|
|
1.05%
|
|
Investment cost |
[5] |
|
|
$ 18,348
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 18,982
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2026-06
|
|
|
|
2026-06
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
8.00%
|
|
|
|
8.00%
|
|
Investment exit fee |
[6],[7] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Principal amount |
[6] |
|
|
$ 18,281
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
18,348
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 18,982
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Manufacturing Technology (0.44%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.44%
|
|
|
|
0.44%
|
|
Investment cost |
[5] |
|
|
$ 8,064
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 8,006
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Medical Devices & Equipment (1.20%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.20%
|
|
|
|
1.20%
|
|
Investment cost |
[5] |
|
|
$ 21,572
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 21,572
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Biotechnology Tools (2.66%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
2.66%
|
|
|
|
2.66%
|
|
Investment cost |
[5] |
|
|
$ 47,010
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 48,027
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Biotechnology Tools and Alamar Biosciences, Inc., Senior Secured, June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9] |
|
|
2026-06
|
|
|
|
2026-06
|
|
Investment, basis spread, variable rate |
[7],[8],[9] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Investment, interest rate, floor |
[7],[8],[9] |
|
|
6.50%
|
|
|
|
6.50%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9] |
|
|
1.00%
|
|
|
|
1.00%
|
|
Investment exit fee |
[7],[8],[9] |
|
|
5.95%
|
|
|
|
5.95%
|
|
Principal amount |
[8],[9] |
|
|
$ 15,049
|
|
|
|
|
|
Investment cost |
[5],[8],[9] |
|
|
15,069
|
|
|
|
|
|
Investments, at fair value: |
[8],[9] |
|
|
$ 15,508
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Biotechnology Tools and PathAI, Inc., Senior Secured, January 2027, Prime + 2.15%, Floor rate 9.15%, 9.81% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10] |
|
|
2027-01
|
|
|
|
2027-01
|
|
Investment, basis spread, variable rate |
[7],[10] |
|
|
2.15%
|
|
|
|
2.15%
|
|
Investment, interest rate, floor |
[7],[10] |
|
|
9.15%
|
|
|
|
9.15%
|
|
Investment exit fee |
[7],[10] |
|
|
9.81%
|
|
|
|
9.81%
|
|
Principal amount |
[10] |
|
|
$ 32,000
|
|
|
|
|
|
Investment cost |
[5],[10] |
|
|
31,941
|
|
|
|
|
|
Investments, at fair value: |
[10] |
|
|
$ 32,519
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Communications & Networking and (1.62%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.62%
|
|
|
|
1.62%
|
|
Investment cost |
[5] |
|
|
$ 28,182
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 29,272
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Communications & Networking and Aryaka Networks, Inc., Senior Secured, July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[10] |
|
|
2026-07
|
|
|
|
2026-07
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[10] |
|
|
3.25%
|
|
|
|
3.25%
|
|
Investment, interest rate, floor |
[6],[7],[8],[10] |
|
|
6.75%
|
|
|
|
6.75%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[10] |
|
|
1.05%
|
|
|
|
1.05%
|
|
Investment exit fee |
[6],[7],[8],[10] |
|
|
3.55%
|
|
|
|
3.55%
|
|
Principal amount |
[6],[8],[10] |
|
|
$ 25,153
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[10] |
|
|
24,943
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[10] |
|
|
$ 26,000
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Communications & Networking and Cytracom Holdings LLC, Senior Secured, February 2025, 3-month SOFR + 9.72%, Floor rate 10.62% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[12],[13] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[7],[11],[12],[13] |
|
|
9.72%
|
|
|
|
9.72%
|
|
Investment, interest rate, floor |
[7],[11],[12],[13] |
|
|
10.62%
|
|
|
|
10.62%
|
|
Principal amount |
[11],[12],[13] |
|
|
$ 3,267
|
|
|
|
|
|
Investment cost |
[5],[11],[12],[13] |
|
|
3,239
|
|
|
|
|
|
Investments, at fair value: |
[11],[12],[13] |
|
|
$ 3,272
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services (28.24%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
28.24%
|
|
|
|
28.24%
|
|
Investment cost |
[5] |
|
|
$ 507,063
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 509,053
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Altumint, Inc., Senior Secured, December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[14] |
|
|
2027-12
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[7],[12],[14] |
|
|
3.65%
|
|
|
|
3.65%
|
|
Investment, interest rate, floor |
[7],[12],[14] |
|
|
12.15%
|
|
|
|
12.15%
|
|
Investment exit fee |
[7],[12],[14] |
|
|
2.50%
|
|
|
|
2.50%
|
|
Principal amount |
[12],[14] |
|
|
$ 10,000
|
|
|
|
|
|
Investment cost |
[5],[12],[14] |
|
|
9,905
|
|
|
|
|
|
Investments, at fair value: |
[12],[14] |
|
|
$ 9,905
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and AppDirect, Inc., Senior Secured, April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10] |
|
|
2026-04
|
|
|
|
2026-04
|
|
Investment, basis spread, variable rate |
[7],[10] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, interest rate, floor |
[7],[10] |
|
|
8.75%
|
|
|
|
8.75%
|
|
Investment exit fee |
[7],[10] |
|
|
7.12%
|
|
|
|
7.12%
|
|
Principal amount |
[10] |
|
|
$ 55,790
|
|
|
|
|
|
Investment cost |
[5],[10] |
|
|
57,653
|
|
|
|
|
|
Investments, at fair value: |
[10] |
|
|
$ 59,507
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Carwow LTD, Senior Secured, December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[15],[16] |
|
|
2024-12
|
|
|
|
2024-12
|
|
Investment, basis spread, variable rate |
[7],[8],[15],[16] |
|
|
4.70%
|
|
|
|
4.70%
|
|
Investment, interest rate, floor |
[7],[8],[15],[16] |
|
|
7.95%
|
|
|
|
7.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[15],[16] |
|
|
1.45%
|
|
|
|
1.45%
|
|
Investment exit fee |
[7],[8],[15],[16] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Principal amount | £ |
[8],[15],[16] |
|
|
|
|
|
|
£ 19,146
|
|
Investment cost |
[5],[8],[15],[16] |
|
|
$ 26,834
|
|
|
|
|
|
Investments, at fair value: |
[8],[15],[16] |
|
|
$ 25,157
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 8.50% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[17] |
|
|
2028-05
|
|
|
|
2028-05
|
|
Investment, interest rate, paid in kind |
[7],[8],[17] |
|
|
8.50%
|
|
|
|
8.50%
|
|
Principal amount |
[8],[17] |
|
|
$ 23,340
|
|
|
|
|
|
Investment cost |
[5],[8],[17] |
|
|
23,340
|
|
|
|
|
|
Investments, at fair value: |
[8],[17] |
|
|
$ 23,244
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[16] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[7],[15],[16] |
|
|
8.86%
|
|
|
|
8.86%
|
|
Investment, interest rate, floor |
[7],[15],[16] |
|
|
9.75%
|
|
|
|
9.75%
|
|
Investment exit fee |
[7],[15],[16] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[15],[16] |
|
|
$ 14,000
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
14,095
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 14,259
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[15],[16] |
|
|
2026-10
|
|
|
|
2026-10
|
|
Investment, basis spread, variable rate |
[7],[12],[15],[16] |
|
|
2.55%
|
|
|
|
2.55%
|
|
Investment, interest rate, floor |
[7],[12],[15],[16] |
|
|
11.05%
|
|
|
|
11.05%
|
|
Investment exit fee |
[7],[12],[15],[16] |
|
|
2.95%
|
|
|
|
2.95%
|
|
Principal amount |
[12],[15],[16] |
|
|
$ 875
|
|
|
|
|
|
Investment cost |
[5],[12],[15],[16] |
|
|
853
|
|
|
|
|
|
Investments, at fair value: |
[12],[15],[16] |
|
|
$ 853
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Provi, Senior Secured, December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2026-12
|
|
|
|
2026-12
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
4.40%
|
|
|
|
4.40%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
10.65%
|
|
|
|
10.65%
|
|
Investment exit fee |
[7],[14] |
|
|
2.95%
|
|
|
|
2.95%
|
|
Principal amount |
[14] |
|
|
$ 15,000
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
14,904
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 15,046
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[14] |
|
|
2026-12
|
|
|
|
2026-12
|
|
Investment, basis spread, variable rate |
[7],[8],[9],[14] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, interest rate, floor |
[7],[8],[9],[14] |
|
|
6.50%
|
|
|
|
6.50%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[14] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Principal amount |
[8],[9],[14] |
|
|
$ 28,876
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[14] |
|
|
28,404
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[14] |
|
|
$ 28,888
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Rhino Labs, Inc., Senior Secured, June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[14] |
|
|
2024-06
|
|
|
|
2024-06
|
|
Investment, basis spread, variable rate |
[7],[8],[14] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, interest rate, floor |
[7],[8],[14] |
|
|
8.75%
|
|
|
|
8.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[14] |
|
|
2.25%
|
|
|
|
2.25%
|
|
Principal amount |
[8],[14] |
|
|
$ 4,710
|
|
|
|
|
|
Investment cost |
[5],[8],[14] |
|
|
4,704
|
|
|
|
|
|
Investments, at fair value: |
[8],[14] |
|
|
$ 4,704
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Riviera Partners LLC, Senior Secured, April 2027, 3-month SOFR + 8.26%, Floor rate 9.26% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2027-04
|
|
|
|
2027-04
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
8.26%
|
|
|
|
8.26%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
9.26%
|
|
|
|
9.26%
|
|
Principal amount |
[12],[13] |
|
|
$ 36,868
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
36,339
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 34,659
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10],[18] |
|
|
2026-07
|
|
|
|
2026-07
|
|
Investment, basis spread, variable rate |
[7],[8],[10],[18] |
|
|
2.50%
|
|
|
|
2.50%
|
|
Investment, interest rate, floor |
[7],[8],[10],[18] |
|
|
10.75%
|
|
|
|
10.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10],[18] |
|
|
0.50%
|
|
|
|
0.50%
|
|
Investment exit fee |
[7],[8],[10],[18] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[8],[10],[18] |
|
|
$ 77,642
|
|
|
|
|
|
Investment cost |
[5],[8],[10],[18] |
|
|
77,170
|
|
|
|
|
|
Investments, at fair value: |
[8],[10],[18] |
|
|
$ 79,119
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[11],[18] |
|
|
2026-05
|
|
|
|
2026-05
|
|
Investment, basis spread, variable rate |
[7],[8],[11],[18] |
|
|
7.00%
|
|
|
|
7.00%
|
|
Investment, interest rate, floor |
[7],[8],[11],[18] |
|
|
10.50%
|
|
|
|
10.50%
|
|
Investment, interest rate, paid in kind |
[7],[8],[11],[18] |
|
|
0.50%
|
|
|
|
0.50%
|
|
Investment exit fee |
[7],[8],[11],[18] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Principal amount |
[8],[11],[18] |
|
|
$ 25,199
|
|
|
|
|
|
Investment cost |
[5],[8],[11],[18] |
|
|
25,126
|
|
|
|
|
|
Investments, at fair value: |
[8],[11],[18] |
|
|
$ 25,869
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Skyword, Inc., Senior Secured, November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9] |
|
|
2026-11
|
|
|
|
2026-11
|
|
Investment, basis spread, variable rate |
[7],[8],[9] |
|
|
2.75%
|
|
|
|
2.75%
|
|
Investment, interest rate, floor |
[7],[8],[9] |
|
|
9.25%
|
|
|
|
9.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9] |
|
|
1.75%
|
|
|
|
1.75%
|
|
Investment exit fee |
[7],[8],[9] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[8],[9] |
|
|
$ 9,169
|
|
|
|
|
|
Investment cost |
[5],[8],[9] |
|
|
9,189
|
|
|
|
|
|
Investments, at fair value: |
[8],[9] |
|
|
$ 9,311
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Tectura Corporation, Senior Secured, July 2024, FIXED 8.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[19] |
|
|
2024-07
|
|
|
|
2024-07
|
|
Investment, interest rate, paid in cash |
[7],[19] |
|
|
8.25%
|
|
|
|
8.25%
|
|
Principal amount |
[19] |
|
|
$ 8,250
|
|
|
|
|
|
Investment cost |
[5],[19] |
|
|
8,250
|
|
|
|
|
|
Investments, at fair value: |
[19] |
|
|
$ 8,250
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Thumbtack, Inc., Senior Secured, April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10],[12] |
|
|
2026-04
|
|
|
|
2026-04
|
|
Investment, basis spread, variable rate |
[7],[8],[10],[12] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Investment, interest rate, floor |
[7],[8],[10],[12] |
|
|
8.20%
|
|
|
|
8.20%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10],[12] |
|
|
1.50%
|
|
|
|
1.50%
|
|
Investment exit fee |
[7],[8],[10],[12] |
|
|
3.95%
|
|
|
|
3.95%
|
|
Principal amount |
[8],[10],[12] |
|
|
$ 10,258
|
|
|
|
|
|
Investment cost |
[5],[8],[10],[12] |
|
|
10,317
|
|
|
|
|
|
Investments, at fair value: |
[8],[10],[12] |
|
|
10,639
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total SeatGeek, Inc |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
102,841
|
|
|
|
|
|
Investment cost |
[5] |
|
|
102,296
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
104,988
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total Veem, Inc., |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
10,217
|
|
|
|
|
|
Investment cost |
[5] |
|
|
10,365
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
10,516
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total Worldremit Group Limited |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
94,500
|
|
|
|
|
|
Investment cost |
[5] |
|
|
95,626
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 95,997
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Udacity, Inc., Senior Secured, September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10] |
|
|
2024-09
|
|
|
|
2024-09
|
|
Investment, basis spread, variable rate |
[7],[8],[10] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Investment, interest rate, floor |
[7],[8],[10] |
|
|
7.75%
|
|
|
|
7.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10] |
|
|
2.00%
|
|
|
|
2.00%
|
|
Investment exit fee |
[7],[8],[10] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[8],[10] |
|
|
$ 53,000
|
|
|
|
|
|
Investment cost |
[5],[8],[10] |
|
|
53,989
|
|
|
|
|
|
Investments, at fair value: |
[8],[10] |
|
|
$ 53,130
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9] |
|
|
2025-03
|
|
|
|
2025-03
|
|
Investment, basis spread, variable rate |
[7],[8],[9] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Investment, interest rate, floor |
[7],[8],[9] |
|
|
7.25%
|
|
|
|
7.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9] |
|
|
1.25%
|
|
|
|
1.25%
|
|
Investment exit fee |
[7],[8],[9] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Principal amount |
[8],[9] |
|
|
$ 5,107
|
|
|
|
|
|
Investment cost |
[5],[8],[9] |
|
|
5,176
|
|
|
|
|
|
Investments, at fair value: |
[8],[9] |
|
|
$ 5,230
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10] |
|
|
2025-03
|
|
|
|
2025-03
|
|
Investment, basis spread, variable rate |
[7],[8],[10] |
|
|
4.70%
|
|
|
|
4.70%
|
|
Investment, interest rate, floor |
[7],[8],[10] |
|
|
7.95%
|
|
|
|
7.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10] |
|
|
1.50%
|
|
|
|
1.50%
|
|
Investment exit fee |
[7],[8],[10] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Principal amount |
[8],[10] |
|
|
$ 5,110
|
|
|
|
|
|
Investment cost |
[5],[8],[10] |
|
|
5,189
|
|
|
|
|
|
Investments, at fair value: |
[8],[10] |
|
|
$ 5,286
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[15],[16],[18] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[6],[7],[15],[16],[18] |
|
|
9.35%
|
|
|
|
9.35%
|
|
Investment, interest rate, floor |
[6],[7],[15],[16],[18] |
|
|
10.25%
|
|
|
|
10.25%
|
|
Investment exit fee |
[6],[7],[15],[16],[18] |
|
|
3.20%
|
|
|
|
3.20%
|
|
Principal amount |
[6],[15],[16],[18] |
|
|
$ 6,250
|
|
|
|
|
|
Investment cost |
[5],[6],[15],[16],[18] |
|
|
6,308
|
|
|
|
|
|
Investments, at fair value: |
[6],[15],[16],[18] |
|
|
$ 6,344
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[10],[11],[15],[16],[18] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[6],[7],[10],[11],[15],[16],[18] |
|
|
9.40%
|
|
|
|
9.40%
|
|
Investment, interest rate, floor |
[6],[7],[10],[11],[15],[16],[18] |
|
|
10.25%
|
|
|
|
10.25%
|
|
Investment exit fee |
[6],[7],[10],[11],[15],[16],[18] |
|
|
3.20%
|
|
|
|
3.20%
|
|
Principal amount |
[6],[10],[11],[15],[16],[18] |
|
|
$ 88,250
|
|
|
|
|
|
Investment cost |
[5],[6],[10],[11],[15],[16],[18] |
|
|
89,318
|
|
|
|
|
|
Investments, at fair value: |
[6],[10],[11],[15],[16],[18] |
|
|
$ 89,653
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services (3.17%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
3.17%
|
|
|
|
3.17%
|
|
Investment cost |
[5] |
|
|
$ 56,764
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 57,096
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, September 2026, FIXED 11.50% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[19],[20] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, interest rate, paid in cash |
[7],[19],[20] |
|
|
11.50%
|
|
|
|
11.50%
|
|
Principal amount |
[19],[20] |
|
|
$ 25,000
|
|
|
|
|
|
Investment cost |
[5],[19],[20] |
|
|
24,663
|
|
|
|
|
|
Investments, at fair value: |
[19],[20] |
|
|
$ 24,663
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, September 2026, FIXED 11.95% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[19],[20] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, interest rate, paid in cash |
[7],[19],[20] |
|
|
11.95%
|
|
|
|
11.95%
|
|
Principal amount |
[19],[20] |
|
|
$ 10,000
|
|
|
|
|
|
Investment cost |
[5],[19],[20] |
|
|
9,815
|
|
|
|
|
|
Investments, at fair value: |
[19],[20] |
|
|
$ 9,815
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Hercules Adviser LLC, Unsecured, June 2025, FIXED 5.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[19],[21] |
|
|
2025-06
|
|
|
|
2025-06
|
|
Investment, interest rate, paid in cash |
[7],[19],[21] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Principal amount |
[19],[21] |
|
|
$ 12,000
|
|
|
|
|
|
Investment cost |
[5],[19],[21] |
|
|
12,000
|
|
|
|
|
|
Investments, at fair value: |
[19],[21] |
|
|
$ 12,000
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Next Insurance, Inc., Senior Secured, February 2028, Prime - (1.50%), Floor rate 4.75%, PIK Interest 5.50% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[12] |
|
|
2028-02
|
|
|
|
2028-02
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[12] |
|
|
(1.50%)
|
|
|
|
(1.50%)
|
|
Investment, interest rate, floor |
[6],[7],[8],[12] |
|
|
4.75%
|
|
|
|
4.75%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[12] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Principal amount |
[6],[8],[12] |
|
|
$ 10,469
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[12] |
|
|
10,286
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[12] |
|
|
10,618
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Total Gibraltar Acquisition, LLC |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
35,000
|
|
|
|
|
|
Investment cost |
[5] |
|
|
34,478
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 34,478
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development (66.60%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
66.60%
|
|
|
|
66.60%
|
|
Investment cost |
[5] |
|
|
$ 1,184,022
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 1,200,667
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and ATAI Life Sciences N.V., Senior Secured, August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[16] |
|
|
2026-08
|
|
|
|
2026-08
|
|
Investment, basis spread, variable rate |
[7],[15],[16] |
|
|
4.55%
|
|
|
|
4.55%
|
|
Investment, interest rate, floor |
[7],[15],[16] |
|
|
8.55%
|
|
|
|
8.55%
|
|
Investment exit fee |
[7],[15],[16] |
|
|
6.95%
|
|
|
|
6.95%
|
|
Principal amount |
[15],[16] |
|
|
$ 10,500
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
10,695
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 10,904
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Akero Therapeutics, Inc., Senior Secured, January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12],[16] |
|
|
2027-01
|
|
|
|
2027-01
|
|
Investment, basis spread, variable rate |
[7],[9],[12],[16] |
|
|
3.65%
|
|
|
|
3.65%
|
|
Investment, interest rate, floor |
[7],[9],[12],[16] |
|
|
7.65%
|
|
|
|
7.65%
|
|
Investment exit fee |
[7],[9],[12],[16] |
|
|
5.85%
|
|
|
|
5.85%
|
|
Principal amount |
[9],[12],[16] |
|
|
$ 12,500
|
|
|
|
|
|
Investment cost |
[5],[9],[12],[16] |
|
|
12,525
|
|
|
|
|
|
Investments, at fair value: |
[9],[12],[16] |
|
|
$ 13,065
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Aldeyra Therapeutics, Inc., Senior Secured, October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[11] |
|
|
2024-10
|
|
|
|
2024-10
|
|
Investment, basis spread, variable rate |
[7],[11] |
|
|
3.10%
|
|
|
|
3.10%
|
|
Investment, interest rate, floor |
[7],[11] |
|
|
8.60%
|
|
|
|
8.60%
|
|
Investment exit fee |
[7],[11] |
|
|
8.90%
|
|
|
|
8.90%
|
|
Principal amount |
[11] |
|
|
$ 15,000
|
|
|
|
|
|
Investment cost |
[5],[11] |
|
|
15,152
|
|
|
|
|
|
Investments, at fair value: |
[11] |
|
|
$ 15,152
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Alladapt Immunotherapeutics Inc., Senior Secured, September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[7],[9] |
|
|
3.65%
|
|
|
|
3.65%
|
|
Investment, interest rate, floor |
[7],[9] |
|
|
8.40%
|
|
|
|
8.40%
|
|
Investment, interest rate, cap |
[7],[9] |
|
|
10.90%
|
|
|
|
10.90%
|
|
Investment exit fee |
[7],[9] |
|
|
5.30%
|
|
|
|
5.30%
|
|
Principal amount |
[9] |
|
|
$ 35,000
|
|
|
|
|
|
Investment cost |
[5],[9] |
|
|
35,173
|
|
|
|
|
|
Investments, at fair value: |
[9] |
|
|
$ 36,855
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2027-01
|
|
|
|
2027-01
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
2.50%
|
|
|
|
2.50%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
9.50%
|
|
|
|
9.50%
|
|
Investment, interest rate, cap |
[7],[14] |
|
|
10.75%
|
|
|
|
10.75%
|
|
Investment exit fee |
[7],[14] |
|
|
5.85%
|
|
|
|
5.85%
|
|
Principal amount |
[14] |
|
|
$ 24,000
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
24,120
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 24,514
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Axsome Therapeutics, Inc., Senior Secured, January 2028, Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[11],[16],[18] |
|
|
2028-01
|
|
|
|
2028-01
|
|
Investment, basis spread, variable rate |
[7],[10],[11],[16],[18] |
|
|
2.20%
|
|
|
|
2.20%
|
|
Investment, interest rate, floor |
[7],[10],[11],[16],[18] |
|
|
9.95%
|
|
|
|
9.95%
|
|
Investment, interest rate, cap |
[7],[10],[11],[16],[18] |
|
|
10.70%
|
|
|
|
10.70%
|
|
Investment exit fee |
[7],[10],[11],[16],[18] |
|
|
5.78%
|
|
|
|
5.78%
|
|
Principal amount |
[10],[11],[16],[18] |
|
|
$ 143,350
|
|
|
|
|
|
Investment cost |
[5],[10],[11],[16],[18] |
|
|
143,646
|
|
|
|
|
|
Investments, at fair value: |
[10],[11],[16],[18] |
|
|
$ 150,255
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[11],[15],[16] |
|
|
2025-07
|
|
|
|
2025-07
|
|
Investment, basis spread, variable rate |
[7],[10],[11],[15],[16] |
|
|
4.55%
|
|
|
|
4.55%
|
|
Investment, interest rate, floor |
[7],[10],[11],[15],[16] |
|
|
8.05%
|
|
|
|
8.05%
|
|
Investment, interest rate, cap |
[7],[10],[11],[15],[16] |
|
|
9.05%
|
|
|
|
9.05%
|
|
Investment exit fee |
[7],[10],[11],[15],[16] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Principal amount |
[10],[11],[15],[16] |
|
|
$ 11,500
|
|
|
|
|
|
Investment cost |
[5],[10],[11],[15],[16] |
|
|
11,880
|
|
|
|
|
|
Investments, at fair value: |
[10],[11],[15],[16] |
|
|
$ 11,783
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and BiomX, INC, Senior Secured, September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[15],[16] |
|
|
2025-09
|
|
|
|
2025-09
|
|
Investment, basis spread, variable rate |
[7],[11],[15],[16] |
|
|
5.70%
|
|
|
|
5.70%
|
|
Investment, interest rate, floor |
[7],[11],[15],[16] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Investment exit fee |
[7],[11],[15],[16] |
|
|
6.55%
|
|
|
|
6.55%
|
|
Principal amount |
[11],[15],[16] |
|
|
$ 6,448
|
|
|
|
|
|
Investment cost |
[5],[11],[15],[16] |
|
|
6,807
|
|
|
|
|
|
Investments, at fair value: |
[11],[15],[16] |
|
|
$ 6,790
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Braeburn, Inc., Senior Secured, October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8] |
|
|
2028-10
|
|
|
|
2028-10
|
|
Investment, basis spread, variable rate |
[7],[8] |
|
|
2.45%
|
|
|
|
2.45%
|
|
Investment, interest rate, floor |
[7],[8] |
|
|
10.95%
|
|
|
|
10.95%
|
|
Investment, interest rate, paid in kind |
[7],[8] |
|
|
1.10%
|
|
|
|
1.10%
|
|
Investment exit fee |
[7],[8] |
|
|
5.45%
|
|
|
|
5.45%
|
|
Principal amount |
[8] |
|
|
$ 52,601
|
|
|
|
|
|
Investment cost |
[5],[8] |
|
|
52,185
|
|
|
|
|
|
Investments, at fair value: |
[8] |
|
|
$ 52,185
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and BridgeBio Pharma, Inc., Senior Secured, November 2026, FIXED 9.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[10] |
|
|
2026-11
|
|
|
|
2026-11
|
|
Investment, interest rate, paid in cash |
[7],[8],[9],[10] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment exit fee |
[7],[8],[9],[10] |
|
|
2.00%
|
|
|
|
2.00%
|
|
Principal amount |
[8],[9],[10] |
|
|
$ 38,167
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[10] |
|
|
38,124
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[10] |
|
|
$ 35,498
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and COMPASS Pathways plc, Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[15],[16] |
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[8],[15],[16] |
|
|
1.50%
|
|
|
|
1.50%
|
|
Investment, interest rate, floor |
[7],[8],[15],[16] |
|
|
9.75%
|
|
|
|
9.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[15],[16] |
|
|
1.40%
|
|
|
|
1.40%
|
|
Investment exit fee |
[7],[8],[15],[16] |
|
|
4.75%
|
|
|
|
4.75%
|
|
Principal amount |
[8],[15],[16] |
|
|
$ 24,144
|
|
|
|
|
|
Investment cost |
[5],[8],[15],[16] |
|
|
23,798
|
|
|
|
|
|
Investments, at fair value: |
[8],[15],[16] |
|
|
$ 24,601
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Cellarity, Inc., Senior Secured, June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[14] |
|
|
2026-06
|
|
|
|
2026-06
|
|
Investment, basis spread, variable rate |
[7],[9],[14] |
|
|
5.70%
|
|
|
|
5.70%
|
|
Investment, interest rate, floor |
[7],[9],[14] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Investment exit fee |
[7],[9],[14] |
|
|
3.75%
|
|
|
|
3.75%
|
|
Principal amount |
[9],[14] |
|
|
$ 29,193
|
|
|
|
|
|
Investment cost |
[5],[9],[14] |
|
|
29,482
|
|
|
|
|
|
Investments, at fair value: |
[9],[14] |
|
|
$ 30,051
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Corium, Inc., Senior Secured, September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[18] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[7],[9],[18] |
|
|
5.70%
|
|
|
|
5.70%
|
|
Investment, interest rate, floor |
[7],[9],[18] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Investment exit fee |
[7],[9],[18] |
|
|
7.75%
|
|
|
|
7.75%
|
|
Principal amount |
[9],[18] |
|
|
$ 105,225
|
|
|
|
|
|
Investment cost |
[5],[9],[18] |
|
|
107,667
|
|
|
|
|
|
Investments, at fair value: |
[9],[18] |
|
|
$ 108,545
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Curevo, Inc., Senior Secured, June 2027, Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2027-06
|
|
|
|
2027-06
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
1.70%
|
|
|
|
1.70%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
9.70%
|
|
|
|
9.70%
|
|
Investment exit fee |
[7],[14] |
|
|
6.95%
|
|
|
|
6.95%
|
|
Principal amount |
[14] |
|
|
$ 10,000
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
9,821
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 10,076
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Eloxx Pharmaceuticals, Inc., Senior Secured, April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2025-04
|
|
|
|
2025-04
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
6.25%
|
|
|
|
6.25%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
9.50%
|
|
|
|
9.50%
|
|
Investment exit fee |
[7],[14] |
|
|
6.55%
|
|
|
|
6.55%
|
|
Principal amount |
[14] |
|
|
$ 3,099
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
3,789
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 3,731
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and G1 Therapeutics, Inc., Senior Secured, November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[11],[14] |
|
|
2026-11
|
|
|
|
2026-11
|
|
Investment, basis spread, variable rate |
[7],[10],[11],[14] |
|
|
5.65%
|
|
|
|
5.65%
|
|
Investment, interest rate, floor |
[7],[10],[11],[14] |
|
|
9.15%
|
|
|
|
9.15%
|
|
Investment exit fee |
[7],[10],[11],[14] |
|
|
11.41%
|
|
|
|
11.41%
|
|
Principal amount |
[10],[11],[14] |
|
|
$ 38,750
|
|
|
|
|
|
Investment cost |
[5],[10],[11],[14] |
|
|
39,679
|
|
|
|
|
|
Investments, at fair value: |
[10],[11],[14] |
|
|
$ 40,421
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Geron Corporation, Senior Secured, April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[10],[16] |
|
|
2025-04
|
|
|
|
2025-04
|
|
Investment, basis spread, variable rate |
[7],[9],[10],[16] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Investment, interest rate, floor |
[7],[9],[10],[16] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment exit fee |
[7],[9],[10],[16] |
|
|
6.55%
|
|
|
|
6.55%
|
|
Principal amount |
[9],[10],[16] |
|
|
$ 30,200
|
|
|
|
|
|
Investment cost |
[5],[9],[10],[16] |
|
|
31,005
|
|
|
|
|
|
Investments, at fair value: |
[9],[10],[16] |
|
|
$ 31,210
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Gritstone Bio, Inc., Senior Secured, July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9] |
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[8],[9] |
|
|
3.15%
|
|
|
|
3.15%
|
|
Investment, interest rate, floor |
[7],[8],[9] |
|
|
7.15%
|
|
|
|
7.15%
|
|
Investment, interest rate, cap |
[7],[8],[9] |
|
|
8.65%
|
|
|
|
8.65%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9] |
|
|
2.00%
|
|
|
|
2.00%
|
|
Investment exit fee |
[7],[8],[9] |
|
|
5.75%
|
|
|
|
5.75%
|
|
Principal amount |
[8],[9] |
|
|
$ 30,532
|
|
|
|
|
|
Investment cost |
[5],[8],[9] |
|
|
30,717
|
|
|
|
|
|
Investments, at fair value: |
[8],[9] |
|
|
$ 30,909
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12],[14] |
|
|
2026-02
|
|
|
|
2026-02
|
|
Investment, basis spread, variable rate |
[7],[8],[12],[14] |
|
|
1.70%
|
|
|
|
1.70%
|
|
Investment, interest rate, floor |
[7],[8],[12],[14] |
|
|
9.95%
|
|
|
|
9.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12],[14] |
|
|
1.50%
|
|
|
|
1.50%
|
|
Investment exit fee |
[7],[8],[12],[14] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[8],[12],[14] |
|
|
$ 20,095
|
|
|
|
|
|
Investment cost |
[5],[8],[12],[14] |
|
|
19,788
|
|
|
|
|
|
Investments, at fair value: |
[8],[12],[14] |
|
|
$ 19,788
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Hibercell, Inc., Senior Secured, May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[14] |
|
|
2025-05
|
|
|
|
2025-05
|
|
Investment, basis spread, variable rate |
[7],[9],[14] |
|
|
5.40%
|
|
|
|
5.40%
|
|
Investment, interest rate, floor |
[7],[9],[14] |
|
|
8.65%
|
|
|
|
8.65%
|
|
Investment exit fee |
[7],[9],[14] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Principal amount |
[9],[14] |
|
|
$ 12,535
|
|
|
|
|
|
Investment cost |
[5],[9],[14] |
|
|
13,117
|
|
|
|
|
|
Investments, at fair value: |
[9],[14] |
|
|
$ 13,181
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and HilleVax, Inc., Senior Secured, May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[14] |
|
|
2027-05
|
|
|
|
2027-05
|
|
Investment, basis spread, variable rate |
[7],[8],[14] |
|
|
1.05%
|
|
|
|
1.05%
|
|
Investment, interest rate, floor |
[7],[8],[14] |
|
|
4.55%
|
|
|
|
4.55%
|
|
Investment, interest rate, cap |
[7],[8],[14] |
|
|
6.05%
|
|
|
|
6.05%
|
|
Investment, interest rate, paid in kind |
[7],[8],[14] |
|
|
2.85%
|
|
|
|
2.85%
|
|
Investment exit fee |
[7],[8],[14] |
|
|
7.15%
|
|
|
|
7.15%
|
|
Principal amount |
[8],[14] |
|
|
$ 20,524
|
|
|
|
|
|
Investment cost |
[5],[8],[14] |
|
|
20,685
|
|
|
|
|
|
Investments, at fair value: |
[8],[14] |
|
|
$ 20,335
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[14],[16] |
|
|
2027-11
|
|
|
|
2027-11
|
|
Investment, basis spread, variable rate |
[7],[12],[14],[16] |
|
|
2.40%
|
|
|
|
2.40%
|
|
Investment, interest rate, floor |
[7],[12],[14],[16] |
|
|
8.65%
|
|
|
|
8.65%
|
|
Investment exit fee |
[7],[12],[14],[16] |
|
|
15.13%
|
|
|
|
15.13%
|
|
Principal amount |
[12],[14],[16] |
|
|
$ 5,500
|
|
|
|
|
|
Investment cost |
[5],[12],[14],[16] |
|
|
5,532
|
|
|
|
|
|
Investments, at fair value: |
[12],[14],[16] |
|
|
$ 5,752
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Locus Biosciences, Inc., Senior Secured, July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2025-07
|
|
|
|
2025-07
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
6.10%
|
|
|
|
6.10%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
9.35%
|
|
|
|
9.35%
|
|
Investment exit fee |
[7],[14] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Principal amount |
[14] |
|
|
$ 5,399
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
5,651
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 5,686
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[16] |
|
|
2026-05
|
|
|
|
2026-05
|
|
Investment, basis spread, variable rate |
[7],[16] |
|
|
2.45%
|
|
|
|
2.45%
|
|
Investment, interest rate, floor |
[7],[16] |
|
|
8.25%
|
|
|
|
8.25%
|
|
Investment exit fee |
[7],[16] |
|
|
5.35%
|
|
|
|
5.35%
|
|
Principal amount |
[16] |
|
|
$ 78,200
|
|
|
|
|
|
Investment cost |
[5],[16] |
|
|
78,728
|
|
|
|
|
|
Investments, at fair value: |
[16] |
|
|
$ 81,945
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.29% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10],[12],[14],[16],[18],[22] |
|
|
2027-12
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[7],[8],[10],[12],[14],[16],[18],[22] |
|
|
1.35%
|
|
|
|
1.35%
|
|
Investment, interest rate, floor |
[7],[8],[10],[12],[14],[16],[18],[22] |
|
|
9.85%
|
|
|
|
9.85%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10],[12],[14],[16],[18],[22] |
|
|
2.15%
|
|
|
|
2.15%
|
|
Investment exit fee |
[7],[8],[10],[12],[14],[16],[18],[22] |
|
|
7.29%
|
|
|
|
7.29%
|
|
Principal amount |
[8],[10],[12],[14],[16],[18],[22] |
|
|
$ 129,699
|
|
|
|
|
|
Investment cost |
[5],[8],[10],[12],[14],[16],[18],[22] |
|
|
130,934
|
|
|
|
|
|
Investments, at fair value: |
[8],[10],[12],[14],[16],[18],[22] |
|
|
$ 128,326
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Redshift Bioanalytics, Inc., Senior Secured, January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2026-01
|
|
|
|
2026-01
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
4.25%
|
|
|
|
4.25%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
7.50%
|
|
|
|
7.50%
|
|
Investment exit fee |
[7],[14] |
|
|
3.80%
|
|
|
|
3.80%
|
|
Principal amount |
[14] |
|
|
$ 5,000
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
5,047
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 5,119
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Replimune Group, Inc., Senior Secured, October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10],[16] |
|
|
2027-10
|
|
|
|
2027-10
|
|
Investment, basis spread, variable rate |
[7],[8],[10],[16] |
|
|
1.75%
|
|
|
|
1.75%
|
|
Investment, interest rate, floor |
[7],[8],[10],[16] |
|
|
7.25%
|
|
|
|
7.25%
|
|
Investment, interest rate, cap |
[7],[8],[10],[16] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10],[16] |
|
|
1.50%
|
|
|
|
1.50%
|
|
Investment exit fee |
[7],[8],[10],[16] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Principal amount |
[8],[10],[16] |
|
|
$ 31,416
|
|
|
|
|
|
Investment cost |
[5],[8],[10],[16] |
|
|
31,450
|
|
|
|
|
|
Investments, at fair value: |
[8],[10],[16] |
|
|
$ 32,702
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and TG Therapeutics, Inc., Senior Secured, January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10],[11],[16] |
|
|
2026-01
|
|
|
|
2026-01
|
|
Investment, basis spread, variable rate |
[7],[8],[10],[11],[16] |
|
|
1.20%
|
|
|
|
1.20%
|
|
Investment, interest rate, floor |
[7],[8],[10],[11],[16] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10],[11],[16] |
|
|
2.25%
|
|
|
|
2.25%
|
|
Investment exit fee |
[7],[8],[10],[11],[16] |
|
|
5.69%
|
|
|
|
5.69%
|
|
Principal amount |
[8],[10],[11],[16] |
|
|
$ 65,770
|
|
|
|
|
|
Investment cost |
[5],[8],[10],[11],[16] |
|
|
66,439
|
|
|
|
|
|
Investments, at fair value: |
[8],[10],[11],[16] |
|
|
$ 67,610
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Senior Secured, February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12],[16] |
|
|
2027-02
|
|
|
|
2027-02
|
|
Investment, basis spread, variable rate |
[7],[9],[12],[16] |
|
|
4.45%
|
|
|
|
4.45%
|
|
Investment, interest rate, floor |
[7],[9],[12],[16] |
|
|
8.45%
|
|
|
|
8.45%
|
|
Investment, interest rate, cap |
[7],[9],[12],[16] |
|
|
11.45%
|
|
|
|
11.45%
|
|
Investment exit fee |
[7],[9],[12],[16] |
|
|
4.75%
|
|
|
|
4.75%
|
|
Principal amount |
[9],[12],[16] |
|
|
$ 12,375
|
|
|
|
|
|
Investment cost |
[5],[9],[12],[16] |
|
|
12,488
|
|
|
|
|
|
Investments, at fair value: |
[9],[12],[16] |
|
|
$ 12,916
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Valo Health, LLC, Senior Secured, May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[11] |
|
|
2024-05
|
|
|
|
2024-05
|
|
Investment, basis spread, variable rate |
[7],[9],[11] |
|
|
6.45%
|
|
|
|
6.45%
|
|
Investment, interest rate, floor |
[7],[9],[11] |
|
|
9.70%
|
|
|
|
9.70%
|
|
Investment exit fee |
[7],[9],[11] |
|
|
3.85%
|
|
|
|
3.85%
|
|
Principal amount |
[9],[11] |
|
|
$ 2,396
|
|
|
|
|
|
Investment cost |
[5],[9],[11] |
|
|
2,808
|
|
|
|
|
|
Investments, at fair value: |
[9],[11] |
|
|
$ 2,808
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Verona Pharma, Inc., Senior Secured, December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[16] |
|
|
2028-12
|
|
|
|
2028-12
|
|
Investment, basis spread, variable rate |
[7],[15],[16] |
|
|
5.85%
|
|
|
|
5.85%
|
|
Investment, interest rate, floor |
[7],[15],[16] |
|
|
11.19%
|
|
|
|
11.19%
|
|
Investment, interest rate, cap |
[7],[15],[16] |
|
|
13.19%
|
|
|
|
13.19%
|
|
Investment exit fee |
[7],[15],[16] |
|
|
3.50%
|
|
|
|
3.50%
|
|
Principal amount |
[15],[16] |
|
|
$ 15,750
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
15,646
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 15,646
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[16] |
|
|
2026-10
|
|
|
|
2026-10
|
|
Investment, basis spread, variable rate |
[7],[9],[16] |
|
|
4.20%
|
|
|
|
4.20%
|
|
Investment, interest rate, floor |
[7],[9],[16] |
|
|
7.45%
|
|
|
|
7.45%
|
|
Investment, interest rate, cap |
[7],[9],[16] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Investment exit fee |
[7],[9],[16] |
|
|
6.00%
|
|
|
|
6.00%
|
|
Principal amount |
[9],[16] |
|
|
$ 8,000
|
|
|
|
|
|
Investment cost |
[5],[9],[16] |
|
|
8,057
|
|
|
|
|
|
Investments, at fair value: |
[9],[16] |
|
|
$ 8,023
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[10],[11] |
|
|
2026-10
|
|
|
|
2026-10
|
|
Investment, basis spread, variable rate |
[7],[9],[10],[11] |
|
|
3.15%
|
|
|
|
3.15%
|
|
Investment, interest rate, floor |
[7],[9],[10],[11] |
|
|
10.15%
|
|
|
|
10.15%
|
|
Investment exit fee |
[7],[9],[10],[11] |
|
|
3.80%
|
|
|
|
3.80%
|
|
Principal amount |
[9],[10],[11] |
|
|
$ 55,000
|
|
|
|
|
|
Investment cost |
[5],[9],[10],[11] |
|
|
54,680
|
|
|
|
|
|
Investments, at fair value: |
[9],[10],[11] |
|
|
$ 55,417
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and enGene, Inc., Senior Secured, July 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[16] |
|
|
2028-01
|
|
|
|
2028-01
|
|
Investment, basis spread, variable rate |
[7],[15],[16] |
|
|
0.75%
|
|
|
|
0.75%
|
|
Investment, interest rate, floor |
[7],[15],[16] |
|
|
9.25%
|
|
|
|
9.25%
|
|
Investment, interest rate, cap |
[7],[15],[16] |
|
|
9.75%
|
|
|
|
9.75%
|
|
Investment, interest rate, paid in kind |
[7],[15],[16] |
|
|
1.15%
|
|
|
|
1.15%
|
|
Investment exit fee |
[7],[15],[16] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Principal amount |
[15],[16] |
|
|
$ 15,750
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
15,550
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 15,550
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and uniQure B.V., Senior Secured, January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[11],[15],[16] |
|
|
2027-01
|
|
|
|
2027-01
|
|
Investment, basis spread, variable rate |
[7],[10],[11],[15],[16] |
|
|
4.70%
|
|
|
|
4.70%
|
|
Investment, interest rate, floor |
[7],[10],[11],[15],[16] |
|
|
7.95%
|
|
|
|
7.95%
|
|
Investment exit fee |
[7],[10],[11],[15],[16] |
|
|
6.10%
|
|
|
|
6.10%
|
|
Principal amount |
[10],[11],[15],[16] |
|
|
$ 70,000
|
|
|
|
|
|
Investment cost |
[5],[10],[11],[15],[16] |
|
|
71,157
|
|
|
|
|
|
Investments, at fair value: |
[10],[11],[15],[16] |
|
|
$ 73,318
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other (16.56%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
16.56%
|
|
|
|
16.56%
|
|
Investment cost |
[5] |
|
|
$ 301,164
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 298,523
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Better Therapeutics, Inc., Senior Secured, August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2025-08
|
|
|
|
2025-08
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
5.70%
|
|
|
|
5.70%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Investment exit fee |
[7],[14] |
|
|
5.95%
|
|
|
|
5.95%
|
|
Principal amount |
[14] |
|
|
$ 10,865
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
11,285
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 8,455
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, November 2026, 1-month SOFR + 5.11% , Floor rate 6.00%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[11] |
|
|
2026-11
|
|
|
|
2026-11
|
|
Investment, basis spread, variable rate |
[7] |
|
|
5.11%
|
|
|
|
5.11%
|
|
Investment, interest rate, floor |
[7],[8],[9],[11] |
|
|
6.00%
|
|
|
|
6.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[11] |
|
|
4.45%
|
|
|
|
4.45%
|
|
Principal amount |
[8],[9],[11] |
|
|
$ 69,032
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[11] |
|
|
68,277
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[11] |
|
|
$ 68,393
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[11] |
|
|
2025-03
|
|
|
|
2025-03
|
|
Investment, basis spread, variable rate |
[7],[9],[11] |
|
|
5.60%
|
|
|
|
5.60%
|
|
Investment, interest rate, floor |
[7],[9],[11] |
|
|
8.85%
|
|
|
|
8.85%
|
|
Investment exit fee |
[7],[9],[11] |
|
|
4.61%
|
|
|
|
4.61%
|
|
Principal amount |
[9],[11] |
|
|
$ 46,125
|
|
|
|
|
|
Investment cost |
[5],[9],[11] |
|
|
47,193
|
|
|
|
|
|
Investments, at fair value: |
[9],[11] |
|
|
$ 46,242
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Equality Health, LLC, Senior Secured, February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10],[11] |
|
|
2026-02
|
|
|
|
2026-02
|
|
Investment, basis spread, variable rate |
[7],[8],[10],[11] |
|
|
6.25%
|
|
|
|
6.25%
|
|
Investment, interest rate, floor |
[7],[8],[10],[11] |
|
|
9.50%
|
|
|
|
9.50%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10],[11] |
|
|
1.55%
|
|
|
|
1.55%
|
|
Principal amount |
[8],[10],[11] |
|
|
$ 54,425
|
|
|
|
|
|
Investment cost |
[5],[8],[10],[11] |
|
|
54,142
|
|
|
|
|
|
Investments, at fair value: |
[8],[10],[11] |
|
|
$ 54,697
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[14] |
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[12],[14] |
|
|
1.95%
|
|
|
|
1.95%
|
|
Investment, interest rate, floor |
[7],[12],[14] |
|
|
9.95%
|
|
|
|
9.95%
|
|
Investment exit fee |
[7],[12],[14] |
|
|
6.85%
|
|
|
|
6.85%
|
|
Principal amount |
[12],[14] |
|
|
$ 24,500
|
|
|
|
|
|
Investment cost |
[5],[12],[14] |
|
|
24,476
|
|
|
|
|
|
Investments, at fair value: |
[12],[14] |
|
|
$ 24,929
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Modern Life, Inc., Senior Secured, February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12] |
|
|
2027-02
|
|
|
|
2027-02
|
|
Investment, basis spread, variable rate |
[7],[9],[12] |
|
|
2.75%
|
|
|
|
2.75%
|
|
Investment, interest rate, floor |
[7],[9],[12] |
|
|
8.75%
|
|
|
|
8.75%
|
|
Investment exit fee |
[7],[9],[12] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Principal amount |
[9],[12] |
|
|
$ 13,000
|
|
|
|
|
|
Investment cost |
[5],[9],[12] |
|
|
12,888
|
|
|
|
|
|
Investments, at fair value: |
[9],[12] |
|
|
$ 13,111
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Recover Together, Inc., Senior Secured, July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7] |
|
|
1.90%
|
|
|
|
1.90%
|
|
Investment, interest rate, floor |
[7] |
|
|
10.15%
|
|
|
|
10.15%
|
|
Investment exit fee |
[7] |
|
|
7.50%
|
|
|
|
7.50%
|
|
Principal amount |
|
|
|
$ 35,000
|
|
|
|
|
|
Investment cost |
[5] |
|
|
34,683
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 34,683
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[14] |
|
|
2027-09
|
|
|
|
2027-09
|
|
Investment, basis spread, variable rate |
[7],[14] |
|
|
0.70%
|
|
|
|
0.70%
|
|
Investment, interest rate, floor |
[7],[14] |
|
|
9.20%
|
|
|
|
9.20%
|
|
Investment exit fee |
[7],[14] |
|
|
5.95%
|
|
|
|
5.95%
|
|
Principal amount |
[14] |
|
|
$ 12,000
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
11,868
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 11,868
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Vida Health, Inc., Senior Secured, March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[11] |
|
|
2026-03
|
|
|
|
2026-03
|
|
Investment, basis spread, variable rate |
[7],[11] |
|
|
3.25%
|
|
|
|
3.25%
|
|
Investment, interest rate, floor |
[7],[11] |
|
|
9.20%
|
|
|
|
9.20%
|
|
Investment, interest rate, cap |
[7],[11] |
|
|
10.20%
|
|
|
|
10.20%
|
|
Investment, interest rate, paid in kind |
[7],[11] |
|
|
1.00%
|
|
|
|
1.00%
|
|
Investment exit fee |
[7],[11] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Principal amount |
[11] |
|
|
$ 36,500
|
|
|
|
|
|
Investment cost |
[5],[11] |
|
|
36,352
|
|
|
|
|
|
Investments, at fair value: |
[11] |
|
|
$ 36,145
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Information Services (6.65%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
6.65%
|
|
|
|
6.65%
|
|
Investment cost |
[5] |
|
|
$ 117,099
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 119,876
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Information Services and Capella Space Corp., Senior Secured, November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[14] |
|
|
2025-11
|
|
|
|
2025-11
|
|
Investment, basis spread, variable rate |
[7],[8],[14] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Investment, interest rate, floor |
[7],[8],[14] |
|
|
8.25%
|
|
|
|
8.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[14] |
|
|
1.10%
|
|
|
|
1.10%
|
|
Investment exit fee |
[7],[8],[14] |
|
|
7.00%
|
|
|
|
7.00%
|
|
Principal amount |
[8],[14] |
|
|
$ 20,477
|
|
|
|
|
|
Investment cost |
[5],[8],[14] |
|
|
21,166
|
|
|
|
|
|
Investments, at fair value: |
[8],[14] |
|
|
$ 21,351
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Information Services and Checkr Group, Inc., Senior Secured, August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12] |
|
|
2028-08
|
|
|
|
2028-08
|
|
Investment, basis spread, variable rate |
[7],[8],[12] |
|
|
1.45%
|
|
|
|
1.45%
|
|
Investment, interest rate, floor |
[7],[8],[12] |
|
|
8.00%
|
|
|
|
8.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12] |
|
|
2.00%
|
|
|
|
2.00%
|
|
Investment exit fee |
[7],[8],[12] |
|
|
2.75%
|
|
|
|
2.75%
|
|
Principal amount |
[8],[12] |
|
|
$ 47,621
|
|
|
|
|
|
Investment cost |
[5],[8],[12] |
|
|
47,460
|
|
|
|
|
|
Investments, at fair value: |
[8],[12] |
|
|
$ 49,382
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Information Services and Saama Technologies, LLC, Senior Secured, July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12] |
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[8],[12] |
|
|
0.70%
|
|
|
|
0.70%
|
|
Investment, interest rate, floor |
[7],[8],[12] |
|
|
8.95%
|
|
|
|
8.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12] |
|
|
2.00%
|
|
|
|
2.00%
|
|
Investment exit fee |
[7],[8],[12] |
|
|
2.95%
|
|
|
|
2.95%
|
|
Principal amount |
[8],[12] |
|
|
$ 11,725
|
|
|
|
|
|
Investment cost |
[5],[8],[12] |
|
|
11,627
|
|
|
|
|
|
Investments, at fair value: |
[8],[12] |
|
|
$ 11,876
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Information Services and Signal Media Limited, Senior Secured, June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[16] |
|
|
2025-06
|
|
|
|
2025-06
|
|
Investment, basis spread, variable rate |
[7],[15],[16] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, interest rate, floor |
[7],[15],[16] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment, interest rate, cap |
[7],[15],[16] |
|
|
12.00%
|
|
|
|
12.00%
|
|
Investment exit fee |
[7],[15],[16] |
|
|
3.45%
|
|
|
|
3.45%
|
|
Principal amount |
[15],[16] |
|
|
$ 5,400
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
5,364
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 5,392
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Information Services and Yipit, LLC, Senior Secured, September 2026, 1-month SOFR + 8.45%, Floor rate 9.35% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
8.45%
|
|
|
|
8.45%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
9.35%
|
|
|
|
9.35%
|
|
Principal amount |
[12],[13] |
|
|
$ 31,875
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
31,482
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 31,875
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Manufacturing Technology and Bright Machines, Inc., Senior Secured, May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9] |
|
|
2025-05
|
|
|
|
2025-05
|
|
Investment, basis spread, variable rate |
[7],[9] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Investment, interest rate, floor |
[7],[9] |
|
|
9.50%
|
|
|
|
9.50%
|
|
Investment exit fee |
[7],[9] |
|
|
5.00%
|
|
|
|
5.00%
|
|
Principal amount |
[9] |
|
|
$ 7,827
|
|
|
|
|
|
Investment cost |
[5],[9] |
|
|
8,064
|
|
|
|
|
|
Investments, at fair value: |
[9] |
|
|
$ 8,006
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Media/Content/Info (0.69%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.69%
|
|
|
|
0.69%
|
|
Investment cost |
[5] |
|
|
$ 12,340
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 12,469
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2025-12
|
|
|
|
2025-12
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
3.50%
|
|
|
|
3.50%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment exit fee |
[6],[7] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[6] |
|
|
$ 1,333
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
1,342
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 1,351
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2026-06
|
|
|
|
2026-06
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
3.50%
|
|
|
|
3.50%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment exit fee |
[6],[7] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[6] |
|
|
$ 1,667
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
1,647
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 1,653
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2026-03
|
|
|
|
2026-03
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
3.50%
|
|
|
|
3.50%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment exit fee |
[6],[7] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[6] |
|
|
$ 1,500
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
1,501
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 1,509
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2025-09
|
|
|
|
2025-09
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
3.50%
|
|
|
|
3.50%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment exit fee |
[6],[7] |
|
|
3.00%
|
|
|
|
3.00%
|
|
Principal amount |
[6] |
|
|
$ 1,167
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
1,178
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 1,188
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[6],[7] |
|
|
3.50%
|
|
|
|
3.50%
|
|
Investment, interest rate, floor |
[6],[7] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment exit fee |
[6],[7] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Principal amount |
[6] |
|
|
$ 6,667
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
6,672
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
6,768
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Total Fever Labs, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
12,334
|
|
|
|
|
|
Investment cost |
[5] |
|
|
12,340
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 12,469
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12] |
|
|
2027-09
|
|
|
|
2027-09
|
|
Investment, basis spread, variable rate |
[7],[12] |
|
|
1.40%
|
|
|
|
1.40%
|
|
Investment, interest rate, floor |
[7],[12] |
|
|
9.90%
|
|
|
|
9.90%
|
|
Investment exit fee |
[7],[12] |
|
|
6.95%
|
|
|
|
6.95%
|
|
Principal amount |
[12] |
|
|
$ 21,875
|
|
|
|
|
|
Investment cost |
[5],[12] |
|
|
21,572
|
|
|
|
|
|
Investments, at fair value: |
[12] |
|
|
$ 21,572
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software (40.39%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
40.39%
|
|
|
|
40.39%
|
|
Investment cost |
[5] |
|
|
$ 751,108
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
728,139
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Total Cybermaxx Intermediate Holdings, Inc., |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
10,501
|
|
|
|
|
|
Investment cost |
[5] |
|
|
10,324
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 10,334
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and 3GTMS, LLC, Senior Secured, February 2025, 3-month SOFR + 6.88%, Floor rate 7.78% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[7],[12] |
|
|
6.88%
|
|
|
|
6.88%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
7.78%
|
|
|
|
7.78%
|
|
Principal amount |
[12],[13] |
|
|
$ 1,990
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
1,988
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 1,986
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and 3GTMS, LLC, Senior Secured, February 2025, 3-month SOFR + 9.70%, Floor rate 10.60% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[12],[13] |
|
|
2025-02
|
|
|
|
2025-02
|
|
Investment, basis spread, variable rate |
[7],[11],[12],[13] |
|
|
9.70%
|
|
|
|
9.70%
|
|
Investment, interest rate, floor |
[7],[11],[12],[13] |
|
|
10.60%
|
|
|
|
10.60%
|
|
Principal amount |
[11],[12],[13] |
|
|
$ 13,110
|
|
|
|
|
|
Investment cost |
[5],[11],[12],[13] |
|
|
13,029
|
|
|
|
|
|
Investments, at fair value: |
[11],[12],[13] |
|
|
$ 13,103
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Agilence, Inc., Senior Secured, October 2026, 1-month BSBY + 9.00%, Floor rate 10.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[12],[13] |
|
|
2026-10
|
|
|
|
2026-10
|
|
Investment, basis spread, variable rate |
[7],[10],[12],[13] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment, interest rate, floor |
[7],[10],[12],[13] |
|
|
10.00%
|
|
|
|
10.00%
|
|
Principal amount |
[10],[12],[13] |
|
|
$ 9,212
|
|
|
|
|
|
Investment cost |
[5],[10],[12],[13] |
|
|
9,040
|
|
|
|
|
|
Investments, at fair value: |
[10],[12],[13] |
|
|
$ 9,212
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Alchemer LLC, Senior Secured, May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12],[13] |
|
|
2028-05
|
|
|
|
2028-05
|
|
Investment, basis spread, variable rate |
[7],[9],[12],[13] |
|
|
8.14%
|
|
|
|
8.14%
|
|
Investment, interest rate, floor |
[7],[9],[12],[13] |
|
|
9.14%
|
|
|
|
9.14%
|
|
Principal amount |
[9],[12],[13] |
|
|
$ 20,908
|
|
|
|
|
|
Investment cost |
[5],[9],[12],[13] |
|
|
20,508
|
|
|
|
|
|
Investments, at fair value: |
[9],[12],[13] |
|
|
$ 21,297
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Allvue Systems, LLC, Senior Secured, September 2029, 6-month SOFR + 7.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12] |
|
|
2029-09
|
|
|
|
2029-09
|
|
Investment, basis spread, variable rate |
[7],[12] |
|
|
7.25%
|
|
|
|
7.25%
|
|
Investment, interest rate, floor |
[7],[12] |
|
|
8.25%
|
|
|
|
8.25%
|
|
Principal amount |
[12] |
|
|
$ 36,410
|
|
|
|
|
|
Investment cost |
[5],[12] |
|
|
35,530
|
|
|
|
|
|
Investments, at fair value: |
[12] |
|
|
$ 35,530
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Annex Cloud, Senior Secured, February 2027, 1-month BSBY + 9.41%, Floor rate 10.41% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12] |
|
|
2027-02
|
|
|
|
2027-02
|
|
Investment, basis spread, variable rate |
[7],[9],[12] |
|
|
9.41%
|
|
|
|
9.41%
|
|
Investment, interest rate, floor |
[7],[9],[12] |
|
|
10.41%
|
|
|
|
10.41%
|
|
Principal amount |
[9],[12] |
|
|
$ 9,823
|
|
|
|
|
|
Investment cost |
[5],[9],[12] |
|
|
9,649
|
|
|
|
|
|
Investments, at fair value: |
[9],[12] |
|
|
$ 9,761
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Automation Anywhere, Inc., Senior Secured, September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[11],[12] |
|
|
2027-09
|
|
|
|
2027-09
|
|
Investment, basis spread, variable rate |
[6],[7],[11],[12] |
|
|
4.25%
|
|
|
|
4.25%
|
|
Investment, interest rate, floor |
[6],[7],[11],[12] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment exit fee |
[6],[7],[11],[12] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Principal amount |
[6],[11],[12] |
|
|
$ 19,600
|
|
|
|
|
|
Investment cost |
[5],[6],[11],[12] |
|
|
19,345
|
|
|
|
|
|
Investments, at fair value: |
[6],[11],[12] |
|
|
$ 20,269
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Babel Street, Senior Secured, December 2027, 3-month SOFR + 7.89%, Floor rate 8.89% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13],[14] |
|
|
2027-12
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[7],[12],[13],[14] |
|
|
7.89%
|
|
|
|
7.89%
|
|
Investment, interest rate, floor |
[7],[12],[13],[14] |
|
|
8.89%
|
|
|
|
8.89%
|
|
Principal amount |
[12],[13],[14] |
|
|
$ 45,000
|
|
|
|
|
|
Investment cost |
[5],[12],[13],[14] |
|
|
43,983
|
|
|
|
|
|
Investments, at fair value: |
[12],[13],[14] |
|
|
$ 44,928
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Brain Corporation, Senior Secured, April 2026, Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9],[12],[14] |
|
|
2026-04
|
|
|
|
2026-04
|
|
Investment, basis spread, variable rate |
[7],[8],[9],[12],[14] |
|
|
3.70%
|
|
|
|
3.70%
|
|
Investment, interest rate, floor |
[7],[8],[9],[12],[14] |
|
|
9.20%
|
|
|
|
9.20%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9],[12],[14] |
|
|
1.00%
|
|
|
|
1.00%
|
|
Investment exit fee |
[7],[8],[9],[12],[14] |
|
|
3.95%
|
|
|
|
3.95%
|
|
Principal amount |
[8],[9],[12],[14] |
|
|
$ 30,415
|
|
|
|
|
|
Investment cost |
[5],[8],[9],[12],[14] |
|
|
30,678
|
|
|
|
|
|
Investments, at fair value: |
[8],[9],[12],[14] |
|
|
$ 30,989
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Campaign Monitor Limited, Senior Secured, November 2025, 3-month SOFR + 9.05%, Floor rate 9.90% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[9] |
|
|
2025-11
|
|
|
|
2025-11
|
|
Investment, basis spread, variable rate |
[6],[7],[9] |
|
|
9.05%
|
|
|
|
9.05%
|
|
Investment, interest rate, floor |
[6],[7],[9] |
|
|
9.90%
|
|
|
|
9.90%
|
|
Principal amount |
[6],[9] |
|
|
$ 33,000
|
|
|
|
|
|
Investment cost |
[5],[6],[9] |
|
|
32,706
|
|
|
|
|
|
Investments, at fair value: |
[6],[9] |
|
|
$ 33,000
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Catchpoint Systems, Inc., Senior Secured, November 2025, 3-month SOFR + 9.41%, Floor rate 11.81% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[13] |
|
|
2025-11
|
|
|
|
2025-11
|
|
Investment, basis spread, variable rate |
[7],[13] |
|
|
9.41%
|
|
|
|
9.41%
|
|
Investment, interest rate, floor |
[7],[13] |
|
|
11.81%
|
|
|
|
11.81%
|
|
Principal amount |
[13] |
|
|
$ 10,073
|
|
|
|
|
|
Investment cost |
[5],[13] |
|
|
9,931
|
|
|
|
|
|
Investments, at fair value: |
[13] |
|
|
$ 9,940
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Ceros, Inc., Senior Secured, September 2026, 6-month SOFR + 8.99%, Floor rate 9.89% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[7] |
|
|
8.99%
|
|
|
|
8.99%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
9.89%
|
|
|
|
9.89%
|
|
Principal amount |
[12],[13] |
|
|
$ 22,867
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
22,498
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 23,075
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Constructor.io Corporation, Senior Secured, July 2027, 1-month SOFR + 8.44%, Floor rate 9.44% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12],[13] |
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[9],[12],[13] |
|
|
8.44%
|
|
|
|
8.44%
|
|
Investment, interest rate, floor |
[7],[9],[12],[13] |
|
|
9.44%
|
|
|
|
9.44%
|
|
Principal amount |
[9],[12],[13] |
|
|
$ 4,688
|
|
|
|
|
|
Investment cost |
[5],[9],[12],[13] |
|
|
4,592
|
|
|
|
|
|
Investments, at fair value: |
[9],[12],[13] |
|
|
$ 4,790
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Convoy, Inc., Senior Secured, March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[23] |
|
|
2026-03
|
|
|
|
2026-03
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[23] |
|
|
3.20%
|
|
|
|
3.20%
|
|
Investment, interest rate, floor |
[6],[7],[8],[23] |
|
|
6.45%
|
|
|
|
6.45%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[23] |
|
|
1.95%
|
|
|
|
1.95%
|
|
Investment exit fee |
[6],[7],[8],[23] |
|
|
4.55%
|
|
|
|
4.55%
|
|
Principal amount |
[6],[8],[23] |
|
|
$ 31,049
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[23] |
|
|
30,916
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[23] |
|
|
$ 0
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Copper CRM, Inc, Senior Secured, March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.96% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[11] |
|
|
2025-03
|
|
|
|
2025-03
|
|
Investment, basis spread, variable rate |
[7],[8],[11] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Investment, interest rate, floor |
[7],[8],[11] |
|
|
8.25%
|
|
|
|
8.25%
|
|
Investment, interest rate, cap |
[7],[8],[11] |
|
|
10.25%
|
|
|
|
10.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[11] |
|
|
1.95%
|
|
|
|
1.95%
|
|
Investment exit fee |
[7],[8],[11] |
|
|
3.96%
|
|
|
|
3.96%
|
|
Principal amount |
[8],[11] |
|
|
$ 9,141
|
|
|
|
|
|
Investment cost |
[5],[8],[11] |
|
|
9,307
|
|
|
|
|
|
Investments, at fair value: |
[8],[11] |
|
|
$ 9,153
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Cutover, Inc., Senior Secured, October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[10],[12],[15],[16] |
|
|
2025-10
|
|
|
|
2025-10
|
|
Investment, basis spread, variable rate |
[7],[10],[12],[15],[16] |
|
|
5.20%
|
|
|
|
5.20%
|
|
Investment, interest rate, floor |
[7],[10],[12],[15],[16] |
|
|
9.95%
|
|
|
|
9.95%
|
|
Investment exit fee |
[7],[10],[12],[15],[16] |
|
|
4.95%
|
|
|
|
4.95%
|
|
Principal amount |
[10],[12],[15],[16] |
|
|
$ 5,500
|
|
|
|
|
|
Investment cost |
[5],[10],[12],[15],[16] |
|
|
5,544
|
|
|
|
|
|
Investments, at fair value: |
[10],[12],[15],[16] |
|
|
$ 5,715
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, August 2026, 6-month SOFR + 12.36%, Floor rate 13.11% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12] |
|
|
2026-08
|
|
|
|
2026-08
|
|
Investment, basis spread, variable rate |
[7],[12] |
|
|
12.36%
|
|
|
|
12.36%
|
|
Investment, interest rate, floor |
[7],[12] |
|
|
13.11%
|
|
|
|
13.11%
|
|
Principal amount |
[12] |
|
|
$ 2,546
|
|
|
|
|
|
Investment cost |
[5],[12] |
|
|
2,494
|
|
|
|
|
|
Investments, at fair value: |
[12] |
|
|
$ 2,556
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, August 2026, 6-month SOFR + 8.63%, Floor rate 9.38% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12] |
|
|
2026-08
|
|
|
|
2026-08
|
|
Investment, basis spread, variable rate |
[7],[9],[12] |
|
|
8.63%
|
|
|
|
8.63%
|
|
Investment, interest rate, floor |
[7],[9],[12] |
|
|
9.38%
|
|
|
|
9.38%
|
|
Principal amount |
[9],[12] |
|
|
$ 7,955
|
|
|
|
|
|
Investment cost |
[5],[9],[12] |
|
|
7,830
|
|
|
|
|
|
Investments, at fair value: |
[9],[12] |
|
|
$ 7,778
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Dashlane, Inc., Senior Secured, December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 7.26% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[9],[11],[12] |
|
|
2027-12
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[6],[7],[9],[11],[12] |
|
|
3.05%
|
|
|
|
3.05%
|
|
Investment, interest rate, floor |
[6],[7],[9],[11],[12] |
|
|
11.55%
|
|
|
|
11.55%
|
|
Investment, interest rate, paid in kind |
[6],[7],[9],[11],[12] |
|
|
1.10%
|
|
|
|
1.10%
|
|
Investment exit fee |
[6],[7],[9],[11],[12] |
|
|
7.26%
|
|
|
|
7.26%
|
|
Principal amount |
[6],[9],[11],[12] |
|
|
$ 42,863
|
|
|
|
|
|
Investment cost |
[5],[6],[9],[11],[12] |
|
|
43,087
|
|
|
|
|
|
Investments, at fair value: |
[6],[9],[11],[12] |
|
|
$ 43,087
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Dispatch Technologies, Inc., Senior Secured, April 2028, 3-month SOFR + 8.01%, Floor rate 8.76% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2028-04
|
|
|
|
2028-04
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
8.01%
|
|
|
|
8.01%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
8.76%
|
|
|
|
8.76%
|
|
Principal amount |
[12],[13] |
|
|
$ 8,125
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
7,949
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 8,127
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and DroneDeploy, Inc., Senior Secured, July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12] |
|
|
2026-07
|
|
|
|
2026-07
|
|
Investment, basis spread, variable rate |
[7],[12] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Investment, interest rate, floor |
[7],[12] |
|
|
8.75%
|
|
|
|
8.75%
|
|
Investment exit fee |
[7],[12] |
|
|
4.00%
|
|
|
|
4.00%
|
|
Principal amount |
[12] |
|
|
$ 6,250
|
|
|
|
|
|
Investment cost |
[5],[12] |
|
|
6,083
|
|
|
|
|
|
Investments, at fair value: |
[12] |
|
|
$ 6,153
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Eigen Technologies Ltd., Senior Secured, April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[15],[16] |
|
|
2025-04
|
|
|
|
2025-04
|
|
Investment, basis spread, variable rate |
[7],[15],[16] |
|
|
5.10%
|
|
|
|
5.10%
|
|
Investment, interest rate, floor |
[7],[15],[16] |
|
|
8.35%
|
|
|
|
8.35%
|
|
Investment exit fee |
[7],[15],[16] |
|
|
2.95%
|
|
|
|
2.95%
|
|
Principal amount |
[15],[16] |
|
|
$ 3,750
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
3,801
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 3,730
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Elation Health, Inc., Senior Secured, March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6],[8],[12] |
|
|
2026-03
|
|
|
|
2026-03
|
|
Investment, basis spread, variable rate |
[6],[7],[8],[12] |
|
|
4.25%
|
|
|
|
4.25%
|
|
Investment, interest rate, floor |
[6],[7],[8],[12] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Investment, interest rate, paid in kind |
[6],[7],[8],[12] |
|
|
1.95%
|
|
|
|
1.95%
|
|
Investment exit fee |
[6],[7],[8],[12] |
|
|
3.95%
|
|
|
|
3.95%
|
|
Principal amount |
[6],[8],[12] |
|
|
$ 12,629
|
|
|
|
|
|
Investment cost |
[5],[6],[8],[12] |
|
|
12,253
|
|
|
|
|
|
Investments, at fair value: |
[6],[8],[12] |
|
|
$ 12,692
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Enmark Systems, Inc., Senior Secured, September 2026, 3-month SOFR + 6.73%, Floor rate 7.73%, PIK Interest 2.13% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[11],[12],[13] |
|
|
2026-09
|
|
|
|
2026-09
|
|
Investment, basis spread, variable rate |
[7],[8],[11],[13] |
|
|
6.73%
|
|
|
|
6.73%
|
|
Investment, interest rate, floor |
[7],[8],[11],[12],[13] |
|
|
7.73%
|
|
|
|
7.73%
|
|
Investment, interest rate, paid in kind |
[7],[8],[11],[12],[13] |
|
|
2.13%
|
|
|
|
2.13%
|
|
Principal amount |
[8],[11],[12],[13] |
|
|
$ 8,363
|
|
|
|
|
|
Investment cost |
[5],[8],[11],[12],[13] |
|
|
8,230
|
|
|
|
|
|
Investments, at fair value: |
[8],[11],[12],[13] |
|
|
$ 8,363
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Flight Schedule Pro, LLC, Senior Secured, October 2027, 1-month SOFR + 7.80%, Floor rate 8.70% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2027-10
|
|
|
|
2027-10
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
7.80%
|
|
|
|
7.80%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
8.70%
|
|
|
|
8.70%
|
|
Principal amount |
[12],[13] |
|
|
$ 6,587
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
6,420
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 6,553
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Fortified Health Security, Senior Secured, December 2027, 1-month SOFR + 7.64%, Floor rate 8.54% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[12],[13] |
|
|
2027-12
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[7],[11],[12],[13] |
|
|
7.64%
|
|
|
|
7.64%
|
|
Investment, interest rate, floor |
[7],[11],[12],[13] |
|
|
8.54%
|
|
|
|
8.54%
|
|
Principal amount |
[11],[12],[13] |
|
|
$ 7,000
|
|
|
|
|
|
Investment cost |
[5],[11],[12],[13] |
|
|
6,851
|
|
|
|
|
|
Investments, at fair value: |
[11],[12],[13] |
|
|
$ 6,910
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Ikon Science Limited, Senior Secured, October 2024, 3-month SOFR + 9.26%, Floor rate 10.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13],[15],[16] |
|
|
2024-10
|
|
|
|
2024-10
|
|
Investment, basis spread, variable rate |
[7],[12],[13],[15],[16] |
|
|
9.26%
|
|
|
|
9.26%
|
|
Investment, interest rate, floor |
[7],[12],[13],[15],[16] |
|
|
10.00%
|
|
|
|
10.00%
|
|
Principal amount |
[12],[13],[15],[16] |
|
|
$ 6,213
|
|
|
|
|
|
Investment cost |
[5],[12],[13],[15],[16] |
|
|
6,148
|
|
|
|
|
|
Investments, at fair value: |
[12],[13],[15],[16] |
|
|
$ 6,148
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Khoros (p.k.a Lithium Technologies), Senior Secured, January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8] |
|
|
2025-01
|
|
|
|
2025-01
|
|
Investment, basis spread, variable rate |
[7],[8] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Investment, interest rate, floor |
[7],[8] |
|
|
5.50%
|
|
|
|
5.50%
|
|
Investment, interest rate, paid in kind |
[7],[8] |
|
|
4.50%
|
|
|
|
4.50%
|
|
Principal amount |
[8] |
|
|
$ 57,770
|
|
|
|
|
|
Investment cost |
[5],[8] |
|
|
57,730
|
|
|
|
|
|
Investments, at fair value: |
[8] |
|
|
$ 56,293
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Leapwork ApS, Senior Secured, February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10],[12],[15],[16] |
|
|
2026-02
|
|
|
|
2026-02
|
|
Investment, basis spread, variable rate |
[7],[8],[10],[12],[15],[16] |
|
|
0.25%
|
|
|
|
0.25%
|
|
Investment, interest rate, floor |
[7],[8],[10],[12],[15],[16] |
|
|
7.25%
|
|
|
|
7.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10],[12],[15],[16] |
|
|
1.95%
|
|
|
|
1.95%
|
|
Investment exit fee |
[7],[8],[10],[12],[15],[16] |
|
|
2.70%
|
|
|
|
2.70%
|
|
Principal amount |
[8],[10],[12],[15],[16] |
|
|
$ 3,813
|
|
|
|
|
|
Investment cost |
[5],[8],[10],[12],[15],[16] |
|
|
3,810
|
|
|
|
|
|
Investments, at fair value: |
[8],[10],[12],[15],[16] |
|
|
$ 3,907
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and LinenMaster, LLC, Senior Secured, August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12] |
|
|
2028-08
|
|
|
|
2028-08
|
|
Investment, basis spread, variable rate |
[7],[8],[12] |
|
|
6.25%
|
|
|
|
6.25%
|
|
Investment, interest rate, floor |
[7],[8],[12] |
|
|
7.25%
|
|
|
|
7.25%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12] |
|
|
2.15%
|
|
|
|
2.15%
|
|
Principal amount |
[8],[12] |
|
|
$ 15,083
|
|
|
|
|
|
Investment cost |
[5],[8],[12] |
|
|
14,799
|
|
|
|
|
|
Investments, at fair value: |
[8],[12] |
|
|
$ 14,799
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Loftware, Inc., Senior Secured, March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2028-03
|
|
|
|
2028-03
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
7.88%
|
|
|
|
7.88%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
8.88%
|
|
|
|
8.88%
|
|
Principal amount |
[12],[13] |
|
|
$ 26,469
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
25,897
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 26,566
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and LogicSource, Senior Secured, July 2027, 3-month SOFR + 8.93%, Floor rate 9.93% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
8.93%
|
|
|
|
8.93%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
9.93%
|
|
|
|
9.93%
|
|
Principal amount |
[12],[13] |
|
|
$ 13,300
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
13,074
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 13,493
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Mobile Solutions Services, Senior Secured, December 2025, 6-month SOFR + 9.31%, Floor rate 10.06% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[13] |
|
|
2025-12
|
|
|
|
2025-12
|
|
Investment, basis spread, variable rate |
[7],[13] |
|
|
9.31%
|
|
|
|
9.31%
|
|
Investment, interest rate, floor |
[7],[13] |
|
|
10.06%
|
|
|
|
10.06%
|
|
Principal amount |
[13] |
|
|
$ 18,366
|
|
|
|
|
|
Investment cost |
[5],[13] |
|
|
18,116
|
|
|
|
|
|
Investments, at fair value: |
[13] |
|
|
$ 18,176
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and New Relic, Inc., Senior Secured, November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12] |
|
|
2030-11
|
|
|
|
2030-11
|
|
Investment, basis spread, variable rate |
[7],[12] |
|
|
6.75%
|
|
|
|
6.75%
|
|
Investment, interest rate, floor |
[7],[12] |
|
|
7.75%
|
|
|
|
7.75%
|
|
Principal amount |
[12] |
|
|
$ 20,890
|
|
|
|
|
|
Investment cost |
[5],[12] |
|
|
20,375
|
|
|
|
|
|
Investments, at fair value: |
[12] |
|
|
$ 20,375
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Omeda Holdings, LLC, Senior Secured, July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[11],[12],[13] |
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[11],[12],[13] |
|
|
8.05%
|
|
|
|
8.05%
|
|
Investment, interest rate, floor |
[7],[11],[12],[13] |
|
|
9.05%
|
|
|
|
9.05%
|
|
Principal amount |
[11],[12],[13] |
|
|
$ 7,706
|
|
|
|
|
|
Investment cost |
[5],[11],[12],[13] |
|
|
7,508
|
|
|
|
|
|
Investments, at fair value: |
[11],[12],[13] |
|
|
$ 7,702
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Onna Technologies, Inc., Senior Secured, March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest 1.75%, 4.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8] |
|
|
2026-03
|
|
|
|
2026-03
|
|
Investment, basis spread, variable rate |
[7],[8] |
|
|
1.35%
|
|
|
|
1.35%
|
|
Investment, interest rate, floor |
[7],[8] |
|
|
8.85%
|
|
|
|
8.85%
|
|
Investment, interest rate, paid in kind |
[7],[8] |
|
|
1.75%
|
|
|
|
1.75%
|
|
Investment exit fee |
[7],[8] |
|
|
4.45%
|
|
|
|
4.45%
|
|
Principal amount |
[8] |
|
|
$ 3,853
|
|
|
|
|
|
Investment cost |
[5],[8] |
|
|
3,814
|
|
|
|
|
|
Investments, at fair value: |
[8] |
|
|
$ 3,810
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Salary.com, LLC, Senior Secured, September 2027, 3-month SOFR + 8.00%, Floor rate 9.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[13] |
|
|
2027-09
|
|
|
|
2027-09
|
|
Investment, basis spread, variable rate |
[7],[13] |
|
|
8.00%
|
|
|
|
8.00%
|
|
Investment, interest rate, floor |
[7],[13] |
|
|
9.00%
|
|
|
|
9.00%
|
|
Principal amount |
[13] |
|
|
$ 22,185
|
|
|
|
|
|
Investment cost |
[5],[13] |
|
|
21,814
|
|
|
|
|
|
Investments, at fair value: |
[13] |
|
|
$ 22,048
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and ShadowDragon, LLC, Senior Secured, December 2026, 1-month SOFR + 9.01%, Floor rate 9.91% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2026-12
|
|
|
|
2026-12
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
9.01%
|
|
|
|
9.01%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
9.91%
|
|
|
|
9.91%
|
|
Principal amount |
[12],[13] |
|
|
$ 6,000
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
5,883
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 5,921
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Simon Data, Inc., Senior Secured, March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.92% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[10] |
|
|
2027-03
|
|
|
|
2027-03
|
|
Investment, basis spread, variable rate |
[7],[8],[10] |
|
|
1.00%
|
|
|
|
1.00%
|
|
Investment, interest rate, floor |
[7],[8],[10] |
|
|
8.75%
|
|
|
|
8.75%
|
|
Investment, interest rate, paid in kind |
[7],[8],[10] |
|
|
1.95%
|
|
|
|
1.95%
|
|
Investment exit fee |
[7],[8],[10] |
|
|
2.92%
|
|
|
|
2.92%
|
|
Principal amount |
[8],[10] |
|
|
$ 15,065
|
|
|
|
|
|
Investment cost |
[5],[8],[10] |
|
|
14,982
|
|
|
|
|
|
Investments, at fair value: |
[8],[10] |
|
|
$ 15,037
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Sisense Ltd., Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[15],[16] |
|
|
2027-07
|
|
|
|
2027-07
|
|
Investment, basis spread, variable rate |
[7],[8],[15],[16] |
|
|
1.50%
|
|
|
|
1.50%
|
|
Investment, interest rate, floor |
[7],[8],[15],[16] |
|
|
9.50%
|
|
|
|
9.50%
|
|
Investment, interest rate, paid in kind |
[7],[8],[15],[16] |
|
|
1.95%
|
|
|
|
1.95%
|
|
Investment exit fee |
[7],[8],[15],[16] |
|
|
5.95%
|
|
|
|
5.95%
|
|
Principal amount |
[8],[15],[16] |
|
|
$ 34,830
|
|
|
|
|
|
Investment cost |
[5],[8],[15],[16] |
|
|
34,584
|
|
|
|
|
|
Investments, at fair value: |
[8],[15],[16] |
|
|
$ 34,881
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Streamline Healthcare Solutions, Senior Secured, March 2028, 3-month SOFR + 7.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2028-03
|
|
|
|
2028-03
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
7.25%
|
|
|
|
7.25%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
8.25%
|
|
|
|
8.25%
|
|
Principal amount |
[12],[13] |
|
|
$ 13,200
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
12,953
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 13,327
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Sumo Logic, Inc., Senior Secured, May 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12] |
|
|
2030-05
|
|
|
|
2030-05
|
|
Investment, basis spread, variable rate |
[7],[12] |
|
|
6.50%
|
|
|
|
6.50%
|
|
Investment, interest rate, floor |
[7],[12] |
|
|
7.50%
|
|
|
|
7.50%
|
|
Principal amount |
[12] |
|
|
$ 23,000
|
|
|
|
|
|
Investment cost |
[5],[12] |
|
|
22,460
|
|
|
|
|
|
Investments, at fair value: |
[12] |
|
|
$ 23,105
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Suzy, Inc., Senior Secured, August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12],[14] |
|
|
2027-08
|
|
|
|
2027-08
|
|
Investment, basis spread, variable rate |
[7],[8],[12],[14] |
|
|
1.75%
|
|
|
|
1.75%
|
|
Investment, interest rate, floor |
[7],[8],[12],[14] |
|
|
10.00%
|
|
|
|
10.00%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12],[14] |
|
|
1.95%
|
|
|
|
1.95%
|
|
Investment exit fee |
[7],[8],[12],[14] |
|
|
3.45%
|
|
|
|
3.45%
|
|
Principal amount |
[8],[12],[14] |
|
|
$ 12,064
|
|
|
|
|
|
Investment cost |
[5],[8],[12],[14] |
|
|
11,837
|
|
|
|
|
|
Investments, at fair value: |
[8],[12],[14] |
|
|
$ 11,837
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and ThreatConnect, Inc., Senior Secured, May 2026, 6-month SOFR + 9.25%, Floor rate 10.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2026-05
|
|
|
|
2026-05
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
9.25%
|
|
|
|
9.25%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
10.00%
|
|
|
|
10.00%
|
|
Principal amount |
[12],[13] |
|
|
$ 10,920
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
10,730
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 10,920
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Tipalti Solutions Ltd., Senior Secured, April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[12],[15],[16] |
|
|
2027-04
|
|
|
|
2027-04
|
|
Investment, basis spread, variable rate |
[7],[8],[12],[15],[16] |
|
|
0.45%
|
|
|
|
0.45%
|
|
Investment, interest rate, floor |
[7],[8],[12],[15],[16] |
|
|
7.95%
|
|
|
|
7.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[12],[15],[16] |
|
|
2.00%
|
|
|
|
2.00%
|
|
Investment exit fee |
[7],[8],[12],[15],[16] |
|
|
3.75%
|
|
|
|
3.75%
|
|
Principal amount |
[8],[12],[15],[16] |
|
|
$ 10,649
|
|
|
|
|
|
Investment cost |
[5],[8],[12],[15],[16] |
|
|
10,578
|
|
|
|
|
|
Investments, at fair value: |
[8],[12],[15],[16] |
|
|
10,835
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Total 3GTMS, LLC |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
15,100
|
|
|
|
|
|
Investment cost |
[5] |
|
|
15,017
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 15,089
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Zappi, Inc., Senior Secured, December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[9],[12],[13],[15],[16] |
|
|
2027-12
|
|
|
|
2027-12
|
|
Investment, basis spread, variable rate |
[7],[9],[12],[13],[15],[16] |
|
|
8.03%
|
|
|
|
8.03%
|
|
Investment, interest rate, floor |
[7],[9],[12],[13],[15],[16] |
|
|
9.03%
|
|
|
|
9.03%
|
|
Principal amount |
[9],[12],[13],[15],[16] |
|
|
$ 9,000
|
|
|
|
|
|
Investment cost |
[5],[9],[12],[13],[15],[16] |
|
|
8,816
|
|
|
|
|
|
Investments, at fair value: |
[9],[12],[13],[15],[16] |
|
|
$ 8,967
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and Zimperium, Inc., Senior Secured, May 2027, 3-month SOFR + 8.31%, Floor rate 9.31% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[12],[13] |
|
|
2027-05
|
|
|
|
2027-05
|
|
Investment, basis spread, variable rate |
[7],[12],[13] |
|
|
8.31%
|
|
|
|
8.31%
|
|
Investment, interest rate, floor |
[7],[12],[13] |
|
|
9.31%
|
|
|
|
9.31%
|
|
Principal amount |
[12],[13] |
|
|
$ 16,313
|
|
|
|
|
|
Investment cost |
[5],[12],[13] |
|
|
16,057
|
|
|
|
|
|
Investments, at fair value: |
[12],[13] |
|
|
$ 16,394
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Software and iGrafx, LLC, Senior Secured, May 2027, 1-month SOFR + 8.66%, Floor rate 9.56% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[13] |
|
|
2027-05
|
|
|
|
2027-05
|
|
Investment, basis spread, variable rate |
[7],[13] |
|
|
8.66%
|
|
|
|
8.66%
|
|
Investment, interest rate, floor |
[7],[13] |
|
|
9.56%
|
|
|
|
9.56%
|
|
Principal amount |
[13] |
|
|
$ 5,000
|
|
|
|
|
|
Investment cost |
[5],[13] |
|
|
4,901
|
|
|
|
|
|
Investments, at fair value: |
[13] |
|
|
$ 4,901
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Sustainable and Renewable Technology (0.31%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.31%
|
|
|
|
0.31%
|
|
Investment cost |
[5] |
|
|
$ 5,634
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 5,617
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[8],[9] |
|
|
2025-05
|
|
|
|
2025-05
|
|
Investment, basis spread, variable rate |
[7],[8],[9] |
|
|
4.70%
|
|
|
|
4.70%
|
|
Investment, interest rate, floor |
[7],[8],[9] |
|
|
7.95%
|
|
|
|
7.95%
|
|
Investment, interest rate, paid in kind |
[7],[8],[9] |
|
|
1.45%
|
|
|
|
1.45%
|
|
Investment exit fee |
[7],[8],[9] |
|
|
3.78%
|
|
|
|
3.78%
|
|
Principal amount |
[8],[9] |
|
|
$ 3,926
|
|
|
|
|
|
Investment cost |
[5],[8],[9] |
|
|
3,952
|
|
|
|
|
|
Investments, at fair value: |
[8],[9] |
|
|
$ 3,939
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investment Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, June 2027, FIXED 10.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[6] |
|
|
2027-06
|
|
|
|
2027-06
|
|
Investment, interest rate, paid in cash |
[6],[7] |
|
|
10.00%
|
|
|
|
10.00%
|
|
Principal amount |
[6] |
|
|
$ 1,682
|
|
|
|
|
|
Investment cost |
[5],[6] |
|
|
1,682
|
|
|
|
|
|
Investments, at fair value: |
[6] |
|
|
$ 1,678
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments (182.73%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
182.73%
|
|
|
|
182.73%
|
|
|
|
Investment cost |
[2] |
$ 3,410,850
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,392,509
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (1.81%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
1.81%
|
|
|
|
1.81%
|
|
|
|
Investment cost |
[2] |
$ 32,353
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 33,554
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 7.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25] |
2027-01
|
|
|
|
2027-01
|
|
|
|
Investment, basis spread, variable rate |
[25],[26] |
2.15%
|
|
|
|
2.15%
|
|
|
|
Investment, interest rate, floor |
[25],[26] |
9.15%
|
|
|
|
9.15%
|
|
|
|
Investment exit fee |
[25],[26] |
7.85%
|
|
|
|
7.85%
|
|
|
|
Principal amount |
[25] |
$ 32,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[25] |
32,353
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25] |
$ 33,554
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking (1.60%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
1.60%
|
|
|
|
1.60%
|
|
|
|
Investment cost |
[2] |
$ 28,495
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 29,676
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[27],[28] |
2026-07
|
|
|
|
2026-07
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[27],[28] |
3.25%
|
|
|
|
3.25%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[27],[28] |
6.75%
|
|
|
|
6.75%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[27],[28] |
1.05%
|
|
|
|
1.05%
|
|
|
|
Investment exit fee |
[25],[26],[27],[28] |
3.55%
|
|
|
|
3.55%
|
|
|
|
Principal amount |
[25],[27],[28] |
$ 25,283
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[27],[28] |
25,259
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[27],[28] |
$ 26,423
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month SOFR + 10.50%, Floor rate 11.40% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[29],[30],[31] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[29],[30],[31] |
10.50%
|
|
|
|
10.50%
|
|
|
|
Investment, interest rate, floor |
[26],[29],[30],[31] |
11.40%
|
|
|
|
11.40%
|
|
|
|
Principal amount |
[29],[30],[31] |
$ 3,252
|
|
|
|
|
|
|
|
Investment cost |
[2],[29],[30],[31] |
3,236
|
|
|
|
|
|
|
|
Investments, at fair value: |
[29],[30],[31] |
$ 3,253
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (18.39%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
18.39%
|
|
|
|
18.39%
|
|
|
|
Investment cost |
[2] |
$ 340,391
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 341,385
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Altumint, Inc. Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[30] |
2027-12
|
|
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[30] |
3.65%
|
|
|
|
3.65%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[30] |
12.15%
|
|
|
|
12.15%
|
|
|
|
Investment exit fee |
[1],[26],[30] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Principal amount |
[1],[30] |
$ 10,000
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[30] |
9,939
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[30] |
$ 10,150
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[32],[33] |
2027-12
|
|
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[32],[33] |
4.70%
|
|
|
|
4.70%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[32],[33] |
11.45%
|
|
|
|
11.45%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[32],[33] |
1.45%
|
|
|
|
1.45%
|
|
|
|
Investment exit fee |
[26],[28],[32],[33] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount | £ |
[28],[32],[33] |
|
|
|
|
£ 20,212
|
|
|
|
Investment cost |
[2],[28],[32],[33] |
$ 27,551
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[32],[33] |
$ 25,929
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 10.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[34] |
2028-05
|
|
|
|
2028-05
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[34] |
10.00%
|
|
|
|
10.00%
|
|
|
|
Principal amount |
[28],[34] |
$ 24,388
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[34] |
24,388
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[34] |
$ 24,820
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date August 2025, 1-month SOFR + 8.86, Floor rate 9.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[33] |
2025-08
|
|
|
|
2025-08
|
|
|
|
Investment, basis spread, variable rate |
[26],[32],[33] |
8.86%
|
|
|
|
8.86%
|
|
|
|
Investment, interest rate, floor |
[26],[32],[33] |
9.75%
|
|
|
|
9.75%
|
|
|
|
Investment exit fee |
[26],[32],[33] |
3.00%
|
|
|
|
3.00%
|
|
|
|
Principal amount |
[32],[33] |
$ 14,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
14,215
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 14,163
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd. Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[33],[35] |
2026-10
|
|
|
|
2026-10
|
|
|
|
Investment, basis spread, variable rate |
[26],[32],[33],[35] |
2.55%
|
|
|
|
2.55%
|
|
|
|
Investment, interest rate, floor |
[26],[32],[33],[35] |
11.05%
|
|
|
|
11.05%
|
|
|
|
Investment exit fee |
[26],[32],[33],[35] |
2.95%
|
|
|
|
2.95%
|
|
|
|
Principal amount |
[32],[33],[35] |
$ 3,325
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33],[35] |
3,247
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33],[35] |
$ 3,297
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2026-12
|
|
|
|
2026-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[26] |
4.40%
|
|
|
|
4.40%
|
|
|
|
Investment, interest rate, floor |
[1],[26] |
10.65%
|
|
|
|
10.65%
|
|
|
|
Investment exit fee |
[1],[26] |
2.95%
|
|
|
|
2.95%
|
|
|
|
Principal amount |
[1] |
$ 15,000
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
14,995
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 15,267
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[28],[35] |
2026-12
|
|
|
|
2026-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[28],[35] |
5.50%
|
|
|
|
5.50%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[28],[35] |
6.50%
|
|
|
|
6.50%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26],[28],[35] |
4.00%
|
|
|
|
4.00%
|
|
|
|
Principal amount |
[1],[28],[35] |
$ 29,468
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[28],[35] |
29,089
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[28],[35] |
$ 29,620
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC. Senior Secured, Maturity Date April 2027, 3-month SOFR + 8.27%, Floor rate 9.27% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2027-04
|
|
|
|
2027-04
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
8.27%
|
|
|
|
8.27%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
9.27%
|
|
|
|
9.27%
|
|
|
|
Principal amount |
[30],[31] |
$ 36,681
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
36,219
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 34,577
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[36] |
2026-07
|
|
|
|
2026-07
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[36] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[36] |
10.75%
|
|
|
|
10.75%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[36] |
0.50%
|
|
|
|
0.50%
|
|
|
|
Investment exit fee |
[25],[26],[28],[36] |
3.00%
|
|
|
|
3.00%
|
|
|
|
Principal amount |
[25],[28],[36] |
$ 77,840
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[36] |
77,451
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[36] |
$ 79,397
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[29],[36] |
2026-05
|
|
|
|
2026-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[29],[36] |
7.00%
|
|
|
|
7.00%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[29],[36] |
10.50%
|
|
|
|
10.50%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[29],[36] |
0.50%
|
|
|
|
0.50%
|
|
|
|
Investment exit fee |
[26],[28],[29],[36] |
4.00%
|
|
|
|
4.00%
|
|
|
|
Principal amount |
[28],[29],[36] |
$ 25,263
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[29],[36] |
25,249
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[29],[36] |
$ 25,765
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[35] |
2026-11
|
|
|
|
2026-11
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[35] |
2.75%
|
|
|
|
2.75%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[35] |
9.25%
|
|
|
|
9.25%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[35] |
1.75%
|
|
|
|
1.75%
|
|
|
|
Investment exit fee |
[26],[28],[35] |
3.00%
|
|
|
|
3.00%
|
|
|
|
Principal amount |
[28],[35] |
$ 7,924
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[35] |
8,001
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[35] |
$ 8,150
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[37] |
2024-07
|
|
|
|
2024-07
|
|
|
|
Investment, interest rate, paid in cash |
[26] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Principal amount |
[37] |
$ 8,250
|
|
|
|
|
|
|
|
Investment cost |
[2],[37] |
8,250
|
|
|
|
|
|
|
|
Investments, at fair value: |
[37] |
$ 8,250
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[29],[30] |
2028-03
|
|
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[29],[30] |
2.45%
|
|
|
|
2.45%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[29],[30] |
10.95%
|
|
|
|
10.95%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[29],[30] |
1.50%
|
|
|
|
1.50%
|
|
|
|
Principal amount |
[28],[29],[30] |
$ 20,759
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[29],[30] |
20,359
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[29],[30] |
20,359
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total SeatGeek, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
103,103
|
|
|
|
|
|
|
|
Investment cost |
[2] |
102,700
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
105,162
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total Worldremit Group Limited |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
31,083
|
|
|
|
|
|
|
|
Investment cost |
[2] |
30,880
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 31,083
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[35] |
2025-03
|
|
|
|
2025-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[35] |
4.00%
|
|
|
|
4.00%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[35] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[35] |
1.25%
|
|
|
|
1.25%
|
|
|
|
Investment exit fee |
[26],[28],[35] |
4.50%
|
|
|
|
4.50%
|
|
|
|
Principal amount |
[28],[35] |
$ 5,140
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[35] |
5,271
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[35] |
$ 5,271
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28] |
2025-03
|
|
|
|
2025-03
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28] |
4.70%
|
|
|
|
4.70%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28] |
7.95%
|
|
|
|
7.95%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28] |
1.50%
|
|
|
|
1.50%
|
|
|
|
Investment exit fee |
[25],[26],[28] |
4.50%
|
|
|
|
4.50%
|
|
|
|
Principal amount |
[25],[28] |
$ 5,149
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28] |
5,287
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28] |
$ 5,287
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2026, 1-month SOFR + 9.35%, Floor rate 10.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[32],[33] |
2026-02
|
|
|
|
2026-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[32],[33] |
9.35%
|
|
|
|
9.35%
|
|
|
|
Investment, interest rate, floor |
[26],[27],[32],[33] |
10.25%
|
|
|
|
10.25%
|
|
|
|
Principal amount |
[27],[32],[33] |
$ 6,466
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[32],[33] |
6,417
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[32],[33] |
$ 6,466
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2026, 3-month SOFR + 9.40%, Floor rate 10.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[27],[29],[32],[33] |
2026-02
|
|
|
|
2026-02
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[27],[29],[32],[33] |
9.40%
|
|
|
|
9.40%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[27],[29],[32],[33] |
10.25%
|
|
|
|
10.25%
|
|
|
|
Principal amount |
[25],[27],[29],[32],[33] |
$ 24,617
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[27],[29],[32],[33] |
24,463
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[27],[29],[32],[33] |
24,617
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, and Total Veem, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
10,289
|
|
|
|
|
|
|
|
Investment cost |
[2] |
10,558
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 10,558
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (3.12%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
3.12%
|
|
|
|
3.12%
|
|
|
|
Investment cost |
[2] |
$ 57,664
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 57,983
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, FIXED 3.45%, PIK Interest 8.05% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[37],[38] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[37],[38] |
8.05%
|
|
|
|
8.05%
|
|
|
|
Investment, interest rate, paid in cash |
[26],[28],[37],[38] |
3.45%
|
|
|
|
3.45%
|
|
|
|
Principal amount |
[28],[37],[38] |
$ 25,509
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[37],[38] |
25,224
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[37],[38] |
$ 25,224
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, Fixed 11.95% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[37],[38] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, interest rate, paid in cash |
[26],[37],[38] |
11.95%
|
|
|
|
11.95%
|
|
|
|
Principal amount |
[37],[38] |
$ 10,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[37],[38] |
9,844
|
|
|
|
|
|
|
|
Investments, at fair value: |
[37],[38] |
$ 9,844
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[37],[39] |
2025-06
|
|
|
|
2025-06
|
|
|
|
Investment, interest rate, paid in cash |
[26],[37],[39] |
5.00%
|
|
|
|
5.00%
|
|
|
|
Principal amount |
[37],[39] |
$ 12,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[37],[39] |
12,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
[37],[39] |
$ 12,000
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime -(1.50%), Floor rate 4.75%, PIK Interest 5.50% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28],[35] |
2028-02
|
|
|
|
2028-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[28],[35] |
(1.50%)
|
|
|
|
(1.50%)
|
|
|
|
Investment, interest rate, floor |
[26],[27],[28],[35] |
4.75%
|
|
|
|
4.75%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[27],[28],[35] |
5.50%
|
|
|
|
5.50%
|
|
|
|
Principal amount |
[27],[28],[35] |
$ 10,766
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28],[35] |
10,596
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28],[35] |
10,915
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Total Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
35,509
|
|
|
|
|
|
|
|
Investment cost |
[2] |
35,068
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 35,068
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (64.13%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
64.13%
|
|
|
|
64.13%
|
|
|
|
Investment cost |
[2] |
$ 1,167,650
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,190,634
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[32],[33] |
2026-08
|
|
|
|
2026-08
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[32],[33] |
4.55%
|
|
|
|
4.55%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[32],[33] |
8.55%
|
|
|
|
8.55%
|
|
|
|
Investment exit fee |
[26],[30],[32],[33] |
6.95%
|
|
|
|
6.95%
|
|
|
|
Principal amount |
[30],[32],[33] |
$ 10,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[32],[33] |
10,805
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[32],[33] |
$ 10,971
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Adaptimmune Therapeutics plc. Senior Secured, Maturity Date June 2029, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.00%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[32],[33] |
2029-06
|
|
|
|
2029-06
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[32],[33] |
1.15%
|
|
|
|
1.15%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[32],[33] |
9.65%
|
|
|
|
9.65%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[32],[33] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Investment exit fee |
[26],[28],[32],[33] |
5.85%
|
|
|
|
5.85%
|
|
|
|
Principal amount |
[28],[32],[33] |
$ 15,015
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[32],[33] |
14,877
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[32],[33] |
$ 14,877
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[32],[35] |
2027-03
|
|
|
|
2027-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[32],[35] |
3.65%
|
|
|
|
3.65%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[32],[35] |
7.65%
|
|
|
|
7.65%
|
|
|
|
Investment exit fee |
[26],[30],[32],[35] |
5.85%
|
|
|
|
5.85%
|
|
|
|
Principal amount |
[30],[32],[35] |
$ 17,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[32],[35] |
17,505
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[32],[35] |
$ 17,866
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[29] |
2024-10
|
|
|
|
2024-10
|
|
|
|
Investment, basis spread, variable rate |
[26],[29] |
3.10%
|
|
|
|
3.10%
|
|
|
|
Investment, interest rate, floor |
[26],[29] |
8.60%
|
|
|
|
8.60%
|
|
|
|
Investment exit fee |
[26],[29] |
8.90%
|
|
|
|
8.90%
|
|
|
|
Principal amount |
[29] |
$ 15,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[29] |
15,255
|
|
|
|
|
|
|
|
Investments, at fair value: |
[29] |
$ 15,255
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2027-01
|
|
|
|
2027-01
|
|
|
|
Investment, basis spread, variable rate |
[1],[26] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Investment, interest rate, floor |
[1],[26] |
9.50%
|
|
|
|
9.50%
|
|
|
|
Investment, interest rate, cap |
[1],[26] |
10.75%
|
|
|
|
10.75%
|
|
|
|
Investment exit fee |
[1],[26] |
5.85%
|
|
|
|
5.85%
|
|
|
|
Principal amount |
[1] |
$ 24,000
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
24,369
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 24,772
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[29],[32],[36] |
2028-01
|
|
|
|
2028-01
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[29],[32],[36] |
2.20%
|
|
|
|
2.20%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[29],[32],[36] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Investment, interest rate, cap |
[25],[26],[29],[32],[36] |
10.70%
|
|
|
|
10.70%
|
|
|
|
Investment exit fee |
[25],[26],[29],[32],[36] |
5.78%
|
|
|
|
5.78%
|
|
|
|
Principal amount |
[25],[29],[32],[36] |
$ 143,350
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[29],[32],[36] |
144,515
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[29],[32],[36] |
$ 151,632
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[29],[32],[33] |
2025-07
|
|
|
|
2025-07
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[29],[32],[33] |
4.55%
|
|
|
|
4.55%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[29],[32],[33] |
8.05%
|
|
|
|
8.05%
|
|
|
|
Investment, interest rate, cap |
[25],[26],[29],[32],[33] |
9.05%
|
|
|
|
9.05%
|
|
|
|
Investment exit fee |
[25],[26],[29],[32],[33] |
5.00%
|
|
|
|
5.00%
|
|
|
|
Principal amount |
[25],[29],[32],[33] |
$ 11,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[29],[32],[33] |
11,945
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[29],[32],[33] |
$ 12,190
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[30] |
2028-10
|
|
|
|
2028-10
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[30] |
2.45%
|
|
|
|
2.45%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[30] |
10.95%
|
|
|
|
10.95%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[30] |
1.10%
|
|
|
|
1.10%
|
|
|
|
Investment exit fee |
[26],[28],[30] |
5.45%
|
|
|
|
5.45%
|
|
|
|
Principal amount |
[28],[30] |
$ 52,896
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[30] |
52,776
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[30] |
$ 54,925
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and COMPASS Pathways plc Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[32],[33] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[32],[33] |
1.50%
|
|
|
|
1.50%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[32],[33] |
9.75%
|
|
|
|
9.75%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[32],[33] |
1.40%
|
|
|
|
1.40%
|
|
|
|
Investment exit fee |
[26],[28],[32],[33] |
4.75%
|
|
|
|
4.75%
|
|
|
|
Principal amount |
[28],[32],[33] |
$ 24,316
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[32],[33] |
24,195
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[32],[33] |
$ 25,102
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[35],[36] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, basis spread, variable rate |
[26],[35],[36] |
5.70%
|
|
|
|
5.70%
|
|
|
|
Investment, interest rate, floor |
[26],[35],[36] |
8.95%
|
|
|
|
8.95%
|
|
|
|
Investment exit fee |
[26],[35],[36] |
7.75%
|
|
|
|
7.75%
|
|
|
|
Principal amount |
[35],[36] |
$ 105,225
|
|
|
|
|
|
|
|
Investment cost |
[2],[35],[36] |
108,561
|
|
|
|
|
|
|
|
Investments, at fair value: |
[35],[36] |
$ 110,273
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027, Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2027-06
|
|
|
|
2027-06
|
|
|
|
Investment, basis spread, variable rate |
[1],[26] |
1.70%
|
|
|
|
1.70%
|
|
|
|
Investment, interest rate, floor |
[1],[26] |
9.70%
|
|
|
|
9.70%
|
|
|
|
Investment exit fee |
[1],[26] |
6.95%
|
|
|
|
6.95%
|
|
|
|
Principal amount |
[1] |
$ 10,000
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
9,964
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 9,914
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2025-04
|
|
|
|
2025-04
|
|
|
|
Investment, basis spread, variable rate |
[1],[26] |
6.25%
|
|
|
|
6.25%
|
|
|
|
Investment, interest rate, floor |
[1],[26] |
9.50%
|
|
|
|
9.50%
|
|
|
|
Investment exit fee |
[1],[26] |
4.00%
|
|
|
|
4.00%
|
|
|
|
Principal amount |
[1] |
$ 489
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
987
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 987
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25],[29] |
2026-11
|
|
|
|
2026-11
|
|
|
|
Investment, basis spread, variable rate |
[1],[25],[26],[29] |
5.65%
|
|
|
|
5.65%
|
|
|
|
Investment, interest rate, floor |
[1],[25],[26],[29] |
9.15%
|
|
|
|
9.15%
|
|
|
|
Investment exit fee |
[1],[25],[26],[29] |
6.75%
|
|
|
|
6.75%
|
|
|
|
Principal amount |
[1],[25],[29] |
$ 32,399
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25],[29] |
33,437
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25],[29] |
$ 34,030
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date October 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[30],[32],[35] |
2025-10
|
|
|
|
2025-10
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[30],[32],[35] |
4.50%
|
|
|
|
4.50%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[30],[32],[35] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Investment exit fee |
[25],[26],[30],[32],[35] |
6.55%
|
|
|
|
6.55%
|
|
|
|
Principal amount |
[25],[30],[32],[35] |
$ 30,200
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[30],[32],[35] |
31,546
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[30],[32],[35] |
$ 31,859
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[35] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[35] |
3.15%
|
|
|
|
3.15%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[35] |
7.15%
|
|
|
|
7.15%
|
|
|
|
Investment, interest rate, cap |
[26],[28],[35] |
8.65%
|
|
|
|
8.65%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[35] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Investment exit fee |
[26],[28],[35] |
5.75%
|
|
|
|
5.75%
|
|
|
|
Principal amount |
[28],[35] |
$ 30,837
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[35] |
31,246
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[35] |
$ 30,112
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc.. Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[28],[30] |
2026-02
|
|
|
|
2026-02
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[28],[30] |
1.70%
|
|
|
|
1.70%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[28],[30] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26],[28],[30] |
1.50%
|
|
|
|
1.50%
|
|
|
|
Investment exit fee |
[1],[26],[28],[30] |
3.00%
|
|
|
|
3.00%
|
|
|
|
Principal amount |
[1],[28],[30] |
$ 20,249
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[28],[30] |
20,126
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[28],[30] |
$ 20,610
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[35] |
2025-05
|
|
|
|
2025-05
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[35] |
5.40%
|
|
|
|
5.40%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[35] |
8.65%
|
|
|
|
8.65%
|
|
|
|
Investment exit fee |
[1],[26],[35] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount |
[1],[35] |
$ 8,407
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[35] |
9,103
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[35] |
$ 9,028
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[28],[30] |
2027-05
|
|
|
|
2027-05
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[28],[30] |
1.05%
|
|
|
|
1.05%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[28],[30] |
4.55%
|
|
|
|
4.55%
|
|
|
|
Investment, interest rate, cap |
[1],[26],[28],[30] |
6.05%
|
|
|
|
6.05%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26],[28],[30] |
2.85%
|
|
|
|
2.85%
|
|
|
|
Investment exit fee |
[1],[26],[28],[30] |
7.15%
|
|
|
|
7.15%
|
|
|
|
Principal amount |
[1],[28],[30] |
$ 20,823
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[28],[30] |
21,185
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[28],[30] |
$ 20,916
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[32] |
2027-11
|
|
|
|
2027-11
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[32] |
2.40%
|
|
|
|
2.40%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[32] |
8.65%
|
|
|
|
8.65%
|
|
|
|
Investment exit fee |
[1],[26],[32] |
15.13%
|
|
|
|
15.13%
|
|
|
|
Principal amount |
[1],[32] |
$ 5,500
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[32] |
5,577
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[32] |
$ 5,692
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2025-07
|
|
|
|
2025-07
|
|
|
|
Investment, basis spread, variable rate |
[1],[26] |
6.10%
|
|
|
|
6.10%
|
|
|
|
Investment, interest rate, floor |
[1],[26] |
9.35%
|
|
|
|
9.35%
|
|
|
|
Investment exit fee |
[1],[26] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount |
[1] |
$ 3,835
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
4,143
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 4,166
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[35] |
2027-05
|
|
|
|
2027-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[32],[35] |
2.45%
|
|
|
|
2.45%
|
|
|
|
Investment, interest rate, floor |
[26],[32],[35] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Investment exit fee |
[26],[32],[35] |
5.35%
|
|
|
|
5.35%
|
|
|
|
Principal amount |
[32],[35] |
$ 78,200
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[35] |
79,359
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[35] |
$ 82,775
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 6.59% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[25],[28],[30],[32],[36],[40] |
2027-12
|
|
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[25],[26],[28],[30],[32],[36],[40] |
1.35%
|
|
|
|
1.35%
|
|
|
|
Investment, interest rate, floor |
[1],[25],[26],[28],[30],[32],[36],[40] |
9.85%
|
|
|
|
9.85%
|
|
|
|
Investment, interest rate, cap |
[1],[25],[26],[28],[30],[32],[36],[40] |
10.35%
|
|
|
|
10.35%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[25],[26],[28],[30],[32],[36],[40] |
2.15%
|
|
|
|
2.15%
|
|
|
|
Investment exit fee |
[1],[25],[26],[28],[30],[32],[36],[40] |
6.59%
|
|
|
|
6.59%
|
|
|
|
Principal amount |
[1],[25],[28],[30],[32],[36],[40] |
$ 152,455
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[25],[28],[30],[32],[36],[40] |
154,211
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[25],[28],[30],[32],[36],[40] |
$ 155,075
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2026-01
|
|
|
|
2026-01
|
|
|
|
Investment, basis spread, variable rate |
[1],[26] |
4.25%
|
|
|
|
4.25%
|
|
|
|
Investment, interest rate, floor |
[1],[26] |
7.50%
|
|
|
|
7.50%
|
|
|
|
Investment exit fee |
[1],[26] |
3.80%
|
|
|
|
3.80%
|
|
|
|
Principal amount |
[1] |
$ 4,388
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
4,484
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 4,476
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[32],[35] |
2027-10
|
|
|
|
2027-10
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[32],[35] |
1.75%
|
|
|
|
1.75%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[32],[35] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Investment, interest rate, cap |
[25],[26],[28],[32],[35] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[32],[35] |
1.50%
|
|
|
|
1.50%
|
|
|
|
Investment exit fee |
[25],[26],[28],[32],[35] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount |
[25],[28],[32],[35] |
$ 31,647
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[32],[35] |
31,860
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[32],[35] |
$ 33,378
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and SynOx Therapeutics Limited Senior Secured, Maturity Date May 2027, Prime + 1.40%, Floor rate 9.90%, 7.25% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[33] |
2027-05
|
|
|
|
2027-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[32],[33] |
1.40%
|
|
|
|
1.40%
|
|
|
|
Investment, interest rate, floor |
[26],[32],[33] |
9.90%
|
|
|
|
9.90%
|
|
|
|
Investment exit fee |
[26],[32],[33] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Principal amount |
[32],[33] |
$ 4,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
4,393
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 4,393
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[29],[32] |
2026-01
|
|
|
|
2026-01
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[29],[32] |
1.20%
|
|
|
|
1.20%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[29],[32] |
8.95%
|
|
|
|
8.95%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[29],[32] |
2.25%
|
|
|
|
2.25%
|
|
|
|
Investment exit fee |
[25],[26],[28],[29],[32] |
5.69%
|
|
|
|
5.69%
|
|
|
|
Principal amount |
[25],[28],[29],[32] |
$ 66,526
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[29],[32] |
67,887
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[29],[32] |
$ 69,598
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[35] |
2026-10
|
|
|
|
2026-10
|
|
|
|
Investment, basis spread, variable rate |
[26],[32],[35] |
4.20%
|
|
|
|
4.20%
|
|
|
|
Investment, interest rate, floor |
[26],[32],[35] |
7.45%
|
|
|
|
7.45%
|
|
|
|
Investment, interest rate, cap |
[26],[32],[35] |
8.95%
|
|
|
|
8.95%
|
|
|
|
Investment exit fee |
[26],[32],[35] |
6.00%
|
|
|
|
6.00%
|
|
|
|
Principal amount |
[32],[35] |
$ 8,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[35] |
8,145
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[35] |
$ 8,248
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[29],[35] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[29],[35] |
3.15%
|
|
|
|
3.15%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[29],[35] |
10.15%
|
|
|
|
10.15%
|
|
|
|
Investment exit fee |
[25],[26],[29],[35] |
3.72%
|
|
|
|
3.72%
|
|
|
|
Principal amount |
[25],[29],[35] |
$ 75,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[29],[35] |
75,081
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[29],[35] |
$ 75,286
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and bluebird bio, Inc. Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28] |
2029-04
|
|
|
|
2029-04
|
|
|
|
Investment, basis spread, variable rate |
[26],[28] |
1.45%
|
|
|
|
1.45%
|
|
|
|
Investment, interest rate, floor |
[26],[28] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28] |
2.45%
|
|
|
|
2.45%
|
|
|
|
Investment exit fee |
[26],[28] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount |
[28] |
$ 64,843
|
|
|
|
|
|
|
|
Investment cost |
[2],[28] |
62,675
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28] |
$ 62,212
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[32],[33] |
2028-01
|
|
|
|
2028-01
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[32],[33] |
0.75%
|
|
|
|
0.75%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[32],[33] |
9.25%
|
|
|
|
9.25%
|
|
|
|
Investment, interest rate, cap |
[26],[28],[32],[33] |
9.75%
|
|
|
|
9.75%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[32],[33] |
1.15%
|
|
|
|
1.15%
|
|
|
|
Investment exit fee |
[26],[28],[32],[33] |
5.50%
|
|
|
|
5.50%
|
|
|
|
Principal amount |
[28],[32],[33] |
$ 15,832
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[32],[33] |
15,775
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[32],[33] |
$ 15,905
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[29],[32],[33] |
2027-01
|
|
|
|
2027-01
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[29],[32],[33] |
4.70%
|
|
|
|
4.70%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[29],[32],[33] |
7.95%
|
|
|
|
7.95%
|
|
|
|
Investment exit fee |
[25],[26],[29],[32],[33] |
6.10%
|
|
|
|
6.10%
|
|
|
|
Principal amount |
[25],[29],[32],[33] |
$ 70,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[29],[32],[33] |
71,663
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[29],[32],[33] |
$ 74,111
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (4.05%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
4.05%
|
|
|
|
4.05%
|
|
|
|
Investment cost |
[2] |
$ 74,646
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 75,118
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27] |
2026-06
|
|
|
|
2026-06
|
|
|
|
Investment, basis spread, variable rate |
[26],[27] |
4.50%
|
|
|
|
4.50%
|
|
|
|
Investment, interest rate, floor |
[26],[27] |
8.00%
|
|
|
|
8.00%
|
|
|
|
Investment exit fee |
[26],[27] |
4.00%
|
|
|
|
4.00%
|
|
|
|
Principal amount |
[27] |
$ 18,281
|
|
|
|
|
|
|
|
Investment cost |
[2],[27] |
18,446
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27] |
$ 18,918
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Shield AI, Inc. Senior Secured, Maturity Date February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[30] |
2029-02
|
|
|
|
2029-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[30] |
0.85%
|
|
|
|
0.85%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[30] |
6.85%
|
|
|
|
6.85%
|
|
|
|
Investment, interest rate, cap |
[26],[28],[30] |
9.60%
|
|
|
|
9.60%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[30] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Investment exit fee |
[26],[28],[30] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Principal amount |
[28],[30] |
$ 56,677
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[30] |
56,200
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[30] |
$ 56,200
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (30.22%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
30.22%
|
|
|
|
30.22%
|
|
|
|
Investment cost |
[2] |
$ 561,371
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 561,112
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[29],[35] |
2026-11
|
|
|
|
2026-11
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[29],[35] |
5.11%
|
|
|
|
5.11%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[29],[35] |
6.00%
|
|
|
|
6.00%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[29],[35] |
4.45%
|
|
|
|
4.45%
|
|
|
|
Principal amount |
[25],[28],[29],[35] |
$ 70,608
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[29],[35] |
69,953
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[29],[35] |
$ 69,458
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Convertible Debt, Maturity Date December 2025, FIXED 12.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[34] |
2025-12
|
|
|
|
2025-12
|
|
|
|
Investment, interest rate, paid in cash |
[26],[34] |
12.00%
|
|
|
|
12.00%
|
|
|
|
Principal amount |
[34] |
$ 202
|
|
|
|
|
|
|
|
Investment cost |
[2],[34] |
202
|
|
|
|
|
|
|
|
Investments, at fair value: |
[34] |
$ 202
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date June 2026, Prime - (1.50%), Floor rate 7.00%, PIK Interest 7.00%, 5.64% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[29],[35] |
2026-06
|
|
|
|
2026-06
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[29],[35] |
(1.50%)
|
|
|
|
(1.50%)
|
|
|
|
Investment, interest rate, floor |
[26],[28],[29],[35] |
7.00%
|
|
|
|
7.00%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[29],[35] |
7.00%
|
|
|
|
7.00%
|
|
|
|
Investment exit fee |
[26],[28],[29],[35] |
5.64%
|
|
|
|
5.64%
|
|
|
|
Principal amount |
[28],[29],[35] |
$ 48,649
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[29],[35] |
50,068
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[29],[35] |
$ 48,458
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Curana Health Holdings, LLC Senior Secured, Maturity Date January 2028, Prime + 1.45%, Floor rate 9.20%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[30],[35] |
2028-01
|
|
|
|
2028-01
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[30],[35] |
1.45%
|
|
|
|
1.45%
|
|
|
|
Investment, interest rate, floor |
[26],[27],[30],[35] |
9.20%
|
|
|
|
9.20%
|
|
|
|
Investment exit fee |
[26],[27],[30],[35] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount |
[27],[30],[35] |
$ 27,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[30],[35] |
27,542
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[30],[35] |
$ 27,928
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[29] |
2026-02
|
|
|
|
2026-02
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[29] |
6.25%
|
|
|
|
6.25%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[29] |
9.50%
|
|
|
|
9.50%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[29] |
1.55%
|
|
|
|
1.55%
|
|
|
|
Principal amount |
[25],[28],[29] |
$ 70,124
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[29] |
69,752
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[29] |
$ 69,898
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[30],[35] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[30],[35] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[30],[35] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Investment exit fee |
[1],[26],[30],[35] |
6.85%
|
|
|
|
6.85%
|
|
|
|
Principal amount |
[1],[30],[35] |
$ 38,500
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[30],[35] |
38,638
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[30],[35] |
$ 39,043
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC Senior Secured, Maturity Date February 2029,Prime - (0.90%), Floor rate 7.10%, PIK Interest 4.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[30],[36] |
2029-02
|
|
|
|
2029-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[30],[36] |
(0.90%)
|
|
|
|
(0.90%)
|
|
|
|
Investment, interest rate, floor |
[26],[28],[30],[36] |
7.10%
|
|
|
|
7.10%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[30],[36] |
4.00%
|
|
|
|
4.00%
|
|
|
|
Investment exit fee |
[26],[28],[30],[36] |
3.00%
|
|
|
|
3.00%
|
|
|
|
Principal amount |
[28],[30],[36] |
$ 155,977
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[30],[36] |
154,761
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[30],[36] |
$ 154,761
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[35] |
2027-02
|
|
|
|
2027-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[35] |
2.75%
|
|
|
|
2.75%
|
|
|
|
Investment, interest rate, floor |
[26],[35] |
8.75%
|
|
|
|
8.75%
|
|
|
|
Investment exit fee |
[26],[35] |
5.00%
|
|
|
|
5.00%
|
|
|
|
Principal amount |
[35] |
$ 18,200
|
|
|
|
|
|
|
|
Investment cost |
[2],[35] |
18,120
|
|
|
|
|
|
|
|
Investments, at fair value: |
[35] |
$ 18,157
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and NeueHealth, Inc. Senior Secured, Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2028-06
|
|
|
|
2028-06
|
|
|
|
Investment, basis spread, variable rate |
[26] |
1.15%
|
|
|
|
1.15%
|
|
|
|
Investment, interest rate, floor |
[26] |
9.65%
|
|
|
|
9.65%
|
|
|
|
Investment, interest rate, paid in kind |
[26] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Investment exit fee |
[26] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Principal amount |
|
$ 24,750
|
|
|
|
|
|
|
|
Investment cost |
[2] |
23,782
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 23,782
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Recover Together, Inc. Senior Secured, Maturity Date July 2027 Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
|
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[26] |
1.90%
|
|
|
|
1.90%
|
|
|
|
Investment, interest rate, floor |
[26] |
10.15%
|
|
|
|
10.15%
|
|
|
|
Investment exit fee |
[26] |
7.50%
|
|
|
|
7.50%
|
|
|
|
Principal amount |
|
$ 40,000
|
|
|
|
|
|
|
|
Investment cost |
[2] |
40,014
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 41,171
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2027-09
|
|
|
|
2027-09
|
|
|
|
Investment, basis spread, variable rate |
[1],[26] |
0.70%
|
|
|
|
0.70%
|
|
|
|
Investment, interest rate, floor |
[1],[26] |
9.20%
|
|
|
|
9.20%
|
|
|
|
Investment exit fee |
[1],[26] |
5.95%
|
|
|
|
5.95%
|
|
|
|
Principal amount |
[1] |
$ 12,000
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
11,964
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
12,213
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Total Carbon Health Technologies, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
48,851
|
|
|
|
|
|
|
|
Investment cost |
[2] |
50,270
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 48,660
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[29] |
2026-03
|
|
|
|
2026-03
|
|
|
|
Investment, basis spread, variable rate |
[26] |
3.25%
|
|
|
|
3.25%
|
|
|
|
Investment, interest rate, floor |
[26],[29] |
9.20%
|
|
|
|
9.20%
|
|
|
|
Investment, interest rate, cap |
[26],[29] |
10.20%
|
|
|
|
10.20%
|
|
|
|
Investment exit fee |
[26],[29] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount |
[29] |
$ 36,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[29] |
36,742
|
|
|
|
|
|
|
|
Investments, at fair value: |
[29] |
$ 36,208
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee | Minimum |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment, basis spread, variable rate |
[26],[29] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and WellBe Senior Medical, LLC Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[28],[30] |
2029-05
|
|
|
|
2029-05
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[28],[30] |
0.75%
|
|
|
|
0.75%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[28],[30] |
7.75%
|
|
|
|
7.75%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26],[28],[30] |
2.65%
|
|
|
|
2.65%
|
|
|
|
Investment exit fee |
[1],[26],[28],[30] |
6.75%
|
|
|
|
6.75%
|
|
|
|
Principal amount |
[1],[28],[30] |
$ 20,012
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[28],[30] |
19,833
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[28],[30] |
$ 19,833
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services (3.94%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
3.94%
|
|
|
|
3.94%
|
|
|
|
Investment cost |
[2] |
$ 69,871
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 73,240
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services and Checkr Group, Inc. Senior Secured, Maturity Date August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[30] |
2028-08
|
|
|
|
2028-08
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[30] |
1.45%
|
|
|
|
1.45%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[30] |
8.00%
|
|
|
|
8.00%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[30] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Investment exit fee |
[25],[26],[28],[30] |
2.75%
|
|
|
|
2.75%
|
|
|
|
Principal amount |
[25],[28],[30] |
$ 48,107
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[30] |
48,063
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[30] |
$ 50,850
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services and Saama Technologies, LLC Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[30] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[30] |
0.70%
|
|
|
|
0.70%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[30] |
8.95%
|
|
|
|
8.95%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[30] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Investment exit fee |
[25],[26],[28],[30] |
2.95%
|
|
|
|
2.95%
|
|
|
|
Principal amount |
[25],[28],[30] |
$ 15,723
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[30] |
15,632
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[30] |
$ 16,214
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[33] |
2025-06
|
|
|
|
2025-06
|
|
|
|
Investment, basis spread, variable rate |
[26],[32],[33] |
5.50%
|
|
|
|
5.50%
|
|
|
|
Investment, interest rate, floor |
[26],[32],[33] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Investment, interest rate, cap |
[26],[32],[33] |
12.00%
|
|
|
|
12.00%
|
|
|
|
Investment exit fee |
[26],[32],[33] |
3.45%
|
|
|
|
3.45%
|
|
|
|
Principal amount |
[32],[33] |
$ 6,150
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
6,176
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 6,176
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (2.96%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
2.96%
|
|
|
|
2.96%
|
|
|
|
Investment cost |
[2] |
$ 54,638
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 54,923
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc. Senior Secured, Maturity Date September 2027 Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[29] |
2027-09
|
|
|
|
2027-09
|
|
|
|
Investment, basis spread, variable rate |
[26],[29] |
1.40%
|
|
|
|
1.40%
|
|
|
|
Investment, interest rate, floor |
[26],[29] |
9.90%
|
|
|
|
9.90%
|
|
|
|
Investment exit fee |
[26],[29] |
6.95%
|
|
|
|
6.95%
|
|
|
|
Principal amount |
[29] |
$ 30,625
|
|
|
|
|
|
|
|
Investment cost |
[2],[29] |
30,476
|
|
|
|
|
|
|
|
Investments, at fair value: |
[29] |
$ 30,761
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Sight Sciences, Inc. Senior Secured, Maturity Date July 2028 Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30] |
2028-07
|
|
|
|
2028-07
|
|
|
|
Investment, basis spread, variable rate |
[26],[30] |
2.35%
|
|
|
|
2.35%
|
|
|
|
Investment, interest rate, floor |
[26],[30] |
10.35%
|
|
|
|
10.35%
|
|
|
|
Investment exit fee |
[26],[30] |
5.95%
|
|
|
|
5.95%
|
|
|
|
Principal amount |
[30] |
$ 24,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[30] |
24,162
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30] |
$ 24,162
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software (49.17%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
49.17%
|
|
|
|
49.17%
|
|
|
|
Investment cost |
[2] |
$ 961,790
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
912,927
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software , Total Streamline Healthcare Solutions |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
17,600
|
|
|
|
|
|
|
|
Investment cost |
[2] |
17,289
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 18,000
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[28],[30] |
2027-02
|
|
|
|
2027-02
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[28],[30] |
0.65%
|
|
|
|
0.65%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[28],[30] |
9.15%
|
|
|
|
9.15%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26],[28],[30] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Investment exit fee |
[1],[26],[28],[30] |
5.05%
|
|
|
|
5.05%
|
|
|
|
Principal amount |
[1],[28],[30] |
$ 16,109
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[28],[30] |
16,079
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[28],[30] |
$ 16,079
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 6.96%, Floor rate 7.86% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
6.96%
|
|
|
|
6.96%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
7.86%
|
|
|
|
7.86%
|
|
|
|
Principal amount |
[30],[31] |
$ 2,975
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
2,968
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 2,968
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.86%, Floor rate 10.76% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[29],[30],[31] |
2025-02
|
|
|
|
2025-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[29],[30],[31] |
9.86%
|
|
|
|
9.86%
|
|
|
|
Investment, interest rate, floor |
[26],[29],[30],[31] |
10.76%
|
|
|
|
10.76%
|
|
|
|
Principal amount |
[29],[30],[31] |
$ 14,067
|
|
|
|
|
|
|
|
Investment cost |
[2],[29],[30],[31] |
14,020
|
|
|
|
|
|
|
|
Investments, at fair value: |
[29],[30],[31] |
$ 14,020
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 3-month SOFR + 8.14%, Floor rate 9.14% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[31],[35] |
2028-05
|
|
|
|
2028-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[31],[35] |
8.14%
|
|
|
|
8.14%
|
|
|
|
Investment, interest rate, floor |
[26],[31],[35] |
9.14%
|
|
|
|
9.14%
|
|
|
|
Principal amount |
[31],[35] |
$ 21,353
|
|
|
|
|
|
|
|
Investment cost |
[2],[31],[35] |
20,987
|
|
|
|
|
|
|
|
Investments, at fair value: |
[31],[35] |
$ 21,353
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 7.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30] |
2029-09
|
|
|
|
2029-09
|
|
|
|
Investment, basis spread, variable rate |
[26],[30] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Investment, interest rate, floor |
[26],[30] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Principal amount |
[30] |
$ 36,410
|
|
|
|
|
|
|
|
Investment cost |
[2],[30] |
35,583
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30] |
$ 36,844
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and AlphaSense, Inc. Senior Secured, Maturity Date June 2029, 3-month SOFR + 6.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30] |
2029-06
|
|
|
|
2029-06
|
|
|
|
Investment, basis spread, variable rate |
[26],[30] |
6.25%
|
|
|
|
6.25%
|
|
|
|
Investment, interest rate, floor |
[26],[30] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Principal amount |
[30] |
$ 20,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[30] |
19,800
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30] |
$ 19,800
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 10.00%, Floor rate 11.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[35] |
2027-02
|
|
|
|
2027-02
|
|
|
|
Investment, basis spread, variable rate |
[26],[35] |
10.00%
|
|
|
|
10.00%
|
|
|
|
Investment, interest rate, floor |
[26],[35] |
11.00%
|
|
|
|
11.00%
|
|
|
|
Principal amount |
[35] |
$ 11,479
|
|
|
|
|
|
|
|
Investment cost |
[2],[35] |
11,317
|
|
|
|
|
|
|
|
Investments, at fair value: |
[35] |
$ 11,307
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 0.00%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[30] |
2028-03
|
|
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[30] |
0.00%
|
|
|
|
0.00%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[30] |
7.50%
|
|
|
|
7.50%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[30] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Investment exit fee |
[26],[28],[30] |
2.25%
|
|
|
|
2.25%
|
|
|
|
Principal amount |
[28],[30] |
$ 50,220
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[30] |
49,813
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[30] |
$ 49,813
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[29],[30] |
2027-09
|
|
|
|
2027-09
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[29],[30] |
4.25%
|
|
|
|
4.25%
|
|
|
|
Investment, interest rate, floor |
[26],[27],[29],[30] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Investment exit fee |
[26],[27],[29],[30] |
4.50%
|
|
|
|
4.50%
|
|
|
|
Principal amount |
[27],[29],[30] |
$ 19,600
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[29],[30] |
19,503
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[29],[30] |
$ 20,440
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.01%, Floor rate 9.01% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[30],[31] |
2027-12
|
|
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[30],[31] |
8.01%
|
|
|
|
8.01%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[30],[31] |
9.01%
|
|
|
|
9.01%
|
|
|
|
Principal amount |
[1],[30],[31] |
$ 65,500
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[30],[31] |
64,054
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[30],[31] |
$ 65,777
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[28],[35] |
2026-04
|
|
|
|
2026-04
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[28],[35] |
3.70%
|
|
|
|
3.70%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[28],[35] |
9.20%
|
|
|
|
9.20%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26],[28],[35] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment exit fee |
[1],[26],[28],[35] |
3.95%
|
|
|
|
3.95%
|
|
|
|
Principal amount |
[1],[28],[35] |
$ 30,570
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[28],[35] |
31,066
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[28],[35] |
$ 31,755
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.31%, Floor rate 11.81% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[31] |
2025-11
|
|
|
|
2025-11
|
|
|
|
Investment, basis spread, variable rate |
[26],[31] |
9.31%
|
|
|
|
9.31%
|
|
|
|
Investment, interest rate, floor |
[26],[31] |
11.81%
|
|
|
|
11.81%
|
|
|
|
Principal amount |
[31] |
$ 10,022
|
|
|
|
|
|
|
|
Investment cost |
[2],[31] |
9,913
|
|
|
|
|
|
|
|
Investments, at fair value: |
[31] |
$ 9,975
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR+ 8.99%, Floor rate 9.89% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2026-09
|
|
|
|
2026-09
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
8.99%
|
|
|
|
8.99%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
9.89%
|
|
|
|
9.89%
|
|
|
|
Principal amount |
[30],[31] |
$ 22,762
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
22,452
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 22,970
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Constructor io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31],[35] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31],[35] |
8.44%
|
|
|
|
8.44%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31],[35] |
9.44%
|
|
|
|
9.44%
|
|
|
|
Principal amount |
[30],[31],[35] |
$ 4,688
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31],[35] |
4,603
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31],[35] |
$ 4,796
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28],[41] |
2026-03
|
|
|
|
2026-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[28],[41] |
3.20%
|
|
|
|
3.20%
|
|
|
|
Investment, interest rate, floor |
[26],[27],[28],[41] |
6.45%
|
|
|
|
6.45%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[27],[28],[41] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment exit fee |
[26],[27],[28],[41] |
4.55%
|
|
|
|
4.55%
|
|
|
|
Principal amount |
[27],[28],[41] |
$ 31,049
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28],[41] |
30,916
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28],[41] |
$ 0
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[29] |
2025-03
|
|
|
|
2025-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[29] |
4.50%
|
|
|
|
4.50%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[29] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Investment, interest rate, cap |
[26],[28],[29] |
10.25%
|
|
|
|
10.25%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[29] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment exit fee |
[26],[28],[29] |
4.50%
|
|
|
|
4.50%
|
|
|
|
Principal amount |
[28],[29] |
$ 8,748
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[29] |
8,991
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[29] |
$ 8,991
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[32],[33] |
2025-10
|
|
|
|
2025-10
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[32],[33] |
5.20%
|
|
|
|
5.20%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[32],[33] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Investment exit fee |
[25],[26],[32],[33] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount |
[25],[32],[33] |
$ 5,500
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[32],[33] |
5,603
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[32],[33] |
$ 5,769
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[32],[33] |
2025-10
|
|
|
|
2025-10
|
|
|
|
Investment, basis spread, variable rate |
[26],[32],[33] |
5.20%
|
|
|
|
5.20%
|
|
|
|
Investment, interest rate, floor |
[26],[32],[33] |
9.95%
|
|
|
|
9.95%
|
|
|
|
Investment exit fee |
[26],[32],[33] |
4.95%
|
|
|
|
4.95%
|
|
|
|
Principal amount |
[32],[33] |
$ 1,250
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
1,582
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 1,675
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.36%, Floor rate 13.11%, 0.58% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[35] |
2026-08
|
|
|
|
2026-08
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[35] |
12.36%
|
|
|
|
12.36%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[35] |
13.11%
|
|
|
|
13.11%
|
|
|
|
Investment exit fee |
[26] |
0.58%
|
|
|
|
0.58%
|
|
|
|
Principal amount |
[30],[35] |
$ 2,527
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[35] |
2,484
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[35] |
$ 2,581
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.63%, Floor rate 9.38%, 0.58% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[35] |
2026-08
|
|
|
|
2026-08
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[35] |
8.63%
|
|
|
|
8.63%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[35] |
9.38%
|
|
|
|
9.38%
|
|
|
|
Investment exit fee |
[26] |
0.58%
|
|
|
|
0.58%
|
|
|
|
Principal amount |
[30],[35] |
$ 7,896
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[35] |
7,792
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[35] |
$ 7,808
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 6.28% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28],[29],[35] |
2027-12
|
|
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[28],[29],[35] |
3.05%
|
|
|
|
3.05%
|
|
|
|
Investment, interest rate, floor |
[26],[27],[28],[29],[35] |
11.55%
|
|
|
|
11.55%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[27],[28],[29],[35] |
1.10%
|
|
|
|
1.10%
|
|
|
|
Investment exit fee |
[26],[27],[28],[29],[35] |
6.28%
|
|
|
|
6.28%
|
|
|
|
Principal amount |
[27],[28],[29],[35] |
$ 45,224
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28],[29],[35] |
45,861
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28],[29],[35] |
$ 46,932
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2028-04
|
|
|
|
2028-04
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
8.01%
|
|
|
|
8.01%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
8.76%
|
|
|
|
8.76%
|
|
|
|
Principal amount |
[30],[31] |
$ 7,938
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
7,777
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 7,766
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[35] |
2026-07
|
|
|
|
2026-07
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[35] |
4.50%
|
|
|
|
4.50%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[35] |
8.75%
|
|
|
|
8.75%
|
|
|
|
Investment exit fee |
[26],[30],[35] |
4.00%
|
|
|
|
4.00%
|
|
|
|
Principal amount |
[30],[35] |
$ 9,375
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[35] |
9,194
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[35] |
$ 9,442
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Earnix, Inc., Senior Secured, Maturity Date June 2029, Prime - (1.15%), Floor rate 5.35%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30] |
2029-06
|
|
|
|
2029-06
|
|
|
|
Investment, basis spread, variable rate |
[26],[30] |
(1.15%)
|
|
|
|
(1.15%)
|
|
|
|
Investment, interest rate, floor |
[26],[30] |
5.35%
|
|
|
|
5.35%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[30] |
4.45%
|
|
|
|
4.45%
|
|
|
|
Principal amount |
[30] |
$ 18,750
|
|
|
|
|
|
|
|
Investment cost |
[2],[30] |
18,419
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30] |
$ 18,419
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28],[30] |
2026-03
|
|
|
|
2026-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[28],[30] |
4.25%
|
|
|
|
4.25%
|
|
|
|
Investment, interest rate, floor |
[26],[27],[28],[30] |
9.00%
|
|
|
|
9.00%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[27],[28],[30] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment exit fee |
[26],[27],[28],[30] |
3.95%
|
|
|
|
3.95%
|
|
|
|
Principal amount |
[27],[28],[30] |
$ 12,751
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28],[30] |
12,543
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28],[30] |
$ 13,019
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2027-10
|
|
|
|
2027-10
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
7.80%
|
|
|
|
7.80%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
8.70%
|
|
|
|
8.70%
|
|
|
|
Principal amount |
[30],[31] |
$ 6,587
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
6,438
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 6,693
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 1-month SOFR + 7.64%, Floor rate 8.54% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[29],[30],[31] |
2027-12
|
|
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[26],[29],[30],[31] |
7.64%
|
|
|
|
7.64%
|
|
|
|
Investment, interest rate, floor |
[26],[29],[30],[31] |
8.54%
|
|
|
|
8.54%
|
|
|
|
Principal amount |
[29],[30],[31] |
$ 7,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[29],[30],[31] |
6,866
|
|
|
|
|
|
|
|
Investments, at fair value: |
[29],[30],[31] |
$ 7,071
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Harness, Inc., Senior Secured, Maturity Date March 2029, Prime - (2.25%), Floor rate 5.25%, Cap rate 6.50%, PIK Interest 6.25%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28],[30] |
2029-03
|
|
|
|
2029-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[28],[30] |
(2.25%)
|
|
|
|
(2.25%)
|
|
|
|
Investment, interest rate, floor |
[26],[27],[28],[30] |
5.25%
|
|
|
|
5.25%
|
|
|
|
Investment, interest rate, cap |
[26],[27],[28],[30] |
6.50%
|
|
|
|
6.50%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[27],[28],[30] |
6.25%
|
|
|
|
6.25%
|
|
|
|
Investment exit fee |
[26],[27],[28],[30] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Principal amount |
[27],[28],[30] |
$ 17,567
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28],[30] |
17,355
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28],[30] |
$ 17,355
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month SOFR + 9.26%, Floor rate 10.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31],[32],[33] |
2024-10
|
|
|
|
2024-10
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31],[32],[33] |
9.26%
|
|
|
|
9.26%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31],[32],[33] |
10.00%
|
|
|
|
10.00%
|
|
|
|
Principal amount |
[30],[31],[32],[33] |
$ 6,038
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31],[32],[33] |
6,013
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31],[32],[33] |
$ 6,013
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2025, PIK 3-month SOFR + 11.00%, Floor rate 12.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[41] |
2025-01
|
|
|
|
2025-01
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[41] |
11.00%
|
|
|
|
11.00%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[41] |
12.00%
|
|
|
|
12.00%
|
|
|
|
Principal amount |
[28],[41] |
$ 60,860
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[41] |
60,836
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[41] |
$ 32,130
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[30],[32],[33] |
2026-02
|
|
|
|
2026-02
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[30],[32],[33] |
0.25%
|
|
|
|
0.25%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[30],[32],[33] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[30],[32],[33] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment exit fee |
[25],[26],[28],[30],[32],[33] |
2.70%
|
|
|
|
2.70%
|
|
|
|
Principal amount |
[25],[28],[30],[32],[33] |
$ 3,851
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[30],[32],[33] |
3,870
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[30],[32],[33] |
$ 3,997
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28],[30] |
2028-08
|
|
|
|
2028-08
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28],[30] |
6.25%
|
|
|
|
6.25%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28],[30] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28],[30] |
2.15%
|
|
|
|
2.15%
|
|
|
|
Principal amount |
[25],[28],[30] |
$ 15,255
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28],[30] |
14,992
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28],[30] |
$ 15,561
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2028-03
|
|
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
7.88%
|
|
|
|
7.88%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
8.88%
|
|
|
|
8.88%
|
|
|
|
Principal amount |
[30],[31] |
$ 26,344
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
25,812
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 26,721
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.93%, Floor rate 9.93% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
8.93%
|
|
|
|
8.93%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
9.93%
|
|
|
|
9.93%
|
|
|
|
Principal amount |
[30],[31] |
$ 13,300
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
13,100
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 13,493
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Marigold Group, Inc. (p.k.a. Campaign Monitor Limited), Senior Secured, Maturity Date November 2026, PIK 3-month SOFR + 10.55%, Floor rate 11.55% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28],[35] |
2026-11
|
|
|
|
2026-11
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[28],[35] |
10.55%
|
|
|
|
10.55%
|
|
|
|
Investment, interest rate, floor |
[26],[27],[28],[35] |
11.55%
|
|
|
|
11.55%
|
|
|
|
Principal amount |
[27],[28],[35] |
$ 35,923
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28],[35] |
35,345
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28],[35] |
$ 30,025
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 6-month SOFR + 9.31%, Floor rate 10.06% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[31] |
2025-12
|
|
|
|
2025-12
|
|
|
|
Investment, basis spread, variable rate |
[26],[31] |
9.31%
|
|
|
|
9.31%
|
|
|
|
Investment, interest rate, floor |
[26],[31] |
10.06%
|
|
|
|
10.06%
|
|
|
|
Principal amount |
[31] |
$ 18,366
|
|
|
|
|
|
|
|
Investment cost |
[2],[31] |
18,174
|
|
|
|
|
|
|
|
Investments, at fair value: |
[31] |
$ 17,957
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30] |
2030-11
|
|
|
|
2030-11
|
|
|
|
Investment, basis spread, variable rate |
[26],[30] |
6.75%
|
|
|
|
6.75%
|
|
|
|
Investment, interest rate, floor |
[26],[30] |
7.75%
|
|
|
|
7.75%
|
|
|
|
Principal amount |
[30] |
$ 20,890
|
|
|
|
|
|
|
|
Investment cost |
[2],[30] |
20,399
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30] |
$ 20,700
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[29],[30],[31] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[26],[29],[30],[31] |
8.05%
|
|
|
|
8.05%
|
|
|
|
Investment, interest rate, floor |
[26],[29],[30],[31] |
9.05%
|
|
|
|
9.05%
|
|
|
|
Principal amount |
[29],[30],[31] |
$ 7,706
|
|
|
|
|
|
|
|
Investment cost |
[2],[29],[30],[31] |
7,531
|
|
|
|
|
|
|
|
Investments, at fair value: |
[29],[30],[31] |
$ 7,763
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Pindrop Security, Inc., Senior Secured, Maturity Date June 2029, Prime + 3.50%, Floor rate 10.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[30] |
2029-06
|
|
|
|
2029-06
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[30] |
3.50%
|
|
|
|
3.50%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[30] |
10.00%
|
|
|
|
10.00%
|
|
|
|
Investment exit fee |
[1],[26],[30] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Principal amount |
[1],[30] |
$ 31,000
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[30] |
30,479
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[30] |
$ 30,479
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Sandata Technologies, LLC, Senior Secured, Maturity Date May 2029, 3-month SOFR + 8.05%, Floor rate 9.05% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2029-05
|
|
|
|
2029-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
8.05%
|
|
|
|
8.05%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
9.05%
|
|
|
|
9.05%
|
|
|
|
Principal amount |
[30],[31] |
$ 20,769
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
20,207
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 20,207
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Semperis Technologies Inc., Senior Secured, Maturity Date April 2028, Prime - (1.75%), Floor rate 6.75%, PIK Interest 3.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27],[28],[30] |
2028-04
|
|
|
|
2028-04
|
|
|
|
Investment, basis spread, variable rate |
[26],[27],[28],[30] |
(1.75%)
|
|
|
|
(1.75%)
|
|
|
|
Investment, interest rate, floor |
[26],[27],[28],[30] |
6.75%
|
|
|
|
6.75%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[27],[28],[30] |
3.25%
|
|
|
|
3.25%
|
|
|
|
Principal amount |
[27],[28],[30] |
$ 7,526
|
|
|
|
|
|
|
|
Investment cost |
[2],[27],[28],[30] |
7,471
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27],[28],[30] |
$ 7,471
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 8.98%, Floor rate 9.88% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2026-12
|
|
|
|
2026-12
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
8.98%
|
|
|
|
8.98%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
9.88%
|
|
|
|
9.88%
|
|
|
|
Principal amount |
[30],[31] |
$ 6,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
5,900
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 6,000
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[25],[28] |
2027-03
|
|
|
|
2027-03
|
|
|
|
Investment, basis spread, variable rate |
[25],[26],[28] |
1.00%
|
|
|
|
1.00%
|
|
|
|
Investment, interest rate, floor |
[25],[26],[28] |
8.75%
|
|
|
|
8.75%
|
|
|
|
Investment, interest rate, paid in kind |
[25],[26],[28] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment exit fee |
[25],[26],[28] |
2.95%
|
|
|
|
2.95%
|
|
|
|
Principal amount |
[25],[28] |
$ 12,958
|
|
|
|
|
|
|
|
Investment cost |
[2],[25],[28] |
12,952
|
|
|
|
|
|
|
|
Investments, at fair value: |
[25],[28] |
$ 13,094
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[32],[33] |
2027-07
|
|
|
|
2027-07
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[32],[33] |
1.50%
|
|
|
|
1.50%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[32],[33] |
9.50%
|
|
|
|
9.50%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[32],[33] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment exit fee |
[26],[28],[32],[33] |
5.95%
|
|
|
|
5.95%
|
|
|
|
Principal amount |
[28],[32],[33] |
$ 34,582
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[32],[33] |
34,645
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[32],[33] |
$ 35,022
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31],[35] |
2028-03
|
|
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31],[35] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31],[35] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Principal amount |
[30],[31],[35] |
$ 13,200
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31],[35] |
12,977
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31],[35] |
$ 13,500
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 6-month SOFR + 7.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2028-03
|
|
|
|
2028-03
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
7.25%
|
|
|
|
7.25%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
8.25%
|
|
|
|
8.25%
|
|
|
|
Principal amount |
[30],[31] |
$ 4,400
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
4,312
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 4,500
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30] |
2030-05
|
|
|
|
2030-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[30] |
6.50%
|
|
|
|
6.50%
|
|
|
|
Investment, interest rate, floor |
[26],[30] |
7.50%
|
|
|
|
7.50%
|
|
|
|
Principal amount |
[30] |
$ 23,000
|
|
|
|
|
|
|
|
Investment cost |
[2],[30] |
22,489
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30] |
$ 23,656
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[28],[30] |
2027-08
|
|
|
|
2027-08
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[28],[30] |
1.75%
|
|
|
|
1.75%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[28],[30] |
10.00%
|
|
|
|
10.00%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26],[28],[30] |
1.95%
|
|
|
|
1.95%
|
|
|
|
Investment exit fee |
[1],[26],[28],[30] |
3.45%
|
|
|
|
3.45%
|
|
|
|
Principal amount |
[1],[28],[30] |
$ 16,185
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[28],[30] |
15,939
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[28],[30] |
$ 16,502
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 3-month SOFR + 9.15%, Floor rate 10.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2026-05
|
|
|
|
2026-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
9.15%
|
|
|
|
9.15%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
10.00%
|
|
|
|
10.00%
|
|
|
|
Principal amount |
[30],[31] |
$ 10,864
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
10,709
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 10,864
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[32],[33] |
2027-04
|
|
|
|
2027-04
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[32],[33] |
0.45%
|
|
|
|
0.45%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[32],[33] |
7.95%
|
|
|
|
7.95%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[32],[33] |
2.00%
|
|
|
|
2.00%
|
|
|
|
Investment exit fee |
[26],[28],[32],[33] |
3.75%
|
|
|
|
3.75%
|
|
|
|
Principal amount |
[28],[32],[33] |
$ 42,258
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[32],[33] |
41,625
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[32],[33] |
43,035
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Total 3GTMS, LLC |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
17,042
|
|
|
|
|
|
|
|
Investment cost |
[2] |
16,988
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
16,988
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Total Cutover, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
7,185
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
7,444
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Total Cybermaxx Intermediate Holdings, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Principal amount |
|
10,423
|
|
|
|
|
|
|
|
Investment cost |
[2] |
10,276
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 10,389
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31],[32],[33],[35] |
2027-12
|
|
|
|
2027-12
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31],[32],[33],[35] |
8.03%
|
|
|
|
8.03%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31],[32],[33],[35] |
9.03%
|
|
|
|
9.03%
|
|
|
|
Principal amount |
[30],[31],[32],[33],[35] |
$ 12,793
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31],[32],[33],[35] |
12,559
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31],[32],[33],[35] |
$ 13,026
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[30],[31] |
2027-05
|
|
|
|
2027-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[30],[31] |
8.31%
|
|
|
|
8.31%
|
|
|
|
Investment, interest rate, floor |
[26],[30],[31] |
9.31%
|
|
|
|
9.31%
|
|
|
|
Principal amount |
[30],[31] |
$ 14,790
|
|
|
|
|
|
|
|
Investment cost |
[2],[30],[31] |
14,587
|
|
|
|
|
|
|
|
Investments, at fair value: |
[30],[31] |
$ 14,790
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Software and iGrafx, LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.61%, Floor rate 9.51%, 0.47% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[31] |
2027-05
|
|
|
|
2027-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[31] |
8.61%
|
|
|
|
8.61%
|
|
|
|
Investment, interest rate, floor |
[26],[31] |
9.51%
|
|
|
|
9.51%
|
|
|
|
Investment exit fee |
[26] |
0.47%
|
|
|
|
0.47%
|
|
|
|
Principal amount |
[31] |
$ 4,975
|
|
|
|
|
|
|
|
Investment cost |
[2],[31] |
4,888
|
|
|
|
|
|
|
|
Investments, at fair value: |
[31] |
$ 5,003
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Space Technologies (2.40%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
2.40%
|
|
|
|
2.40%
|
|
|
|
Investment cost |
[2] |
$ 44,465
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 44,465
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Space Technologies and Voyager Space Holdings, Inc., Senior Secured, Maturity Date July 2028, Prime + 1.25%, Floor rate 9.75%, PIK Interest 2.50%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1] |
2028-07
|
|
|
|
2028-07
|
|
|
|
Investment, basis spread, variable rate |
[1],[26] |
1.25%
|
|
|
|
1.25%
|
|
|
|
Investment, interest rate, floor |
[1],[26] |
9.75%
|
|
|
|
9.75%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26] |
2.50%
|
|
|
|
2.50%
|
|
|
|
Investment exit fee |
[1],[26] |
5.50%
|
|
|
|
5.50%
|
|
|
|
Principal amount |
[1] |
$ 44,950
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
44,465
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 44,465
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.94%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.94%
|
|
|
|
0.94%
|
|
|
|
Investment cost |
[2] |
$ 17,516
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 17,492
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[28],[35] |
2025-05
|
|
|
|
2025-05
|
|
|
|
Investment, basis spread, variable rate |
[26],[28],[35] |
4.70%
|
|
|
|
4.70%
|
|
|
|
Investment, interest rate, floor |
[26],[28],[35] |
7.95%
|
|
|
|
7.95%
|
|
|
|
Investment, interest rate, paid in kind |
[26],[28],[35] |
1.45%
|
|
|
|
1.45%
|
|
|
|
Investment exit fee |
[26],[28],[35] |
3.95%
|
|
|
|
3.95%
|
|
|
|
Principal amount |
[28],[35] |
$ 3,955
|
|
|
|
|
|
|
|
Investment cost |
[2],[28],[35] |
4,025
|
|
|
|
|
|
|
|
Investments, at fair value: |
[28],[35] |
$ 4,022
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[1],[27],[28] |
2028-05
|
|
|
|
2028-05
|
|
|
|
Investment, basis spread, variable rate |
[1],[26],[27],[28] |
2.25%
|
|
|
|
2.25%
|
|
|
|
Investment, interest rate, floor |
[1],[26],[27],[28] |
10.75%
|
|
|
|
10.75%
|
|
|
|
Investment, interest rate, paid in kind |
[1],[26],[27],[28] |
1.25%
|
|
|
|
1.25%
|
|
|
|
Investment exit fee |
[1],[26],[27],[28] |
4.25%
|
|
|
|
4.25%
|
|
|
|
Principal amount |
[1],[27],[28] |
$ 12,529
|
|
|
|
|
|
|
|
Investment cost |
[1],[2],[27],[28] |
12,014
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1],[27],[28] |
$ 12,014
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date June 2027, FIXED 10.00% |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Maturity Date |
[27] |
2027-06
|
|
|
|
2027-06
|
|
|
|
Investment, interest rate, paid in kind |
[26],[27] |
10.00%
|
|
|
|
10.00%
|
|
|
|
Principal amount |
[27] |
$ 1,477
|
|
|
|
|
|
|
|
Investment cost |
[2],[27] |
1,477
|
|
|
|
|
|
|
|
Investments, at fair value: |
[27] |
$ 1,456
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments (7.55%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
7.55%
|
|
|
|
7.55%
|
|
|
|
Investment cost |
[2] |
$ 161,786
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 140,251
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments (8.44%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
8.44%
|
|
|
|
8.44%
|
|
Investment cost |
[5] |
|
|
$ 155,226
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 152,170
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Biotechnology Tools (0.08%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.08%
|
|
|
|
0.08%
|
|
|
|
Investment cost |
[2] |
$ 1,500
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
1,423
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Biotechnology Tools and Alamar Biosciences, Inc., Equity, Acquisition Date 2/21/2024, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
1,500
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,423
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Feb. 21, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
503,778
|
|
|
|
503,778
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.05%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.05%
|
|
|
|
0.05%
|
|
|
|
Investment cost |
[2] |
$ 1,675
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
917
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.13%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.13%
|
|
|
|
0.13%
|
|
Investment cost |
[5] |
|
|
$ 1,764
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
2,264
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
1,101
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 700
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jul. 16, 2013
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
130,191
|
|
|
|
130,191
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
128
|
[2] |
$ 128
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 37
|
|
$ 96
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 30, 2010
|
[3] |
Apr. 30, 2010
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
42,989
|
|
42,989
|
|
42,989
|
|
42,989
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,101
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 303
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jul. 16, 2013
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
130,191
|
|
|
|
130,191
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 433
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 22
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Apr. 30, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
12,260
|
|
|
|
12,260
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Equity, Acquisition Date 4/30/2021, Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 433
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 21
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Apr. 30, 2021
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
12,260
|
|
|
|
12,260
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 13
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 555
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Apr. 30, 2010
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
172,328
|
|
|
|
172,328
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Equity, Acquisition Date 4/30/2010, Class A Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 13
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 863
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Apr. 30, 2010
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
172,328
|
|
|
|
172,328
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 89
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 584
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Apr. 30, 2010
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
173,180
|
|
|
|
173,180
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Total Fabletics, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,229
|
[2] |
$ 1,229
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 340
|
|
$ 796
|
|
|
|
|
|
Shares (in shares) | shares |
|
173,180
|
|
173,180
|
|
173,180
|
|
173,180
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.37%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.37%
|
|
|
|
0.37%
|
|
|
|
Investment cost |
[2] |
$ 26,127
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
6,907
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.70%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.70%
|
|
|
|
0.70%
|
|
Investment cost |
[5] |
|
|
$ 26,145
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
12,703
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,151
|
[2],[32],[33] |
1,151
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 707
|
[32],[33] |
$ 679
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 15, 2021
|
[3],[32],[33] |
Dec. 15, 2021
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
199,742
|
[32],[33] |
199,742
|
[15],[16] |
199,742
|
[32],[33] |
199,742
|
[15],[16] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 657
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 5,636
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Dec. 20, 2018
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
56,996
|
|
|
|
56,996
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 5,263
|
[2],[3] |
$ 5,263
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 1,421
|
[3] |
$ 1,510
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 26, 2018
|
[3] |
Dec. 26, 2018
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
100,738
|
[3] |
100,738
|
[42] |
100,738
|
[3] |
100,738
|
[42] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2],[3] |
$ 1,000
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 167
|
[3] |
$ 343
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Sep. 17, 2021
|
[3] |
Sep. 17, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
100,000
|
[3] |
100,000
|
[42] |
100,000
|
[3] |
100,000
|
[42] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,663
|
[2] |
$ 1,663
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 400
|
|
$ 377
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 25, 2016
|
[3] |
Oct. 25, 2016
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
286,080
|
|
286,080
|
|
286,080
|
|
286,080
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 632
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 152
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Oct. 25, 2016
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
108,710
|
|
|
|
108,710
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 577
|
[2],[3] |
$ 577
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 140
|
[3] |
$ 189
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 28, 2013
|
[3] |
Jun. 28, 2013
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
48,365
|
[3] |
48,365
|
[42] |
48,365
|
[3] |
48,365
|
[42] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 39
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jul. 31, 2020
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
3,095
|
|
|
|
3,095
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2] |
$ 1,000
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 559
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 24, 2022
|
[3] |
Jan. 24, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
7,063
|
|
7,063
|
|
7,063
|
|
7,063
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 39
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jul. 31, 2020
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
3,095
|
|
|
|
3,095
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 13,263
|
[2],[37] |
$ 13,263
|
[5],[19] |
|
|
|
|
Investments, at fair value: |
|
$ 3,267
|
[37] |
$ 3,251
|
[19] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 29, 2023
|
[3],[37] |
Dec. 29, 2023
|
[19],[42] |
|
|
|
|
Shares (in shares) | shares |
|
3,235,298
|
[37] |
3,235,298
|
[19] |
3,235,298
|
[37] |
3,235,298
|
[19] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 900
|
[2],[37] |
$ 900
|
[5],[19] |
|
|
|
|
Investments, at fair value: |
|
$ 5
|
[37] |
$ 4
|
[19] |
|
|
|
|
Investments owned acquisition date |
|
May 23, 2018
|
[3],[37] |
May 23, 2018
|
[19],[42] |
|
|
|
|
Shares (in shares) | shares |
|
414,994,863
|
[37] |
414,994,863
|
[19] |
414,994,863
|
[37] |
414,994,863
|
[19] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 0
|
[2],[37] |
$ 0
|
[5],[19] |
|
|
|
|
Investments, at fair value: |
|
$ 12
|
[37] |
$ 12
|
[19] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 06, 2016
|
[3],[37] |
Jun. 06, 2016
|
[19],[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,000,000
|
[37] |
1,000,000
|
[19] |
1,000,000
|
[37] |
1,000,000
|
[19] |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,295
|
[2] |
$ 2,295
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 552
|
|
$ 520
|
|
|
|
|
|
Shares (in shares) | shares |
|
394,790
|
|
394,790
|
|
394,790
|
|
394,790
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 14,163
|
[2] |
$ 14,163
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 3,284
|
|
$ 3,267
|
|
|
|
|
|
Shares (in shares) | shares |
|
419,230,161
|
|
419,230,161
|
|
419,230,161
|
|
419,230,161
|
|
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Worldremit Group Limited, Equity, Acquisition Date 6/24/2024, Series Preferred Series X |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
$ 639
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 636
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Jun. 24, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[32],[33] |
6,641
|
|
|
|
6,641
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.84%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
2.84%
|
|
|
|
2.84%
|
|
|
|
Investment cost |
[2] |
$ 34,444
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
52,808
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (3.17%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
3.17%
|
|
|
|
3.17%
|
|
Investment cost |
[5] |
|
|
$ 34,444
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
57,072
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
34,006
|
[2],[37],[38] |
34,006
|
[5],[19],[20] |
|
|
|
|
Investments, at fair value: |
|
$ 21,743
|
[37],[38] |
$ 28,034
|
[19],[20] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 01, 2018
|
[3],[37],[38] |
Mar. 01, 2018
|
[19],[20],[42] |
|
|
|
|
Shares (in shares) | shares |
|
1
|
[37],[38] |
1
|
[19],[20] |
1
|
[37],[38] |
1
|
[19],[20] |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 35
|
[2],[37],[39] |
$ 35
|
[5],[19],[21] |
|
|
|
|
Investments, at fair value: |
|
$ 30,728
|
[37],[39] |
$ 28,713
|
[19],[21] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 26, 2021
|
[3],[37],[39] |
Mar. 26, 2021
|
[19],[21],[42] |
|
|
|
|
Shares (in shares) | shares |
|
1
|
[37],[39] |
1
|
[19],[21] |
1
|
[37],[39] |
1
|
[19],[21] |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 403
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 337
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Sep. 30, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
210,282
|
|
|
|
210,282
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 403
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 325
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Sep. 30, 2021
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
210,282
|
|
|
|
210,282
|
|
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.00%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.00%
|
[24] |
0.00%
|
[4] |
0.00%
|
[24] |
0.00%
|
[4] |
Investment cost |
|
$ 3,638
|
[2] |
$ 3,638
|
[5] |
|
|
|
|
Investments, at fair value: |
|
17
|
|
21
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,500
|
[2],[3] |
1,500
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 2
|
[3] |
$ 2
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 28, 2014
|
[3] |
Mar. 28, 2014
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
680
|
[3] |
680
|
[42] |
680
|
[3] |
680
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2] |
$ 500
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 08, 2015
|
[3] |
Dec. 08, 2015
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
165,000
|
|
165,000
|
|
165,000
|
|
165,000
|
|
Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 309
|
[2],[3] |
$ 309
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 7
|
[3] |
$ 12
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Apr. 06, 2015
|
[3] |
Apr. 06, 2015
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
2,498
|
[3] |
2,498
|
[42] |
2,498
|
[3] |
2,498
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc, Equity, Acquisition Date 12/10/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 1,329
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 8
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Dec. 10, 2018
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
8,836
|
|
|
|
8,836
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc. (p.k.a. AcelRx Pharmaceuticals, Inc.), Equity, Acquisition Date 12/10/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 1,329
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 7
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Dec. 10, 2018
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
8,836
|
|
|
|
8,836
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.04%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
2.04%
|
|
|
|
2.04%
|
|
|
|
Investment cost |
[2] |
$ 39,878
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
37,797
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.47%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
2.47%
|
|
|
|
2.47%
|
|
Investment cost |
[5] |
|
|
$ 40,735
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
44,500
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 3/8/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[32] |
1,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[32] |
$ 809
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32] |
Mar. 08, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[32] |
34,483
|
|
|
|
34,483
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2],[3] |
1,000
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 1
|
[3] |
$ 0
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Aug. 19, 2014
|
[3] |
Aug. 19, 2014
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
42
|
[3] |
42
|
[42] |
42
|
[3] |
42
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[32],[36] |
$ 4,165
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[32],[36] |
$ 10,225
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[36] |
May 09, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[32],[36] |
127,021
|
|
|
|
127,021
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc.., Equity, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[16],[18],[42] |
|
|
$ 4,165
|
|
|
|
|
|
Investments, at fair value: |
[16],[18],[42] |
|
|
$ 10,110
|
|
|
|
|
|
Investments owned acquisition date |
[16],[18],[42] |
|
|
May 09, 2022
|
|
|
|
|
|
Shares (in shares) | shares |
[16],[18],[42] |
|
|
127,021
|
|
|
|
127,021
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[15],[16],[42] |
|
|
$ 1,871
|
|
|
|
|
|
Investments, at fair value: |
[15],[16],[42] |
|
|
$ 1,774
|
|
|
|
|
|
Investments owned acquisition date |
[15],[16],[42] |
|
|
Oct. 05, 2020
|
|
|
|
|
|
Shares (in shares) | shares |
[15],[16],[42] |
|
|
98,100
|
|
|
|
98,100
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[32],[33] |
$ 1,871
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[32],[33] |
$ 1,986
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Oct. 05, 2020
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[32],[33] |
98,100
|
|
|
|
98,100
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,255
|
[2],[3] |
$ 2,255
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 5,860
|
[3] |
$ 9,339
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 21, 2018
|
[3] |
Jun. 21, 2018
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
231,329
|
[3] |
231,329
|
[42] |
231,329
|
[3] |
231,329
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport)., Equity, Acquisition Date 4/06/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[16],[42] |
|
|
$ 42
|
|
|
|
|
|
Investments, at fair value: |
[16],[42] |
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[16],[42] |
|
|
Apr. 06, 2021
|
|
|
|
|
|
Shares (in shares) | shares |
[16],[42] |
|
|
134
|
|
|
|
134
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc., Equity, Acquisition Date 4/6/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[32] |
$ 42
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[32] |
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32] |
Apr. 06, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[32] |
134
|
|
|
|
134
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 1,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 5
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jan. 08, 2015
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
13,550
|
|
|
|
13,550
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 1,000
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 4
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jan. 08, 2015
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
13,550
|
|
|
|
13,550
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 550
|
[2],[3],[32] |
$ 550
|
[5],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 225
|
[3],[32] |
$ 280
|
[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Jul. 22, 2015
|
[3],[32] |
Jul. 22, 2015
|
[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
20,000
|
[3],[32] |
20,000
|
[16],[42] |
20,000
|
[3],[32] |
20,000
|
[16],[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2],[3] |
$ 1,000
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 273
|
[3] |
$ 903
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Oct. 26, 2022
|
[3] |
Oct. 26, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
442,477
|
[3] |
442,477
|
[42] |
442,477
|
[3] |
442,477
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2],[3] |
$ 500
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 1,277
|
[3] |
$ 620
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Jul. 25, 2023
|
[3] |
Jul. 25, 2023
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
364,963
|
[3] |
364,963
|
[42] |
364,963
|
[3] |
364,963
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,250
|
[1],[2] |
$ 4,250
|
[5],[14] |
|
|
|
|
Investments, at fair value: |
|
$ 91
|
[1] |
$ 1,834
|
[14] |
|
|
|
|
Investments owned acquisition date |
|
May 07, 2021
|
[1],[3] |
May 07, 2021
|
[14],[42] |
|
|
|
|
Shares (in shares) | shares |
|
3,466,840
|
[1] |
3,466,840
|
[14] |
3,466,840
|
[1] |
3,466,840
|
[14] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 4,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 3,402
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
May 03, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
235,295
|
|
|
|
235,295
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, Acquisition Date 5/3/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 4,000
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 3,777
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
May 03, 2022
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
235,295
|
|
|
|
235,295
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[16],[42] |
|
|
$ 800
|
|
|
|
|
|
Investments, at fair value: |
[16],[42] |
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[16],[42] |
|
|
Mar. 31, 2021
|
|
|
|
|
|
Shares (in shares) | shares |
[16],[42] |
|
|
43,243
|
|
|
|
43,243
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 550
|
[2],[3],[32] |
$ 550
|
[5],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 985
|
[3],[32] |
$ 688
|
[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 16, 2023
|
[3],[32] |
Jun. 16, 2023
|
[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
47,826
|
[3],[32] |
47,826
|
[16],[42] |
47,826
|
[3],[32] |
47,826
|
[16],[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 773
|
[2],[3],[32] |
$ 773
|
[5],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 1,429
|
[3],[32] |
$ 1,180
|
[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Sep. 29, 2023
|
[3],[32] |
Sep. 29, 2023
|
[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
5,100
|
[3],[32] |
5,100
|
[16],[42] |
5,100
|
[3],[32] |
5,100
|
[16],[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2],[30],[32],[33] |
$ 2,000
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 1,148
|
[30],[32],[33] |
$ 1,427
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 15, 2021
|
[3],[30],[32],[33] |
Dec. 15, 2021
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
983
|
[30],[32],[33] |
983
|
[15],[16] |
983
|
[30],[32],[33] |
983
|
[15],[16] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,730
|
[2],[3],[32],[36] |
$ 1,730
|
[5],[16],[18],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 1,516
|
[3],[32],[36] |
$ 1,344
|
[16],[18],[42] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 09, 2023
|
[3],[32],[36] |
Jun. 09, 2023
|
[16],[18],[42] |
|
|
|
|
Shares (in shares) | shares |
|
147,233
|
[3],[32],[36] |
147,233
|
[16],[18],[42] |
147,233
|
[3],[32],[36] |
147,233
|
[16],[18],[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500
|
[2],[3] |
$ 1,500
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 20
|
[3] |
$ 28
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Aug. 22, 2007
|
[3] |
Aug. 22, 2007
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
944
|
[3] |
944
|
[42] |
944
|
[3] |
944
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 203
|
[2],[3] |
$ 203
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 45
|
[3] |
$ 52
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Aug. 11, 2015
|
[3] |
Aug. 11, 2015
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
11,119
|
[3] |
11,119
|
[42] |
11,119
|
[3] |
11,119
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,262
|
[2] |
$ 1,269
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 6
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Feb. 02, 2017
|
[3] |
Feb. 02, 2017
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
16,228
|
|
16,228
|
[42] |
16,228
|
|
16,228
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,050
|
[2],[3],[32] |
$ 2,100
|
[5],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 2,114
|
[3],[32] |
$ 3,150
|
[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
May 05, 2022
|
[3],[32] |
May 05, 2022
|
[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
77,778
|
[3],[32] |
155,555
|
[16],[42] |
77,778
|
[3],[32] |
155,555
|
[16],[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health, LLC |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 4,000
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 4,098
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
680,410
|
|
|
|
680,410
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2] |
$ 1,000
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 1,111
|
|
$ 1,187
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 31, 2022
|
[3] |
Oct. 31, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
170,102
|
|
170,102
|
|
170,102
|
|
170,102
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,000
|
[2] |
$ 3,000
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 2,450
|
|
$ 2,911
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 11, 2020
|
[3] |
Dec. 11, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
510,308
|
|
510,308
|
|
510,308
|
|
510,308
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500
|
[2] |
$ 1,500
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 1,420
|
|
$ 1,753
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 06, 2023
|
[3] |
Sep. 06, 2023
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
208,588
|
|
208,588
|
|
208,588
|
|
208,588
|
|
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 400
|
[2],[3],[32] |
$ 400
|
[5],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 420
|
[3],[32] |
$ 704
|
[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Nov. 06, 2023
|
[3],[32] |
Nov. 06, 2023
|
[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
32,310
|
[3],[32] |
32,310
|
[16],[42] |
32,310
|
[3],[32] |
32,310
|
[16],[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,945
|
[2],[3] |
$ 2,945
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 908
|
[3] |
$ 1,313
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Nov. 26, 2019
|
[3] |
Nov. 26, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,566,064
|
[3] |
1,566,064
|
[42] |
1,566,064
|
[3] |
1,566,064
|
[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 332
|
[2],[3],[32],[33] |
$ 332
|
[5],[15],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 77
|
[3],[32],[33] |
$ 116
|
[15],[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Jan. 31, 2019
|
[3],[32],[33] |
Jan. 31, 2019
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
17,175
|
[3],[32],[33] |
17,175
|
[15],[16],[42] |
17,175
|
[3],[32],[33] |
17,175
|
[15],[16],[42] |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development, Total Valo Health LLC |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 4,000
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,561
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
680,410
|
|
|
|
680,410
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.05%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.05%
|
[24] |
0.05%
|
[4] |
0.05%
|
[24] |
0.05%
|
[4] |
Investment cost |
|
$ 2,150
|
[2] |
$ 2,150
|
[5] |
|
|
|
|
Investments, at fair value: |
|
842
|
|
951
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
650
|
[2] |
650
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 291
|
|
$ 407
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 17, 2022
|
[3] |
Nov. 17, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
15,116
|
|
15,116
|
|
15,116
|
|
15,116
|
|
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,500
|
[2] |
$ 1,500
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 551
|
|
$ 544
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 08, 2022
|
[3] |
Mar. 08, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
248,900
|
|
248,900
|
|
248,900
|
|
248,900
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.05%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.05%
|
|
|
|
0.05%
|
|
Investment cost |
[5] |
|
|
$ 6,782
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
960
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.33%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.33%
|
|
|
|
0.33%
|
|
|
|
Investment cost |
[2] |
$ 12,543
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
6,121
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
5,094
|
[2],[3] |
5,094
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 323
|
[3] |
$ 754
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 11, 2019
|
[3] |
Mar. 11, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
825,732
|
[3] |
825,732
|
[42] |
825,732
|
[3] |
825,732
|
[42] |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,687
|
[2] |
$ 1,688
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 10
|
|
$ 206
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 30, 2021
|
[3] |
Mar. 30, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
217,880
|
|
217,880
|
|
217,880
|
|
217,880
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Click Therapeutics, Inc., Equity, Acquisition Date 5/20/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 1,662
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 1,689
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
May 20, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
560,000
|
|
|
|
560,000
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Curana Health Holdings, LLC, Equity, Acquisition Date 5/13/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 2,500
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 2,499
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
May 13, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
1,114,380
|
|
|
|
1,114,380
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Equity, Acquisition Date 6/10/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,600
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,600
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jun. 10, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
181,163
|
|
|
|
181,163
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Information Services (0.22%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.22%
|
|
|
|
0.22%
|
|
|
|
Investment cost |
[2] |
$ 3,825
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
4,163
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Information Services (0.35%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.35%
|
|
|
|
0.35%
|
|
Investment cost |
[5] |
|
|
$ 4,440
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
6,243
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
615
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 1,353
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jun. 21, 2019
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
547,880
|
|
|
|
547,880
|
|
Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
3,825
|
[2] |
$ 3,825
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 4,163
|
|
$ 4,890
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 30, 2021
|
[3] |
Dec. 30, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
41,021
|
|
41,021
|
|
41,021
|
|
41,021
|
|
Investment, Identifier [Axis]: Equity Investments Manufacturing Technology (0.03%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.03%
|
|
|
|
0.03%
|
|
|
|
Investment cost |
[2] |
$ 47
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
603
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Manufacturing Technology and Xometry, Inc., Equity, Acquisition Date 5/9/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
47
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 603
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
May 09, 2018
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
52,126
|
|
|
|
52,126
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.01%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.01%
|
[24] |
0.01%
|
[4] |
0.01%
|
[24] |
0.01%
|
[4] |
Investment cost |
|
$ 250
|
[2] |
$ 250
|
[5] |
|
|
|
|
Investments, at fair value: |
|
186
|
|
262
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
0
|
[2],[37] |
0
|
[5],[19] |
|
|
|
|
Investments, at fair value: |
|
$ 1
|
[37] |
$ 2
|
[19] |
|
|
|
|
Investments owned acquisition date |
|
Oct. 15, 2021
|
[3],[37] |
Oct. 15, 2021
|
[19],[42] |
|
|
|
|
Shares (in shares) | shares |
|
180,000
|
[37] |
180,000
|
[19] |
180,000
|
[37] |
180,000
|
[19] |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[37] |
$ 250
|
|
|
|
|
|
|
|
Investments, at fair value: |
[37] |
$ 185
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[37] |
Oct. 15, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[37] |
5,000,000
|
|
|
|
5,000,000
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 250
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 262
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
5,180,000
|
|
|
|
5,180,000
|
|
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Total Coronado Aesthetics, LLC |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 250
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 186
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
5,180,000
|
|
|
|
5,180,000
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.02%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.02%
|
[24] |
0.02%
|
[4] |
0.02%
|
[24] |
0.02%
|
[4] |
Investment cost |
|
$ 160
|
[2] |
$ 160
|
[5] |
|
|
|
|
Investments, at fair value: |
|
291
|
|
394
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
160
|
[2] |
160
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 291
|
|
$ 394
|
|
|
|
|
|
Investments owned acquisition date |
|
Jul. 01, 2011
|
[3] |
Jul. 01, 2011
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
277,995
|
|
277,995
|
|
277,995
|
|
277,995
|
|
Investment, Identifier [Axis]: Equity Investments Software (1.27%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.27%
|
|
|
|
1.27%
|
|
Investment cost |
[5] |
|
|
$ 23,210
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
22,919
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software (1.33%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
1.33%
|
|
|
|
1.33%
|
|
|
|
Investment cost |
[2] |
$ 23,968
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
24,688
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
1,000
|
[2] |
1,000
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 795
|
|
$ 863
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 09, 2021
|
[3] |
Aug. 09, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,000,000
|
|
1,000,000
|
|
1,000,000
|
|
1,000,000
|
|
Investment, Identifier [Axis]: Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,406
|
[2],[43] |
$ 2,406
|
[5],[44] |
|
|
|
|
Investments, at fair value: |
|
$ 2,406
|
[43] |
$ 2,406
|
[44] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 24, 2021
|
[3],[43] |
Mar. 24, 2021
|
[42],[44] |
|
|
|
|
Shares (in shares) | shares |
|
3
|
[43] |
3
|
[44] |
3
|
[43] |
3
|
[44] |
Investment, Identifier [Axis]: Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 51
|
[2] |
$ 51
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 26, 2012
|
[3] |
Oct. 26, 2012
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
53,614
|
|
53,614
|
|
53,614
|
|
53,614
|
|
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2],[32],[33] |
$ 500
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 759
|
[32],[33] |
$ 842
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Nov. 20, 2018
|
[3],[32],[33] |
Nov. 20, 2018
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
108,500
|
[32],[33] |
108,500
|
[15],[16] |
108,500
|
[32],[33] |
108,500
|
[15],[16] |
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 138
|
[2],[32],[33] |
$ 138
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 271
|
[32],[33] |
$ 303
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 22, 2020
|
[3],[32],[33] |
Dec. 22, 2020
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
41,000
|
[32],[33] |
41,000
|
[15],[16] |
41,000
|
[32],[33] |
41,000
|
[15],[16] |
Investment, Identifier [Axis]: Equity Investments Software and DNAnexus, Inc, Equity, Acquisition Date 3/21/2014, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 97
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 7
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 21, 2014
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
51,948
|
|
|
|
51,948
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,284
|
[2] |
$ 4,284
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 180
|
|
$ 636
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 29, 2018
|
[3] |
Nov. 29, 2018
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
20,000
|
|
20,000
|
|
20,000
|
|
20,000
|
|
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,000
|
[2] |
$ 1,000
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 2,544
|
|
$ 2,752
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 22, 2015
|
[3] |
Oct. 22, 2015
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
458,841
|
|
458,841
|
|
458,841
|
|
458,841
|
|
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 300
|
[2] |
$ 300
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 545
|
|
$ 587
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 24, 2017
|
[3] |
Aug. 24, 2017
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
93,620
|
|
93,620
|
|
93,620
|
|
93,620
|
|
Investment, Identifier [Axis]: Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 307
|
[2] |
$ 307
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Jan. 18, 2013
|
[3] |
Jan. 18, 2013
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
190
|
|
190
|
|
190
|
|
190
|
|
Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS, Equity, Acquisition Date 8/25/2023, Preferred Series B2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
$ 250
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 231
|
|
|
|
|
|
Investments owned acquisition date |
[15],[16],[42] |
|
|
Aug. 25, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
[15],[16] |
|
|
183,073
|
|
|
|
183,073
|
|
Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
$ 250
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 162
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Aug. 25, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[32],[33] |
183,073
|
|
|
|
183,073
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 265
|
[2] |
$ 265
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 18
|
|
$ 23
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 04, 2020
|
[3] |
Dec. 04, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
38,461
|
|
38,461
|
|
38,461
|
|
38,461
|
|
Investment, Identifier [Axis]: Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,854
|
[2],[3] |
$ 4,854
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 2,834
|
[3] |
$ 1,927
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Aug. 01, 2018
|
[3] |
Aug. 01, 2018
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,019,255
|
[3] |
1,019,255
|
[42] |
1,019,255
|
[3] |
1,019,255
|
[42] |
Investment, Identifier [Axis]: Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,445
|
[2],[3] |
$ 3,474
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 10,132
|
[3] |
$ 9,758
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Sep. 23, 2020
|
[3] |
Sep. 23, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
400,000
|
[3] |
568,337
|
[42] |
400,000
|
[3] |
568,337
|
[42] |
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2] |
$ 2,000
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 1,746
|
|
$ 1,721
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 25, 2020
|
[3] |
Nov. 25, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
580,983
|
|
580,983
|
|
580,983
|
|
580,983
|
|
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 280
|
[2] |
$ 280
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 196
|
|
$ 196
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 12, 2021
|
[3] |
Aug. 12, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
52,956
|
|
52,956
|
|
52,956
|
|
52,956
|
|
Investment, Identifier [Axis]: Equity Investments Software and Sirion Labs, Inc., Equity, Acquisition Date 6/30/2024, Series Preferred Series F1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
$ 1,791
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 1,791
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Jun. 30, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[32],[33] |
152,250
|
|
|
|
152,250
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software and Total Contentful Global, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 638
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 1,145
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
149,500
|
|
|
|
149,500
|
|
Investment, Identifier [Axis]: Equity Investments Software and Total Druva Holdings, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 1,300
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,339
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
552,461
|
|
|
|
552,461
|
|
Investment, Identifier [Axis]: Equity Investments Software and Total SingleStore, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 2,280
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 1,917
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
633,939
|
|
|
|
633,939
|
|
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2] |
$ 2,000
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 302
|
|
$ 422
|
|
|
|
|
|
Investments owned acquisition date |
|
Jul. 08, 2021
|
[3] |
Jul. 08, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
952,562
|
|
952,562
|
|
952,562
|
|
952,562
|
|
Investment, Identifier [Axis]: Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 101
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 252
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
May 07, 2020
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
289,992
|
|
|
|
289,992
|
|
Investment, Identifier [Axis]: Equity Investments Software, Total Contentful Global, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 638
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,030
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
149,500
|
|
|
|
149,500
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software, Total Druva Holdings, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 1,300
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,089
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
552,461
|
|
|
|
552,461
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Software, Total SingleStore, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 2,280
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 1,942
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
633,939
|
|
|
|
633,939
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Space Technologies (0.05%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.05%
|
|
|
|
0.05%
|
|
|
|
Investment cost |
[2] |
$ 615
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
1,019
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Space Technologies and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
615
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 1,019
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jun. 21, 2019
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
547,880
|
|
|
|
547,880
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.13%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.13%
|
|
|
|
0.13%
|
|
|
|
Investment cost |
[2] |
$ 10,966
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
2,469
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.22%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.22%
|
|
|
|
0.22%
|
|
Investment cost |
[5] |
|
|
$ 11,508
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
3,881
|
|
|
|
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
711
|
[2] |
711
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 529
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 13, 2012
|
[3] |
Sep. 13, 2012
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
187,265
|
|
187,265
|
|
187,265
|
|
187,265
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 2,000
|
[2] |
$ 2,000
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 270
|
|
$ 479
|
|
|
|
|
|
Investments owned acquisition date |
|
May 10, 2019
|
[3] |
May 10, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
188,611
|
|
188,611
|
|
188,611
|
|
188,611
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 500
|
[2] |
$ 500
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 01, 2015
|
[3] |
Jun. 01, 2015
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,035
|
|
1,035
|
|
1,035
|
|
1,035
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 102
|
[2] |
$ 102
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 31, 2013
|
[3] |
Aug. 31, 2013
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
59,665
|
|
59,665
|
|
59,665
|
|
59,665
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 3,153
|
[2],[3] |
$ 3,153
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 28
|
[3] |
$ 180
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 10, 2020
|
[3] |
Dec. 10, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
20,299
|
[3] |
304,487
|
[42] |
20,299
|
[3] |
304,487
|
[42] |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 4,500
|
[2] |
$ 4,500
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 2,171
|
|
$ 2,684
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 28, 2021
|
[3] |
Jun. 28, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
593,080
|
|
593,080
|
|
593,080
|
|
593,080
|
|
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 542
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 9
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
May 28, 2015
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
457,841
|
|
|
|
457,841
|
|
Investment, Identifier [Axis]: Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[19] |
|
|
$ 250
|
|
|
|
|
|
Investments, at fair value: |
[19] |
|
|
$ 260
|
|
|
|
|
|
Investments owned acquisition date |
[19],[42] |
|
|
Oct. 15, 2021
|
|
|
|
|
|
Shares (in shares) | shares |
[19] |
|
|
5,000,000
|
|
|
|
5,000,000
|
|
Investment, Identifier [Axis]: Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date10/25/2016, Series Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 632
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 143
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Oct. 25, 2016
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
108,710
|
|
|
|
108,710
|
|
Investment, Identifier [Axis]: Investment Fund After Cash & Cash Equivalents (183.28%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
|
|
183.28%
|
|
|
|
183.28%
|
|
Investment cost |
[5] |
|
|
$ 3,303,033
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
3,304,046
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
56,000
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 56,000
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Fund In Cash & Cash Equivalents (3.11%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
|
|
3.11%
|
|
|
|
3.11%
|
|
Investment cost |
[5] |
|
|
$ 56,000
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 56,000
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.26%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.26%
|
|
|
|
0.26%
|
|
Investment cost |
[5] |
|
|
$ 4,483
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 4,608
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.37%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.37%
|
|
|
|
0.37%
|
|
|
|
Investment cost |
[2] |
$ 4,937
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 6,857
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.23%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.23%
|
|
|
|
0.23%
|
|
Investment cost |
[5] |
|
|
$ 4,102
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
4,230
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.35%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.35%
|
|
|
|
0.35%
|
|
|
|
Investment cost |
[2] |
$ 4,556
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
6,462
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
3,783
|
[2],[30],[32],[33] |
3,783
|
[5],[12],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 5,439
|
[30],[32],[33] |
$ 3,619
|
[12],[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Nov. 16, 2020
|
[3],[30],[32],[33] |
Nov. 16, 2020
|
[12],[15],[16],[42] |
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 773
|
[2],[30],[32],[33] |
$ 319
|
[5],[12],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 1,023
|
[30],[32],[33] |
$ 611
|
[12],[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 23, 2022
|
[3],[30],[32],[33] |
Jun. 23, 2022
|
[12],[15],[16],[42] |
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.02%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.02%
|
[24] |
0.02%
|
[4] |
0.02%
|
[24] |
0.02%
|
[4] |
Investment cost |
|
$ 381
|
[2] |
$ 381
|
[5] |
|
|
|
|
Investments, at fair value: |
|
395
|
|
$ 378
|
|
|
|
|
|
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
381
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 395
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Jul. 21, 2022
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments (180.18%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
180.18%
|
|
|
|
180.18%
|
|
Investment cost |
[5] |
|
|
$ 3,247,033
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,248,046
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments (192.21%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
192.21%
|
|
|
|
192.21%
|
|
|
|
Investment cost |
[2] |
$ 3,609,118
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,568,539
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments in Securities (179.92%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
179.92%
|
|
|
|
179.92%
|
|
Investment cost |
[5] |
|
|
$ 3,242,550
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,243,438
|
|
|
|
|
|
Investment, Identifier [Axis]: Investments in Securities (191.84%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
191.84%
|
|
|
|
191.84%
|
|
|
|
Investment cost |
[2] |
$ 3,604,181
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 3,561,682
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Total Debt Investments (169.59%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
169.59%
|
|
|
|
169.59%
|
|
Investment cost |
[5] |
|
|
$ 3,058,370
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,057,299
|
|
|
|
|
|
Investment, Identifier [Axis]: Total Warrant Investments (1.88%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
1.88%
|
|
|
|
1.88%
|
|
Investment cost |
[5] |
|
|
$ 28,954
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 33,969
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Diversified Financial Services (0.03%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
|
|
0.03%
|
|
|
|
0.03%
|
|
Investment cost |
|
|
|
$ 214
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 554
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments (1.56%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
1.56%
|
|
|
|
1.56%
|
|
|
|
Investment cost |
[2] |
$ 31,545
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 28,922
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.01%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.01%
|
|
|
|
0.01%
|
|
|
|
Investment cost |
[2] |
$ 496
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
172
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.02%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.02%
|
|
|
|
0.02%
|
|
Investment cost |
[5] |
|
|
$ 496
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
354
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
36
|
[2] |
36
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 76
|
|
$ 20
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 21, 2022
|
[3] |
Jun. 21, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
46,197
|
|
46,197
|
|
46,197
|
|
46,197
|
|
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 460
|
[2],[25] |
$ 460
|
[5],[10] |
|
|
|
|
Investments, at fair value: |
|
$ 96
|
[25] |
$ 334
|
[10] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 23, 2022
|
[3],[25] |
Dec. 23, 2022
|
[10],[42] |
|
|
|
|
Shares (in shares) | shares |
|
53,418
|
[25] |
53,418
|
[10] |
53,418
|
[25] |
53,418
|
[10] |
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking (0.01%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.01%
|
[24] |
0.01%
|
[4] |
0.01%
|
[24] |
0.01%
|
[4] |
Investment cost |
|
$ 123
|
[2] |
$ 123
|
[5] |
|
|
|
|
Investments, at fair value: |
|
102
|
|
128
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
123
|
[2],[25] |
123
|
[5],[10] |
|
|
|
|
Investments, at fair value: |
|
$ 102
|
[25] |
$ 128
|
[10] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 28, 2022
|
[3],[25] |
Jun. 28, 2022
|
[10],[42] |
|
|
|
|
Shares (in shares) | shares |
|
229,611
|
[25] |
229,611
|
[10] |
229,611
|
[25] |
229,611
|
[10] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.02%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.02%
|
[24] |
0.02%
|
[4] |
0.02%
|
[24] |
0.02%
|
[4] |
Investment cost |
|
$ 611
|
[2] |
$ 611
|
[5] |
|
|
|
|
Investments, at fair value: |
|
306
|
|
325
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
228
|
[2] |
228
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 03, 2014
|
[3] |
Jun. 03, 2014
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,662,441
|
|
1,662,441
|
|
1,662,441
|
|
1,662,441
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 365
|
[2] |
$ 365
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 13, 2014
|
[3] |
Aug. 13, 2014
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
54,054
|
|
54,054
|
|
54,054
|
|
54,054
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 18
|
[2] |
$ 18
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 306
|
|
$ 325
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 27, 2018
|
[3] |
Jun. 27, 2018
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
686,270
|
|
686,270
|
|
686,270
|
|
686,270
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.18%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.18%
|
|
|
|
0.18%
|
|
|
|
Investment cost |
[2] |
$ 4,163
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
3,340
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.23%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.23%
|
|
|
|
0.23%
|
|
Investment cost |
[5] |
|
|
$ 4,208
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
4,217
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services , Total Carwow LTD |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
184
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 68
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
283,420
|
|
|
|
283,420
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 164
|
[2],[32],[33] |
164
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 57
|
[32],[33] |
$ 75
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 14, 2021
|
[3],[32],[33] |
Dec. 14, 2021
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
174,163
|
[32],[33] |
174,163
|
[15],[16] |
174,163
|
[32],[33] |
174,163
|
[15],[16] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
$ 20
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 11
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Feb. 13, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[32],[33] |
109,257
|
|
|
|
109,257
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 20
|
[2] |
$ 20
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 29, 2019
|
[3] |
Oct. 29, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
529,661
|
|
529,661
|
|
529,661
|
|
529,661
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 116
|
[1],[2] |
$ 116
|
[5],[14] |
|
|
|
|
Investments, at fair value: |
|
$ 302
|
[1] |
$ 298
|
[14] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 12, 2021
|
[1],[3] |
Mar. 12, 2021
|
[14],[42] |
|
|
|
|
Shares (in shares) | shares |
|
11,806
|
[1] |
11,806
|
[14] |
11,806
|
[1] |
11,806
|
[14] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 39
|
[2] |
$ 39
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 20
|
|
$ 33
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 29, 2019
|
[3] |
Mar. 29, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
127,032
|
|
127,032
|
|
127,032
|
|
127,032
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
$ 60
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 42
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Oct. 03, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[32],[33] |
27,298
|
|
|
|
27,298
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary shares |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
$ 48
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 51
|
|
|
|
|
|
Investments owned acquisition date |
[15],[16],[42] |
|
|
Oct. 03, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
[15],[16] |
|
|
19,499
|
|
|
|
19,499
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 166
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 88
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Dec. 22, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
117,042
|
|
|
|
117,042
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
$ 166
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 74
|
|
|
|
|
|
Investments owned acquisition date |
[14],[42] |
|
|
Dec. 22, 2022
|
|
|
|
|
|
Shares (in shares) | shares |
[14] |
|
|
117,042
|
|
|
|
117,042
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 470
|
[1],[2] |
$ 470
|
[5],[14] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[1] |
$ 4
|
[14] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 12, 2021
|
[1],[3] |
Mar. 12, 2021
|
[14],[42] |
|
|
|
|
Shares (in shares) | shares |
|
13,106
|
[1] |
13,106
|
[14] |
13,106
|
[1] |
13,106
|
[14] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 842
|
[2],[36] |
$ 842
|
[5],[18] |
|
|
|
|
Investments, at fair value: |
|
$ 2,039
|
[36] |
$ 3,065
|
[18] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 12, 2019
|
[3],[36] |
Jun. 12, 2019
|
[18],[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,379,761
|
[36] |
1,379,761
|
[18] |
1,379,761
|
[36] |
1,379,761
|
[18] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 57
|
[2] |
$ 57
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 54
|
|
$ 58
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 14, 2022
|
[3] |
Nov. 14, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,607,143
|
|
1,607,143
|
|
1,607,143
|
|
1,607,143
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 83
|
[2] |
$ 83
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 5
|
|
$ 5
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 23, 2019
|
[3] |
Aug. 23, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
444,444
|
|
444,444
|
|
444,444
|
|
444,444
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 16
|
[2] |
$ 16
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 20, 2020
|
[3] |
Apr. 20, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
600,000
|
|
600,000
|
|
600,000
|
|
600,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 782
|
[2] |
$ 782
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2016
|
[3] |
Jun. 30, 2016
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,800,000
|
|
1,800,000
|
|
1,800,000
|
|
1,800,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 62
|
[2] |
$ 62
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 01, 2018
|
[3] |
Aug. 01, 2018
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,211,537
|
|
1,211,537
|
|
1,211,537
|
|
1,211,537
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 985
|
[2],[25] |
$ 844
|
[5],[10] |
|
|
|
|
Investments, at fair value: |
|
$ 610
|
[25] |
$ 515
|
[10] |
|
|
|
|
Investments owned acquisition date |
|
May 01, 2018
|
[3],[25] |
May 01, 2018
|
[10],[42] |
|
|
|
|
Shares (in shares) | shares |
|
343,497
|
[25] |
267,225
|
[10] |
343,497
|
[25] |
267,225
|
[10] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Skyword, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 140
|
[2] |
$ 140
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 59
|
|
$ 63
|
|
|
|
|
|
Shares (in shares) | shares |
|
2,051,587
|
|
2,051,587
|
|
2,051,587
|
|
2,051,587
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc. |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 860
|
[2] |
$ 860
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Shares (in shares) | shares |
|
3,611,537
|
|
3,611,537
|
|
3,611,537
|
|
3,611,537
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 155
|
[2] |
$ 155
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 104
|
|
$ 23
|
|
|
|
|
|
Shares (in shares) | shares |
|
79,083
|
|
79,083
|
|
79,083
|
|
79,083
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[10] |
|
|
$ 218
|
|
|
|
|
|
Investments, at fair value: |
[10] |
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[10],[42] |
|
|
Sep. 25, 2020
|
|
|
|
|
|
Shares (in shares) | shares |
[10] |
|
|
486,359
|
|
|
|
486,359
|
|
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 126
|
[2],[25] |
$ 126
|
[5],[10] |
|
|
|
|
Investments, at fair value: |
|
$ 8
|
[25] |
$ 16
|
[10] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 31, 2022
|
[3],[25] |
Mar. 31, 2022
|
[10],[42] |
|
|
|
|
Shares (in shares) | shares |
|
98,428
|
[25] |
98,428
|
[10] |
98,428
|
[25] |
98,428
|
[10] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 129
|
[2],[25],[32],[33] |
$ 129
|
[5],[10],[15],[16],[18] |
|
|
|
|
Investments, at fair value: |
|
$ 104
|
[25],[32],[33] |
$ 23
|
[10],[15],[16],[18] |
|
|
|
|
Investments owned acquisition date |
|
Feb. 11, 2021
|
[3],[25],[32],[33] |
Feb. 11, 2021
|
[10],[15],[16],[18],[42] |
|
|
|
|
Shares (in shares) | shares |
|
77,215
|
[25],[32],[33] |
77,215
|
[10],[15],[16],[18] |
77,215
|
[25],[32],[33] |
77,215
|
[10],[15],[16],[18] |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 26
|
[2],[32],[33] |
$ 26
|
[5],[15],[16],[18] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[32],[33] |
$ 0
|
[15],[16],[18] |
|
|
|
|
Investments owned acquisition date |
|
Aug. 27, 2021
|
[3],[32],[33] |
Aug. 27, 2021
|
[15],[16],[18],[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,868
|
[32],[33] |
1,868
|
[15],[16],[18] |
1,868
|
[32],[33] |
1,868
|
[15],[16],[18] |
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
|
|
$ 214
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 554
|
|
|
|
|
|
Investments owned acquisition date |
|
|
|
Feb. 03, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
522,930
|
|
|
|
522,930
|
|
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.03%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.03%
|
|
|
|
0.03%
|
|
|
|
Investment cost |
[2] |
$ 214
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
521
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
214
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 521
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Feb. 03, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
522,930
|
|
|
|
522,930
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery (0.00%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.00%
|
[24] |
0.00%
|
[4] |
0.00%
|
[24] |
0.00%
|
[4] |
Investment cost |
|
$ 392
|
[2] |
$ 392
|
[5] |
|
|
|
|
Investments, at fair value: |
|
0
|
|
0
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
0
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jun. 01, 2016
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
67,069
|
|
|
|
67,069
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
2
|
[2] |
$ 2
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Oct. 27, 2014
|
[3] |
Oct. 27, 2014
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
459,183
|
|
459,183
|
|
459,183
|
|
459,183
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 390
|
[2],[3] |
$ 390
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 0
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Aug. 28, 2014
|
[3] |
Aug. 28, 2014
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
3,929
|
[3] |
3,929
|
[42] |
3,929
|
[3] |
3,929
|
[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.46%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.46%
|
|
|
|
0.46%
|
|
Investment cost |
[5] |
|
|
$ 7,517
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
8,302
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.53%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.53%
|
|
|
|
0.53%
|
|
|
|
Investment cost |
[2] |
$ 9,068
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
9,889
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc.., Warrant, Acquisition Date 2/24/2014 Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[42] |
|
|
166
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 11
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Feb. 24, 2014
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
58,000
|
|
|
|
58,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
330
|
[2],[3],[32] |
$ 175
|
[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 454
|
[3],[32] |
$ 335
|
[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 15, 2022
|
[3],[32] |
Jun. 15, 2022
|
[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
32,128
|
[3],[32] |
22,949
|
[16],[42] |
32,128
|
[3],[32] |
22,949
|
[16],[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, Warrant, Acquisition Date 12/27/2022, Series Class A Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[14] |
|
|
$ 237
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 184
|
|
|
|
|
|
Investments owned acquisition date |
[14],[42] |
|
|
Dec. 27, 2022
|
|
|
|
|
|
Shares (in shares) | shares |
[14] |
|
|
69,239
|
|
|
|
69,239
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,290
|
[2],[3],[25],[32],[36] |
$ 1,290
|
[10],[16],[18],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 1,535
|
[3],[25],[32],[36] |
$ 1,657
|
[10],[16],[18],[42] |
|
|
|
|
Investments owned acquisition date |
|
Sep. 25, 2020
|
[3],[25],[32],[36] |
Sep. 25, 2020
|
[10],[16],[18],[42] |
|
|
|
|
Shares (in shares) | shares |
|
61,004
|
[3],[25],[32],[36] |
61,004
|
[10],[16],[18],[42] |
61,004
|
[3],[25],[32],[36] |
61,004
|
[10],[16],[18],[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 278
|
[2],[3],[32],[33] |
$ 278
|
[15],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 150
|
[3],[32],[33] |
$ 285
|
[15],[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2023
|
[3],[32],[33] |
Jun. 30, 2023
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
75,376
|
[3],[32],[33] |
75,376
|
[15],[16],[42] |
75,376
|
[3],[32],[33] |
75,376
|
[15],[16],[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 287
|
[1],[2] |
$ 287
|
[14] |
|
|
|
|
Investments, at fair value: |
|
$ 152
|
[1] |
$ 201
|
[14] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 08, 2021
|
[1],[3] |
Dec. 08, 2021
|
[14],[42] |
|
|
|
|
Shares (in shares) | shares |
|
100,000
|
[1] |
100,000
|
[14] |
100,000
|
[1] |
100,000
|
[14] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 37
|
[2],[3] |
$ 37
|
[42] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 1
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Sep. 14, 2020
|
[3] |
Sep. 14, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
16,112
|
[3] |
16,112
|
[42] |
16,112
|
[3] |
16,112
|
[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[14] |
|
|
$ 233
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 251
|
|
|
|
|
|
Investments owned acquisition date |
[14],[42] |
|
|
Jun. 09, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
[14] |
|
|
95,221
|
|
|
|
95,221
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 233
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 308
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Jun. 09, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
95,221
|
|
|
|
95,221
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 101
|
[2],[32],[33] |
$ 101
|
[16] |
|
|
|
|
Investments, at fair value: |
|
$ 6
|
[32],[33] |
$ 7
|
[16] |
|
|
|
|
Investments owned acquisition date |
|
May 31, 2019
|
[3],[32],[33] |
May 31, 2019
|
[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
223,642
|
[32],[33] |
223,642
|
[16] |
223,642
|
[32],[33] |
223,642
|
[16] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[42] |
|
|
$ 266
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jun. 11, 2014
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
3
|
|
|
|
3
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[42] |
|
|
$ 119
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Feb. 18, 2016
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
201
|
|
|
|
201
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc., Warrant, Acquisition Date 2/18/2016, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 119
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Feb. 18, 2016
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
201
|
|
|
|
201
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 228
|
[1],[2],[3] |
$ 228
|
[14],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 494
|
[1],[3] |
$ 223
|
[14],[42] |
|
|
|
|
Investments owned acquisition date |
|
Aug. 09, 2023
|
[1],[3] |
Aug. 09, 2023
|
[14],[42] |
|
|
|
|
Shares (in shares) | shares |
|
238,095
|
[1],[3] |
238,095
|
[14],[42] |
238,095
|
[1],[3] |
238,095
|
[14],[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 110
|
[2],[3] |
$ 110
|
[42] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 0
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Dec. 20, 2019
|
[3] |
Dec. 20, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
2,202
|
[3] |
2,202
|
[42] |
2,202
|
[3] |
2,202
|
[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 88
|
[1],[2],[3],[32] |
$ 88
|
[14],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 107
|
[1],[3],[32] |
$ 63
|
[14],[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Nov. 02, 2022
|
[1],[3],[32] |
Nov. 02, 2022
|
[14],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
14,342
|
[1],[3],[32] |
14,342
|
[14],[16],[42] |
14,342
|
[1],[3],[32] |
14,342
|
[14],[16],[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 570
|
[2],[3],[32] |
$ 570
|
[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 2,209
|
[3],[32] |
$ 1,842
|
[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
May 09, 2022
|
[3],[32] |
May 09, 2022
|
[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
13,229
|
[3],[32] |
13,229
|
[16],[42] |
13,229
|
[3],[32] |
13,229
|
[16],[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 848
|
[1],[2],[3],[25],[32],[36] |
$ 848
|
[10],[14],[16],[18],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 50
|
[1],[3],[25],[32],[36] |
$ 68
|
[10],[14],[16],[18],[42] |
|
|
|
|
Investments owned acquisition date |
|
Sep. 17, 2021
|
[1],[3],[25],[32],[36] |
Sep. 17, 2021
|
[10],[14],[16],[18],[42] |
|
|
|
|
Shares (in shares) | shares |
|
64,687
|
[1],[3],[25],[32],[36] |
64,687
|
[10],[14],[16],[18],[42] |
64,687
|
[1],[3],[25],[32],[36] |
64,687
|
[10],[14],[16],[18],[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 20
|
[1],[2] |
$ 20
|
[14] |
|
|
|
|
Investments, at fair value: |
|
$ 22
|
[1] |
$ 6
|
[14] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 23, 2022
|
[1],[3] |
Mar. 23, 2022
|
[14],[42] |
|
|
|
|
Shares (in shares) | shares |
|
475,510
|
[1] |
475,510
|
[14] |
475,510
|
[1] |
475,510
|
[14] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 296
|
[2],[3] |
$ 296
|
[42] |
|
|
|
|
Investments, at fair value: |
|
$ 11
|
[3] |
$ 28
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
May 14, 2021
|
[3] |
May 14, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
106,035
|
[3] |
106,035
|
[42] |
106,035
|
[3] |
106,035
|
[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and SynOx Therapeutics Limited, Warrant, Acquisition Date 4/18/2024, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
$ 83
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 83
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Apr. 18, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[32],[33] |
251,195
|
|
|
|
251,195
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,284
|
[2],[3],[25],[32] |
$ 1,284
|
[10],[16],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 2,629
|
[3],[25],[32] |
$ 2,583
|
[10],[16],[42] |
|
|
|
|
Investments owned acquisition date |
|
Feb. 28, 2019
|
[3],[25],[32] |
Feb. 28, 2019
|
[10],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
264,226
|
[3],[25],[32] |
264,226
|
[10],[16],[42] |
264,226
|
[3],[25],[32] |
264,226
|
[10],[16],[42] |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
|
|
$ 256
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 153
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jun. 15, 2020
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
102,216
|
|
|
|
102,216
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 256
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 134
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jun. 15, 2020
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
102,216
|
|
|
|
102,216
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 510
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 122
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 18, 2019
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
1,392,787
|
|
|
|
1,392,787
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/218/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[42] |
|
|
$ 510
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 225
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Mar. 18, 2019
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
1,392,787
|
|
|
|
1,392,787
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and blubird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 1,744
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 1,079
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 15, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
2,224,137
|
|
|
|
2,224,137
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[15],[16],[42] |
|
|
$ 118
|
|
|
|
|
|
Investments, at fair value: |
[15],[16],[42] |
|
|
$ 179
|
|
|
|
|
|
Investments owned acquisition date |
[15],[16],[42] |
|
|
Dec. 22, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
[15],[16],[42] |
|
|
43,689
|
|
|
|
43,689
|
|
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3],[32],[33] |
$ 118
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3],[32],[33] |
$ 188
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Dec. 22, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3],[32],[33] |
43,689
|
|
|
|
43,689
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.01%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.01%
|
|
|
|
0.01%
|
|
|
|
Investment cost |
[2] |
$ 692
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
231
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.02%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.02%
|
|
|
|
0.02%
|
|
Investment cost |
[5] |
|
|
$ 692
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
391
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
101
|
[2],[3] |
101
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 31
|
[3] |
$ 175
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 15, 2017
|
[3] |
Mar. 15, 2017
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
49,078
|
[3] |
49,078
|
[42] |
49,078
|
[3] |
49,078
|
[42] |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 34
|
[2] |
$ 34
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 44
|
|
$ 102
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 21, 2022
|
[3] |
Jun. 21, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
8,503
|
|
8,503
|
|
8,503
|
|
8,503
|
|
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 557
|
[2] |
$ 557
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 156
|
|
$ 114
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 08, 2021
|
[3] |
Nov. 08, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
622,255
|
|
622,255
|
|
622,255
|
|
622,255
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.03%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.03%
|
|
|
|
0.03%
|
|
Investment cost |
[5] |
|
|
$ 750
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
596
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.08%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.08%
|
|
|
|
0.08%
|
|
|
|
Investment cost |
[2] |
$ 1,668
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
1,518
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC., Warrant, Acquisition Date 1/4/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
156
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 381
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jan. 04, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
447,410
|
|
|
|
447,410
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
164
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 165
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Mar. 30, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
37,618
|
|
|
|
37,618
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 210
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 161
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 30, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
52,665
|
|
|
|
52,665
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and NeueHealth, Inc., Warrant, Acquisition Date 6/21/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 716
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 756
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jun. 21, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
185,625
|
|
|
|
185,625
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc., , Warrant, Acquisition Date 7/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 382
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 327
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jul. 03, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
194,830
|
|
|
|
194,830
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 382
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 120
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jul. 03, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
194,830
|
|
|
|
194,830
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Warrant, Acquisition Date 9/28/2023, Series Common Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
$ 83
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 95
|
|
|
|
|
|
Investments owned acquisition date |
[14],[42] |
|
|
Sep. 28, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
[14] |
|
|
51,760
|
|
|
|
51,760
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Series Common Units |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 83
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 100
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Sep. 28, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
51,760
|
|
|
|
51,760
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 121
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 28, 2022
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
192,431
|
|
|
|
192,431
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Warrant, Acquisition Date 3/28/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 121
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 9
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Mar. 28, 2022
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
192,431
|
|
|
|
192,431
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.00%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.00%
|
|
|
|
0.00%
|
|
|
|
Investment cost |
[2] |
$ 495
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
31
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.03%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.03%
|
|
|
|
0.03%
|
|
Investment cost |
[5] |
|
|
$ 694
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
486
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
207
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 33
|
|
|
|
|
|
Investments owned acquisition date |
[14],[42] |
|
|
Oct. 21, 2021
|
|
|
|
|
|
Shares (in shares) | shares |
[14] |
|
|
176,200
|
|
|
|
176,200
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
82
|
[2],[32],[33] |
$ 82
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[32],[33] |
$ 0
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Nov. 19, 2014
|
[3],[32],[33] |
Nov. 19, 2014
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
149,165
|
[32],[33] |
65,587
|
[15],[16] |
149,165
|
[32],[33] |
65,587
|
[15],[16] |
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Quid, Inc. (p.k.a NetBase Solutions), Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 356
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Aug. 22, 2017
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
60,000
|
|
|
|
60,000
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 356
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 362
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Aug. 22, 2017
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
60,000
|
|
|
|
60,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 57
|
[2],[32],[33] |
$ 49
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 31
|
[32],[33] |
$ 91
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Jun. 29, 2022
|
[3],[32],[33] |
Jun. 29, 2022
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
129,638
|
[32],[33] |
113,828
|
[15],[16] |
129,638
|
[32],[33] |
113,828
|
[15],[16] |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.06%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.06%
|
|
|
|
0.06%
|
|
|
|
Investment cost |
[2] |
$ 1,065
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
1,077
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.17%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.17%
|
|
|
|
0.17%
|
|
Investment cost |
[5] |
|
|
$ 1,112
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
3,000
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
537
|
[2] |
537
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 923
|
|
$ 279
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 31, 2022
|
[3] |
Mar. 31, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
392,308
|
|
392,308
|
|
392,308
|
|
392,308
|
|
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 528
|
[2] |
$ 528
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 154
|
|
$ 677
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 23, 2022
|
[3] |
Mar. 23, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
1,111,111
|
|
1,111,111
|
|
1,111,111
|
|
1,111,111
|
|
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 47
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 2,044
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
May 09, 2018
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
87,784
|
|
|
|
87,784
|
|
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.01%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
|
0.01%
|
[24] |
0.01%
|
[4] |
0.01%
|
[24] |
0.01%
|
[4] |
Investment cost |
|
$ 67
|
[2] |
$ 67
|
[5] |
|
|
|
|
Investments, at fair value: |
|
94
|
|
235
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
67
|
[2] |
67
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 94
|
|
$ 235
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 30, 2022
|
[3] |
Dec. 30, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
369,370
|
|
369,370
|
|
369,370
|
|
369,370
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.01%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.01%
|
|
|
|
0.01%
|
|
Investment cost |
[5] |
|
|
$ 956
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
262
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.03%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.03%
|
|
|
|
0.03%
|
|
|
|
Investment cost |
[2] |
$ 1,360
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
544
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Series Preferred Series B-1 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
294
|
[2] |
294
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
Dec. 29, 2017
|
[3] |
Dec. 29, 2017
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
3,076,323
|
|
3,076,323
|
|
3,076,323
|
|
3,076,323
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical Inc, Warrant, Acquisition Date 9/27/2013, Series Common stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 401
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 78
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Sep. 27, 2013
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
62,794
|
|
|
|
62,794
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 401
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 43
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Sep. 27, 2013
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
62,794
|
|
|
|
62,794
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
$ 200
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 184
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Sep. 08, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
728,317
|
|
|
|
728,317
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 277
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 135
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Sep. 08, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
1,032,718
|
|
|
|
1,032,718
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[3] |
$ 327
|
|
|
|
|
|
|
|
Investments, at fair value: |
[3] |
$ 366
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jan. 22, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[3] |
94,980
|
|
|
|
94,980
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 61
|
[2],[3] |
$ 61
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
[3] |
$ 0
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 31, 2017
|
[3] |
Mar. 31, 2017
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
15,712
|
[3] |
15,712
|
[42] |
15,712
|
[3] |
15,712
|
[42] |
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.03%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.03%
|
|
|
|
0.03%
|
|
|
|
Investment cost |
[2] |
$ 99
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
612
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.04%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.04%
|
|
|
|
0.04%
|
|
Investment cost |
[5] |
|
|
$ 99
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
811
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
99
|
[2] |
99
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 612
|
|
$ 811
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 26, 2015
|
[3] |
Jun. 26, 2015
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
750,000
|
|
750,000
|
|
750,000
|
|
750,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Software (0.55%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.55%
|
|
|
|
0.55%
|
|
|
|
Investment cost |
[2] |
$ 10,001
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
10,131
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software (0.75%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.75%
|
|
|
|
0.75%
|
|
Investment cost |
[5] |
|
|
$ 10,445
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
13,549
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
74
|
[2] |
74
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
|
May 22, 2015
|
[3] |
May 22, 2015
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
231,535
|
|
231,535
|
|
231,535
|
|
231,535
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 449
|
[2] |
$ 448
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 350
|
|
$ 430
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 23, 2022
|
[3] |
Sep. 23, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
254,778
|
|
254,778
|
|
254,778
|
|
254,778
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 284
|
[2] |
$ 284
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 490
|
|
$ 666
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 18, 2020
|
[3] |
Nov. 18, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
29,691
|
|
29,691
|
|
29,691
|
|
29,691
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 165
|
[1],[2] |
$ 165
|
[5],[14] |
|
|
|
|
Investments, at fair value: |
|
$ 47
|
[1] |
$ 47
|
[14] |
|
|
|
|
Investments owned acquisition date |
|
Oct. 04, 2021
|
[1],[3] |
Oct. 04, 2021
|
[14],[42] |
|
|
|
|
Shares (in shares) | shares |
|
194,629
|
[1] |
194,629
|
[14] |
194,629
|
[1] |
194,629
|
[14] |
Investment, Identifier [Axis]: Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 117
|
[2] |
$ 117
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 10
|
|
$ 12
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 30, 2020
|
[3] |
Sep. 30, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
211,342
|
|
211,342
|
|
211,342
|
|
211,342
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 71
|
[2] |
$ 71
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
$ 29
|
|
|
|
|
|
Investments owned acquisition date |
|
Nov. 06, 2018
|
[3] |
Nov. 06, 2018
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
477,454
|
|
477,454
|
|
477,454
|
|
477,454
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 54
|
[2],[32],[33] |
$ 54
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 1,137
|
[32],[33] |
$ 844
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Apr. 10, 2018
|
[3],[32],[33] |
Apr. 10, 2018
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
6,763
|
[32],[33] |
6,763
|
[15],[16] |
6,763
|
[32],[33] |
6,763
|
[15],[16] |
Investment, Identifier [Axis]: Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 462
|
[2],[3] |
$ 462
|
[5],[42] |
|
|
|
|
Investments, at fair value: |
|
$ 896
|
[3] |
$ 1,225
|
[42] |
|
|
|
|
Investments owned acquisition date |
|
Apr. 25, 2019
|
[3] |
Apr. 25, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
105,350
|
[3] |
105,350
|
[42] |
105,350
|
[3] |
105,350
|
[42] |
Investment, Identifier [Axis]: Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 26
|
[2],[25],[32],[33] |
$ 26
|
[5],[10],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 57
|
[25],[32],[33] |
$ 62
|
[10],[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Sep. 21, 2022
|
[3],[25],[32],[33] |
Sep. 21, 2022
|
[10],[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
102,898
|
[25],[32],[33] |
102,898
|
[10],[15],[16] |
102,898
|
[25],[32],[33] |
102,898
|
[10],[15],[16] |
Investment, Identifier [Axis]: Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 97
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 47
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Mar. 21, 2014
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
909,091
|
|
|
|
909,091
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 461
|
[2] |
$ 461
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 890
|
|
$ 258
|
|
|
|
|
|
Investments owned acquisition date |
|
Mar. 11, 2019
|
[3] |
Mar. 11, 2019
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
770,838
|
|
770,838
|
|
770,838
|
|
770,838
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 1,594
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 3,801
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Oct. 08, 2019
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
718,898
|
|
|
|
718,898
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 545
|
[2] |
$ 545
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 286
|
|
$ 396
|
|
|
|
|
|
Investments owned acquisition date |
|
Aug. 02, 2021
|
[3] |
Aug. 02, 2021
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
727,047
|
|
727,047
|
|
727,047
|
|
727,047
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,452
|
[2] |
$ 1,452
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 852
|
|
$ 1,207
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 28, 2023
|
[3] |
Jun. 28, 2023
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
49,309
|
|
49,309
|
|
49,309
|
|
49,309
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 278
|
[2] |
$ 278
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 324
|
|
$ 413
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2022
|
[3] |
Jun. 30, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
95,911
|
|
95,911
|
|
95,911
|
|
95,911
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Earnix, Inc., Warrant, Acquisition Date 6/6/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 220
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 234
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Jun. 06, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
20,762
|
|
|
|
20,762
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
$ 8
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 4
|
|
|
|
|
|
Investments owned acquisition date |
[15],[16],[42] |
|
|
Apr. 13, 2022
|
|
|
|
|
|
Shares (in shares) | shares |
[15],[16] |
|
|
522
|
|
|
|
522
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 583
|
[2] |
$ 583
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 180
|
|
$ 188
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 12, 2022
|
[3] |
Sep. 12, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
362,837
|
|
362,837
|
|
362,837
|
|
362,837
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 96
|
[2] |
$ 96
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 62
|
|
$ 77
|
|
|
|
|
|
Investments owned acquisition date |
|
May 10, 2018
|
[3] |
May 10, 2018
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
75,917
|
|
75,917
|
|
75,917
|
|
75,917
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 325
|
[2] |
$ 325
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 244
|
|
$ 456
|
|
|
|
|
|
Investments owned acquisition date |
|
Jul. 29, 2022
|
[3] |
Jul. 29, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
84,995
|
|
84,995
|
|
84,995
|
|
84,995
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Harness, Inc., Warrant, Acquisition Date 3/12/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 534
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 760
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 12, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
193,618
|
|
|
|
193,618
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Kore, ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 208
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 243
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Mar. 31, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
64,293
|
|
|
|
64,293
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 208
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 217
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 31, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
64,293
|
|
|
|
64,293
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 16
|
[2],[25],[32],[33] |
$ 16
|
[5],[10],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 23
|
[25],[32],[33] |
$ 35
|
[10],[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Jan. 23, 2023
|
[3],[25],[32],[33] |
Jan. 23, 2023
|
[10],[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
39,948
|
[25],[32],[33] |
39,948
|
[10],[15],[16] |
39,948
|
[25],[32],[33] |
39,948
|
[10],[15],[16] |
Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 131
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 49
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Feb. 14, 2018
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
89,685
|
|
|
|
89,685
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series LB-2 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 131
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 17
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Feb. 14, 2018
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
86,984
|
|
|
|
86,984
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 252
|
[2] |
$ 252
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 210
|
|
$ 306
|
|
|
|
|
|
Investments owned acquisition date |
|
Sep. 30, 2020
|
[3] |
Sep. 30, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
82,362
|
|
82,362
|
|
82,362
|
|
82,362
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Onna TechnologiesInc, Warrant, Acquisition Date 7/5/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 60
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 39
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Jul. 05, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
172,867
|
|
|
|
172,867
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Pindrop Security, Inc., Warrant, Acquisition Date 6/26/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 494
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 537
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Jun. 26, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
134,542
|
|
|
|
134,542
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 0
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
May 28, 2014
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
132,168
|
|
|
|
132,168
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 215
|
[2] |
$ 215
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 635
|
|
$ 447
|
|
|
|
|
|
Investments owned acquisition date |
|
Jun. 30, 2020
|
[3] |
Jun. 30, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
69,120
|
|
69,120
|
|
69,120
|
|
69,120
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Semperis Technologies Inc., Warrant, Acquisition Date 4/23/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 115
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 127
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Apr. 23, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
72,122
|
|
|
|
72,122
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 96
|
[2],[25] |
$ 96
|
[5],[10] |
|
|
|
|
Investments, at fair value: |
|
$ 59
|
[25] |
$ 76
|
[10] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 22, 2023
|
[3],[25] |
Mar. 22, 2023
|
[10],[42] |
|
|
|
|
Shares (in shares) | shares |
|
77,934
|
[25] |
77,934
|
[10] |
77,934
|
[25] |
77,934
|
[10] |
Investment, Identifier [Axis]: Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 103
|
[2] |
$ 103
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 412
|
|
$ 386
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 28, 2020
|
[3] |
Apr. 28, 2020
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
312,596
|
|
312,596
|
|
312,596
|
|
312,596
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2],[32],[33] |
$ 174
|
|
|
|
|
|
|
|
Investments, at fair value: |
[32],[33] |
$ 85
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3],[32],[33] |
Jun. 08, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[32],[33] |
321,956
|
|
|
|
321,956
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
$ 174
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 128
|
|
|
|
|
|
Investments owned acquisition date |
[15],[16],[42] |
|
|
Jun. 08, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
[15],[16] |
|
|
321,956
|
|
|
|
321,956
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Suzy Inc, Warrant, Acquisition Date 8/24/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[14] |
|
|
$ 367
|
|
|
|
|
|
Investments, at fair value: |
[14] |
|
|
$ 354
|
|
|
|
|
|
Investments owned acquisition date |
[14],[42] |
|
|
Aug. 24, 2023
|
|
|
|
|
|
Shares (in shares) | shares |
[14] |
|
|
292,936
|
|
|
|
292,936
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 367
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 234
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Aug. 24, 2023
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
292,936
|
|
|
|
292,936
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Series Preferred Series AA |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 234
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 904
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Nov. 03, 2014
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
8,076
|
|
|
|
8,076
|
|
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 359
|
[2],[32],[33] |
$ 174
|
[5],[15],[16] |
|
|
|
|
Investments, at fair value: |
|
$ 374
|
[32],[33] |
$ 234
|
[15],[16] |
|
|
|
|
Investments owned acquisition date |
|
Mar. 22, 2023
|
[3],[32],[33] |
Mar. 22, 2023
|
[15],[16],[42] |
|
|
|
|
Shares (in shares) | shares |
|
509,753
|
[32],[33] |
254,877
|
[15],[16] |
509,753
|
[32],[33] |
254,877
|
[15],[16] |
Investment, Identifier [Axis]: Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
$ 1,275
|
[1],[2] |
$ 1,275
|
[5],[14] |
|
|
|
|
Investments, at fair value: |
|
$ 382
|
[1] |
$ 186
|
[14] |
|
|
|
|
Investments owned acquisition date |
|
Jan. 21, 2022
|
[1],[3] |
Jan. 21, 2022
|
[14],[42] |
|
|
|
|
Shares (in shares) | shares |
|
152,048
|
[1] |
152,048
|
[14] |
152,048
|
[1] |
152,048
|
[14] |
Investment, Identifier [Axis]: Warrant Investments and Space Technologies (0.00%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.00%
|
|
|
|
0.00%
|
|
|
|
Investment cost |
[2] |
$ 207
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
14
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Space Technologies and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
207
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 14
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Oct. 21, 2021
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
176,200
|
|
|
|
176,200
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices (0.04%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.04%
|
|
|
|
0.04%
|
|
Investment cost |
[5] |
|
|
$ 39
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
676
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[42] |
|
|
39
|
|
|
|
|
|
Investments, at fair value: |
[42] |
|
|
$ 676
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Sep. 11, 2015
|
|
|
|
|
|
Shares (in shares) | shares |
[42] |
|
|
14,440
|
|
|
|
14,440
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.00%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[4] |
|
|
0.00%
|
|
|
|
0.00%
|
|
Investment cost |
[5] |
|
|
$ 539
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
83
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.02%) |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment owned, percent of net assets |
[24] |
0.02%
|
|
|
|
0.02%
|
|
|
|
Investment cost |
[2] |
$ 824
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
340
|
|
|
|
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
|
52
|
[2] |
52
|
[5] |
|
|
|
|
Investments, at fair value: |
|
$ 49
|
|
$ 36
|
|
|
|
|
|
Investments owned acquisition date |
|
Apr. 15, 2022
|
[3] |
Apr. 15, 2022
|
[42] |
|
|
|
|
Shares (in shares) | shares |
|
18,472
|
|
18,472
|
|
18,472
|
|
18,472
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[1],[2] |
$ 440
|
|
|
|
|
|
|
|
Investments, at fair value: |
[1] |
$ 291
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[1],[3] |
Mar. 27, 2024
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
[1] |
197,294
|
|
|
|
197,294
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Series Preferred Series A |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 155
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 36
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Apr. 22, 2014
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
325,000
|
|
|
|
325,000
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Series Common stock |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 63
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Apr. 07, 2015
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
144,914
|
|
|
|
144,914
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 63
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 11
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Apr. 07, 2015
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
131,883
|
|
|
|
131,883
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[2] |
$ 269
|
|
|
|
|
|
|
|
Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
Investments owned acquisition date |
[3] |
Mar. 24, 2015
|
|
|
|
|
|
|
|
Shares (in shares) | shares |
|
150,036
|
|
|
|
150,036
|
|
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Total Halio, Inc., |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 218
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 47
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
456,883
|
|
|
|
456,883
|
|
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Warrant, Polyera Corporation Acquisition Date 3/24/2015, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5] |
|
|
$ 269
|
|
|
|
|
|
Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
Investments owned acquisition date |
[42] |
|
|
Mar. 24, 2015
|
|
|
|
|
|
Shares (in shares) | shares |
|
|
|
150,036
|
|
|
|
150,036
|
|
Investment, Identifier [Axis]: nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |
|
|
|
|
|
|
|
|
|
Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
Investment cost |
[5],[15],[16] |
|
|
$ 381
|
|
|
|
|
|
Investments, at fair value: |
[15],[16] |
|
|
$ 378
|
|
|
|
|
|
Investments owned acquisition date |
[15],[16],[42] |
|
|
Jul. 21, 2022
|
|
|
|
|
|
|
|